Text,EXAMPLE_LABEL-tag,EXAMPLE_LABEL,OTHER_COMPOUND-tag,OTHER_COMPOUND,REACTION_PRODUCT-tag,REACTION_PRODUCT,REAGENT_CATALYST-tag,REAGENT_CATALYST,SOLVENT-tag,SOLVENT,STARTING_MATERIAL-tag,STARTING_MATERIAL,TEMPERATURE-tag,TEMPERATURE,STEP-tag,STEP,TIME-tag,TIME,YIELD_OTHER-tag,YIELD_OTHER,YIELD_PERCENT-tag,YIELD_PERCENT
"Step 5. 4-Bromo-3-fluoro-5-methylbenzaldehyde To a solution of 2-bromo-1-fluoro-3-methyl-5-vinylbenzene (5.46 g, 25.4 mmol) in acetone (46 mL) and water (4.6 mL) was sequentially added sodium periodate (21.7 g, 102 mmol) and a 4% aqueous solution of osmium tetroxide (8.07 mL, 1.27 mmol). The reaction was stirred at r.t. for 2 h. The reaction mixture was then filtered over a pad of celite, diluted with water, and extracted with ethyl acetate. The combined organic phases were washed with brine, dried over magnesium sulfate, and concentrated under reduced pressure. The crude product was purified by Biotage Isolera™ (3.22 g, 58%).","1,2",5,"67,69,76,77,60,61,63,64,79,81",ethyl acetate brine celite water magnesium sulfate,"88,89,2,3",product 4-Bromo-3-fluoro-5-methylbenzaldehyde,"35,37,23,25",osmium tetroxide sodium periodate,"32,33,17,18,13,14",aqueous water acetone,"7,8",2-bromo-1-fluoro-3-methyl-5-vinylbenzene,"46,47",r.t.,"90,91,44,45,22,23,74,75,61,62,55,56,65,66,77,78",purified stirred added washed diluted filtered extracted dried,"48,50",2 h,"94,96",3.22 g,"96,97",58%
"Intermediate 10 3-(bromomethyl)-5-(tert-butyl)-2-methoxypyridine Intermediate 10A (5-bromo-2-methoxypyridin-3-yl)methanol 5-Bromo-2-methoxynicotinaldehyde (2 g, 9.26 mmol) was suspended in methanol (40 mL) and cooled to 0° C. Sodium borohydride (0.350 g, 9.26 mmol) was added, causing bubbling. The reaction mixture was stirred at 0° C. for 15 minutes, the flask was removed from the ice bath, and the mixture was allowed to stir at room temperature for 2 hours. The reaction mixture was concentrated, and the crude material was taken up in methyl tert-butyl ether and saturated aqueous sodium bicarbonate. The phases were separated, and the organic layer was dried over Na2SO4, filtered and concentrated to afford the title compound (1.876 g, 8.60 mmol, 93% yield).","4,5,1,2",10A 10,"83,85,2,3,82,83,96,97,77,80",sodium bicarbonate 3-(bromomethyl)-5-(tert-butyl)-2-methoxypyridine aqueous Na2SO4 methyl tert-butyl ether,"103,105,5,6",title compound (5-bromo-2-methoxypyridin-3-yl)methanol,"14,15,22,24",methanol Sodium borohydride,,,"6,7",5-Bromo-2-methoxynicotinaldehyde,"59,61,20,22,38,40",room temperature 0° C 0° C,"29,30,12,13,36,37,18,19,101,102,57,58,74,75,94,95",added suspended stirred cooled afford stir taken dried,"41,43,62,64",15 minutes 2 hours,"107,109,105,107",8.60 mmol 1.876 g,"109,110",93%
"Example 31 4-{[(6-Bromo-2-phenyl-3-propylquinolin-4-yl)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylic acid 98 mg (0.18 mmol) of the compound from Example 72A were dissolved in 3.2 ml of a THF/methanol mixture (5:1), 0.91 ml (0.91 mmol) of a 1 M lithium hydroxide solution was added and the mixture was stirred at 50° C. for 2 h. After cooling to RT, the mixture was adjusted to pH 1-2 by addition of 4 M hydrochloric acid and purified by preparative HPLC (Method 2). This gave 53 mg (95% of theory, purity 98%) of the title compound","1,2",31,"64,66",hydrochloric acid,"2,4,84,86",4-{[(6-Bromo-2-phenyl-3-propylquinolin-4-yl)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylic acid title compound,"32,34",lithium hydroxide,"21,22",methanol THF,"10,14",compound from Example 72A,"43,45,51,52",50° C RT,"74,75,15,16,36,37,41,42,49,50,60,61",gave dissolved added stirred cooling addition,"46,48",2 h,"75,77",53 mg,"77,78",95%
"Example 64 4-(6-Fluoro-1H-indol-3-yl)-N-[(1R,5S)-3-oxabicyclo[3.1.0]hexan-6-yl]benzamide This compound was prepared from Intermediate 3 and (1R,5S)-3-oxabicyclo[3.1.0]-hexan-6-amine according to the procedure described in Example 1. Purification was performed using preparative HPLC to afford the title compound (15.2 mg, 41%). Data: LCMS (B) Rt: 10.314 min; m/z 337.1 (M+H)+.","1,2",64,,,"4,5,2,3,29,31","compound 4-(6-Fluoro-1H-indol-3-yl)-N-[(1R,5S)-3-oxabicyclo[3.1.0]hexan-6-yl]benzamide title compound",,,,,"9,10,11,12","3 (1R,5S)-3-oxabicyclo[3.1.0]-hexan-6-amine",,,"6,7,27,28",prepared afford,,,"31,33",15.2 mg,"33,34",41%
"Example 64 4-{[(6-Iodo-3-methyl-2-phenylquinolin-4-yl)carbonyl]amino}-2-oxabicyclo [2.2.2]octane-1-carboxylic acid 0.8 ml (0.8 mmol) of 1 M aqueous sodium hydroxide solution were added to a solution of 98 mg (0.14 mmol) of the compound from Example 112A in a mixture of 4.3 ml of THF and 0.9 ml of methanol, and the mixture was stirred at RT for 2 h. 2 ml of 10% strength aqueous citric acid solution were then added, and the mixture was allowed to stand at RT overnight. The mixture was then, without further work-up, pre-purified directly by preparative HPLC (Method 3). The pre-purified product was then purified once more by preparative HPLC (column: Kinetix C18, 5 μm, 100×30 mm; mobile phase: acetonitrile/water gradient]. This gave 37 mg (49% of theory, purity 98%) of the title compound","1,2",64,"61,63,60,61,111,112",citric acid water aqueous acetonitrile,"2,5,124,126",4-{[(6-Iodo-3-methyl-2-phenylquinolin-4-yl)carbonyl]amino}-2-oxabicyclo [2.2.2]octane-1-carboxylic acid title compound,"13,15,12,13",sodium hydroxide aqueous,"39,40,44,45",THF methanol,"28,32",compound from Example 112A,"51,52,75,76",RT RT,"114,115,49,50,17,18,66,67,96,97,73,74",gave stirred added added purified stand,"53,55",2 h,"115,117",37 mg,"117,118",49%
"Example 116 2-Chloro-N-[2-[(3R,4R)-3,4-dihydroxypyrrolidin-1-yl]ethyl]-4-(6-fluoro-1H-indol-3-yl)benzamide This compound was prepared from Intermediate 6 and (3R,4R)-1-(2-aminoethyl)pyrrolidine-3,4-diol dihydrochloride according to the procedure described in Example 1. Purification was performed using preparative HPLC to afford the title compound (6.7 mg, 19%). Data: LCMS (B) Rt: 7.511 min; m/z 418.1 (M+H)+.","1,2",116,,,"2,3,30,32","2-Chloro-N-[2-[(3R,4R)-3,4-dihydroxypyrrolidin-1-yl]ethyl]-4-(6-fluoro-1H-indol-3-yl)benzamide title compound",,,,,"11,13,8,10","(3R,4R)-1-(2-aminoethyl)pyrrolidine-3,4-diol dihydrochloride Intermediate 6",,,"6,7,28,29",prepared afford,,,"32,34",6.7 mg,"34,35",19%
"Exemplary Scheme: 7-Bromo-4-(pyridin-2-yl)-3,4-dihydro-2H-benzo[b] [1,4]oxazine (1) 7-bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine (200 mg, 0.934 mmol, 1.00 eq) was dissolved in DMF (4.7 mL) and sodium hydride (74.8 mg, 1.87 mmol, 2.00 eq) was added. The reaction was stirred for 5 minutes at which point 2-fluoropyridine (181 mg, 1.87 mmol, 2.00 eq) was added and followed by heating in a microwave reactor at 150° C. for 20 minutes. The reaction was diluted with ethyl acetate and washed with water (2×). The aqueous layer was back extracted with ethyl acetate and the combined organics were dried (MgSO4), filtered and concentrated in vacuo. Purification by flash chromatography on silica gel using 0-20% hexanes/ethyl acetate afforded 140 mg (51%) of the title compound as a brown oil.",,,"89,90,81,83,104,105,100,102,72,73,67,69",MgSO4 ethyl acetate hexanes silica gel water ethyl acetate ethyl acetate,"2,4,112,114,4,5","7-Bromo-4-(pyridin-2-yl)-3,4-dihydro-2H-benzo[b] [1,4]oxazine title compound 1","19,21",sodium hydride,"15,16",DMF,"39,40,5,6","2-fluoropyridine 7-bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine","57,59",150° C,"106,107,32,33,28,29,51,52,47,48,13,14,95,96,70,71,88,89,65,66,79,80",afforded stirred added heating added dissolved Purification washed dried diluted extracted,"60,62,34,36",20 minutes 5 minutes,"107,109",140 mg,"109,110",51%
"Step C: 2-Cyclopropyl-6-(trifluoromethyl)pyrazolo[1,5-a]pyridine. A solution of 2-(2-cyclopropylethynyl)-5-(trifluoromethyl)pyridin-1-ium-1-amine 2,4,6-trimethylbenzenesulfonate (1.46 g, 3.42 mmol) in AcOH (14 mL) was stirred at 80° C. for 16 h. After cooling to rt, ice water (20 mL) was added and the pH was adjusted to ˜9 by the addition of 2 M NaOH. The aqueous layer was extracted with DCM (2×70 mL). The combined organic layers were washed with water (1×50 mL), dried over MgSO4, filtered and evaporated. The residue was purified by flash column chromatography (SiO2; 100% diisopropyl ether) to give the title compound (727 mg, 93%) as a light brown liquid.","1,2",C,"81,82,29,30,54,55,64,65,47,48,69,70,83,85",SiO2 water DCM water NaOH MgSO4 diisopropyl ether,"88,90,2,3","title compound 2-Cyclopropyl-6-(trifluoromethyl)pyrazolo[1,5-a]pyridine","13,14",AcOH,,,"6,8","2-(2-cyclopropylethynyl)-5-(trifluoromethyl)pyridin-1-ium-1-amine 2,4,6-trimethylbenzenesulfonate","19,21,27,28",80° C rt,"17,18,86,87,33,34,62,63,43,44,76,77,25,26,52,53,67,68",stirred give added washed addition purified cooling extracted dried,"22,24",16 h,"90,92",727 mg,"92,93",93%
"(Example 3) Synthesis of 3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)-1-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)propan-1-one: Sodium borohydride (0.0360 g, 0.957 mmol) was added to a solution of 1-(1-methyl-1H-imidazol-2-yl)-3-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)propan-1,3 -dione (0.290 g, 0.870 mmol) in methanol (4.4 mL) at room temperature and the reaction liquid was stirred at the same temperature for 3 hours. A saturated aqueous solution of sodium hydrogencarbonate was added to the reaction liquid and the reaction liquid was concentrated under reduced pressure. Distilled water was added to the residue and the reaction liquid was extracted with chloroform. The organic layer was washed with a 10% aqueous solution of sodium chloride and then dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure. The residue was purified by flash column chromatography (NH silica gel, chloroform/methanol) to obtain 3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)-1-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)propan-1-one (0.140 g, 0.417 mmol, 48%) (hereinafter referred to as the compound of Example 3) as a colorless oil.","1,2",3,"120,121,98,100,48,50,118,120,45,46,66,67,88,89,91,93,79,80",chloroform methanol sodium sulfate sodium hydrogencarbonate silica gel aqueous water aqueous sodium chloride chloroform,"4,5,123,124",3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)-1-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)propan-1-one 3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)-1-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)propan-1-one,"5,7,24,25",Sodium borohydride methanol,,,"17,19","1-(1-methyl-1H-imidazol-2-yl)-3-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)propan-1,3 -dione","28,30",room temperature,"122,123,35,36,12,13,84,85,77,78,112,113,68,69,51,52,95,96",obtain stirred added washed extracted purified added added dried,"41,43",3 hours,"126,128,124,126",0.417 mmol 0.140 g,"128,129",48%
"Step B: 5-Bromo-7-methoxyindolin-2-one. To a solution of 5-bromo-7-methoxyindoline-2,3-dione (670 mg, 2.6 mmol) in n-butanol (8 mL) was added hydrazine hydrate (153 μL, 3.1 mmol). The mixture was heated at 80° C. for 3 h. The temperature was maintained at 80° C. and triethylamine (548 μL, 3.9 mmol) was added. The temperature was then increased to 100° C. and the reaction was stirred at reflux for 24 h. The reaction was cooled to rt and the mixture was concentrated in vacuo. The crude residue was suspended in hexanes and the resulting mixture was filtered. The solids were washed with hexanes to afford the title compound (297 mg, 46%).","1,2",B,"86,87,98,99",hexanes hexanes,"2,3,102,104",5-Bromo-7-methoxyindolin-2-one title compound,"42,43,18,20",triethylamine hydrazine hydrate,"13,14",n-butanol,"7,8","5-bromo-7-methoxyindoline-2,3-dione","63,64,55,57,29,31,72,73,39,41",reflux 100° C 80° C rt 80° C,"17,18,61,62,53,54,48,49,27,28,100,101,37,38,70,71,84,85,96,97",added stirred increased added heated afford maintained cooled suspended washed,"32,34,65,67",3 h 24 h,"104,106",297 mg,"106,107",46%
"d. PREPARATION OF (S)-N-((2R,6S,8AS,14AS,20S,23AS)-2,6-DIMETHYL-5,8,14,19,23-PENTAOXOOCTADECADYDRO-1H,5H,14H,19H-PYRIDO[2,1-I]DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-20-YL)-2-(3-(4-ETHYLPHENYL)UREIDO)-3-PHENYLPROPANAMIDE (COMPOUND 4) Compound 4 was synthesized from compound C (78 mg, 0.118 mmol), 1-ethyl-4-isocyanatobenzene (20.83 mg, 0.141 mmol) and triethylamine (77.4 μL, 0.566 mmol) following the general synthesis method as described herein above. Compound 4 was provided as a white solid (14.9 mg, 16%);","0,1",d,,,"38,39,7,8,5,6,3,4","4 4 4 (S)-N-((2R,6S,8AS,14AS,20S,23AS)-2,6-DIMETHYL-5,8,14,19,23-PENTAOXOOCTADECADYDRO-1H,5H,14H,19H-PYRIDO[2,1-I]DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-20-YL)-2-(3-(4-ETHYLPHENYL)UREIDO)-3-PHENYLPROPANAMIDE","23,24",triethylamine,,,"12,13,17,18",C 1-ethyl-4-isocyanatobenzene,,,"40,41,9,10",provided synthesized,,,"45,47",14.9 mg,"47,48",16%
"eee. PREPARATION OF (2S)-3-PHENYL-2-(3-(4-(TRIFLUOROMETHOXY)PHENYL)UREIDO)-N-((6S,9S,11AS,17S)-6,9,10-TRIMETHYL-5,8,11,16,20-PENTAOXOHEXADECAHYDRO-1H,5H,16H-DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-17-YL)PROPANAMIDE (COMPOUND 213) Compound 213 was synthesized from macrocycle C (80 mg, 0.129 mmol), 1-isocyanato-4-(trifluoromethoxy)benzene (31.4 mg, 0.155 mmol) and triethylamine (85 μL, 0.618 mmol) following general synthesis pathway as a white-off solid (41.2 mg, 40.6%);","0,1",eee,,,"7,8,3,4,5,6","213 (2S)-3-PHENYL-2-(3-(4-(TRIFLUOROMETHOXY)PHENYL)UREIDO)-N-((6S,9S,11AS,17S)-6,9,10-TRIMETHYL-5,8,11,16,20-PENTAOXOHEXADECAHYDRO-1H,5H,16H-DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-17-YL)PROPANAMIDE 213","23,24",triethylamine,,,"17,18,11,13",1-isocyanato-4-(trifluoromethoxy)benzene macrocycle C,,,"9,10",synthesized,,,"36,38",41.2 mg,"38,39",40.6%
"A solution of Compound T1A (a side product from preparation of Compound T1, 1.47 g, 2.0 mmol) was treated with 3-fluorophenol (270 mg, 2.4 mmol) and K2CO3 (560 mg, 4 mmol), and the mixture was heated under nitrogen at 110° C. for 9 h. Work-up with ice cold water and extraction with DCM afforded a crude product that was purified by column chromatography using hexane/ethyl acetate (6:1) to give pure Compound T2, 3-(3-fluorophenoxy)-2,2-bis((3-(trifluoromethyl)phenoxy)methyl)propyl 4-methylbenzenesulfonate, (0.78 g, 58% yield) as colorless oil.",,,"48,49,64,65,52,53,12,13,37,38",water hexane DCM T1 nitrogen ethyl acetate,"71,72,72,74","T2 3-(3-fluorophenoxy)-2,2-bis((3-(trifluoromethyl)phenoxy)methyl)propyl 4-methylbenzenesulfonate","26,27",K2CO3,,,"20,21,4,5",3-fluorophenol T1A,"39,41",110° C,"35,36,68,69,18,19,59,60,50,51,44,45",heated give treated purified extraction Work-up,"42,44",9 h,"74,76",0.78 g,"76,77",58%
"Step 4 (E)-3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-6-(6-(1-met hyl-1H-pyrazol-4-yl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylic acid (E)-methyl 3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-6-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinolin-1-yl )phenyl)acrylate 61e (25 mg, 0.0435 mmol) was dissolved in the 4 mL of a mxiture of tetrahydrofuran and methanol (V/V=3:1), then 0.22 mL of 1 M lithium hydroxide solution was added. The reaction was stirred for 2 hours at room temperature. 10% citric acid solution was added to adjust the pH to 3-4. 20 mL of ethyl acetate was added, then the reaction mixture was dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by thin layer chromatography with elution system A to obtain the title compound (E)-3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-6-(6-(1-met hyl-1H-pyrazol-4-yl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylic acid 61 (10 mg, yield 41%) as a yellow solid.","1,2",4,"63,65,49,51,75,77",ethyl acetate citric acid sodium sulfate,"2,5,105,108,108,109,103,105","(E)-3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-6-(6-(1-met hyl-1H-pyrazol-4-yl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylic acid (E)-3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-6-(6-(1-met hyl-1H-pyrazol-4-yl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylic acid 61 title compound","33,35",lithium hydroxide,"25,26,23,24",methanol tetrahydrofuran,"5,8,8,9","(E)-methyl 3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-6-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinolin-1-yl )phenyl)acrylate 61e","46,48",room temperature,"41,42,101,102,14,15,37,38,53,54,72,73,66,67",stirred obtain dissolved added added dried added,"43,45",2 hours,"109,111",10 mg,"112,113",41%
"Synthesis Example 1-2: Synthesis of [Intermediate 1-b] In a round-bottom flask, Intermediate 1-a (33.5 g, 110 mmol) was added to tetrahydrofuran (150 ml) and cooled to −10° C. before slow addition of drops of 3 M methyl magnesium bromide (85 ml, 254 mmol) thereto. After the temperature was elevated to 40° C., stirring was performed for 4 hours. Then, the temperature was reduced to −10° C. and drops of 2 N HCl (70 ml) were slowly added. Subsequently, an aqueous ammonium chloride solution (70 ml) was added, followed by elevation to room temperature. After completion of the reaction, the reaction mixture was washed with water, concentrated in a vacuum, and separated by column chromatography to afford [Intermediate 1-b] (27 g): yield 80%","2,3",1-2,,,"116,118,5,7",Intermediate 1-b Intermediate 1-b,"80,82,71,72",ammonium chloride HCl,"79,80,104,105,20,21",aqueous water tetrahydrofuran,"36,39,11,13",methyl magnesium bromide Intermediate 1-a,"64,66,91,93,26,28,50,52",−10° C room temperature −10° C 40° C,"115,116,62,63,30,31,52,53,48,49,86,87,24,25,18,19,76,77,102,103,86,87,89,90",afford reduced addition stirring elevated added cooled added added washed added elevation,"56,58",4 hours,"118,120",27 g,"121,122",80%
"[Example 30] Synthesis of compound I-1118 Step 1 The compound 51 (900 mg, 5.35 mmol) was dissolved in acetonitrile (10 mL). Silver(II) fluoride (2.34 g, 16.06 mmol) was added to the solution. The mixture was vigorously stirred at room temperature for 1.5 hours. The reaction mixture was warmed to 50°C, and vigorously stirred for 3 hours. Silver(II) fluoride (1.56 g, 10.70 mmol) was further added to the mixture. The mixture was vigorously stirred at 50°C for 2.5 hours. Silver(II) fluoride (0.78 g, 5.35 mmol) was further added to the mixture. The mixture was vigorously stirred at 50°C for 2 hours. Under ice cooling, the saturated aqueous solution of sodium hydrogen carbonate was added to the reaction mixture. Insoluble materials were filtered off. The filtrate was extracted with ethyl acetate. The organic layer was washed by water and brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure. The obtained residue was purified by silica-gel column chromatography (ethyl acetate/hexane) to give the compound 52 (374 mg, yield 38%).","7,8,1,2",1 30,"105,106,142,144,5,6,127,129,160,162,135,136,137,138,157,158,108,111",aqueous sodium sulfate I-1118 ethyl acetate ethyl acetate water brine silica-gel hexane sodium hydrogen carbonate,"166,167",52,"21,23,56,58,78,80",Silver(II) fluoride Silver(II) fluoride Silver(II) fluoride,"18,19",acetonitrile,"10,11",51,"49,50,74,75,96,97,38,40",50°C 50°C 50°C room temperature,"52,53,72,73,94,95,36,37,163,164,47,48,16,17,28,29,86,87,64,65,125,126,139,140,133,134,155,156,112,113",stirred stirred stirred stirred give warmed dissolved added added added extracted dried washed purified added,"98,100,54,56,76,78,41,43",2 hours 3 hours 2.5 hours 1.5 hours,"167,169",374 mg,"170,171",38%
"The fifth step To a solution of Compound 18 (1.3g, 3.65mmol) in methanol (13mL) was added potassium carbonate (1.5g, 11mmol), and the mixture was stirred for 5 hours at 60 °C. After the solvent of the reaction mixture was concentrated, 2 mol / L hydrochloric acid was added thereto, followed by extraction with ethyl acetate, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was dissolved in methanol (6 mL) and toluene (6mL), and 2mol / L trimethylsilyldiazomethane - hexane solution (1.8 mL, 3.7 mL) was added thereto. The mixture was stirred for 1 hour at room temperature, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform-methanol) to yield Compound 19 (800g, yield 70%).","1,2",fifth,"58,60,116,117,53,55,44,46,112,114",sodium sulfate methanol chloroform ethyl acetate hydrochloric acid silica gel,"120,121",19,"16,18,81,82",potassium carbonate trimethylsilyldiazomethane,"75,76,71,72,83,84,12,13",toluene methanol hexane methanol,"8,9",18,"100,102,29,31",room temperature 60 °C,"95,96,69,70,15,16,24,25,118,119,90,91,55,56,47,48,110,111,51,52",stirred dissolved added stirred yield added dried added purified extraction,"26,28,97,99",5 hours 1 hour,"121,122",800g,"123,124",70%
"Intermediate 11 6-(2-Chloroacetyl)-1-methyl-1,2,3,4-tetrahydroquinolin-2-one (0.50 g, 2.10 mmol) and thiourea (0.17 g, 2.21 mmol) suspended in anhydrous ethanol (4 ml) in a sealed tube under argon atmosphere. The sealed tube was microwaved at 120° C. for 35 min. The mixture was diluted with tetrahydrofuran (100 mL), neutralized with triethylamine (2 mL), and extracted with ethyl acetate (2×200 mL) followed by washing with saturated sodium bicarbonate (2×100 mL). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by precipitating in dichloromethane and filtration to give 6-(2-aminothiazol-4-yl)-1-methyl-3,4-dihydroquinolin-2(1H)-one (0.50 g, 92%) as a vanilla solid.","1,2",11,"47,48,24,25,86,87,74,75,42,43,53,55,62,64",triethylamine argon dichloromethane Na2SO4 tetrahydrofuran ethyl acetate sodium bicarbonate,"91,92","6-(2-aminothiazol-4-yl)-1-methyl-3,4-dihydroquinolin-2(1H)-one",,,"16,17",ethanol,"8,9,2,3","thiourea 6-(2-Chloroacetyl)-1-methyl-1,2,3,4-tetrahydroquinolin-2-one","32,34",120° C,"30,31,90,91,13,14,45,46,51,52,40,41,59,60,71,72,82,83",microwaved give suspended neutralized extracted diluted washing dried purified,"35,37",35 min,"92,94",0.50 g,"94,95",92%
"Example 4 (E)-3-(3,5-difluoro-4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,2,3,4-tetr ahydrobenzofuro[2,3-c]pyridin-1-yl)phenyl)acrylic acid Step 1 1-(benzofuran-3-yl)propan-2-amine 1-(benzofuran-3-yl)propan-2-one 4a (1 g, 5.74 mmol, prepared by a well-known method disclosed in ""Khimiya Geterotsiklicheskikh Soedinenii, 1987, (7), 889-93""), ammonium acetate (4.42 g, 57.4 mmol) and sodium acetate (470 mg, 5.74 mmol) were dissolved in 30 mL of methanol. Sodium cyanoborohydride (540 mg, 8.6 mmol) was added, and 10 drops of acetic acid were added dropwise. After the resulting mixture was stirred for 12 hours at 25°C, the reaction was stopped. 1 N NaOH solution was added dropwise to adjust the pH to 7-8. The mixture was dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography with elution system A to obtain the title compound 1-(benzofuran-3-yl)propan-2-amine 4b (600 mg, yield 60%) as a brown liquid.","1,2,6,7",4 1,"2,5,114,116,98,100,81,82","(E)-3-(3,5-difluoro-4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,2,3,4-tetr ahydrobenzofuro[2,3-c]pyridin-1-yl)phenyl)acrylic acid silica gel sodium sulfate NaOH","7,8,128,129,127,128,125,127",1-(benzofuran-3-yl)propan-2-amine 4b 1-(benzofuran-3-yl)propan-2-amine title compound,"47,49,34,36,59,61,27,29",Sodium cyanoborohydride sodium acetate acetic acid ammonium acetate,"46,47",methanol,"9,10,8,9",4a 1-(benzofuran-3-yl)propan-2-one,"74,75",25°C,"123,124,62,63,69,70,54,55,41,42,112,113,95,96,84,85",obtain added stirred added dissolved purified dried added,"71,73",12 hours,"129,131",600 mg,"132,133",60%
"Step 1: (5-methylpyrimidin-2-yl)methanol To a solution of methyl 5-methylpyrimidine-2-carboxylate [Example 9, Step 2] (2.5 g, 16.4 mmol, 1.00 equiv) in methanol (40 mL) was added NaBH4 (1.87 g, 49.3 mmol, 3.00 equiv) at 0° C. The resulting solution was stirred for 3 h at 25° C. The reaction was then quenched by the addition of H2O (40 mL). The resulting mixture was concentrated under vacuum to remove MeOH. The resulting solution was extracted with ethyl acetate (3×50 mL). The organic layers were dried over anhydrous sodium sulfate and concentrated under vacuum to afford 1.3 g (63.9%) of (5-methylpyrimidin-2-yl)methanol as a yellow solid.","1,2",1,"55,56,67,68,85,87,74,76",H2O MeOH sodium sulfate ethyl acetate,"2,3,97,98",(5-methylpyrimidin-2-yl)methanol (5-methylpyrimidin-2-yl)methanol,"25,26",NaBH4,"20,21",methanol,"7,9",methyl 5-methylpyrimidine-2-carboxylate,"44,46,33,35",25° C 0° C,"24,25,39,40,92,93,72,73,50,51,66,67,53,54,82,83",added stirred afford extracted quenched remove addition dried,"41,43",3 h,"93,95",1.3 g,"95,96",63.9%
"Step 2 The compound 55 (2.42 g, 12.3 mmol) was dissolved in methanol (24.2 mL). Under ice cooling, NaOMe (28% MeOH solution, 2.37 g, 12.26 mmol) was slowly added to the solution. The mixture was stirred for 5 hours. Under ice cooling, 10% citric acid was added to the reaction mixture to render the reaction mixture acidic. The mixture was extracted with ethyl acetate. The organic layer was washed by brine, and dried over sodium sulfate. The solvent was evaporated under reduced pressure. The obtained residue was purified by silica-gel column chromatography (ethyl acetate-n-hexane) to give the compound 56 (1.41 g, yield 59%).","1,2",2,"89,90,70,71,43,45,62,64,92,94,74,76",silica-gel brine citric acid n-hexane ethyl acetate ethyl acetate sodium sulfate,"98,99",56,,,"12,13,20,21",methanol MeOH,"18,19,4,5",NaOMe 55,,,"28,29,35,36,10,11,95,96,68,69,72,73,46,47,87,88,60,61",added stirred dissolved give washed dried added purified extracted,"37,39",5 hours,"99,101",1.41 g,"102,103",59%
"Step 2: Preparation of (4-(3-hydroxyprop-1-ynyl)phenyl)(morpholino)methanone (4-(3-hydroxyprop-1-ynyl)phenyl)(morpholino)methanone was obtained (371 mg, yield 90%) by the same method as described in Step 3 of Example 1 using the (4-bromophenyl)(morpholino)methanone (455 mg, 1.68 mmol) obtained in Step 1 and propargyl alcohol (0.196 ml, 3.36 mmol).","1,2",2,,,"5,6,4,5",(4-(3-hydroxyprop-1-ynyl)phenyl)(morpholino)methanone (4-(3-hydroxyprop-1-ynyl)phenyl)(morpholino)methanone,,,,,"26,27,36,38",(4-bromophenyl)(morpholino)methanone propargyl alcohol,,,"7,8,24,25",obtained using,,,"8,10",371 mg,"11,12",90%
"Example 66 (2S,3S,4S,5S)-3-tert-butyl-4-{[(5-tert-butyl-2-methoxyphenyl)methyl]amino}-5-[2-(dimethylamino)pyridin-3-yl]-1-{[(propan-2-yl)oxy]carbonyl}pyrrolidine-2-carboxylic acid Example 66A (2S,3R,4S,5S)-2-ethyl 1-isopropyl 3-(tert-butyl)-5-(2-(dimethylamino)pyridin-3-yl)-4-nitropyrrolidine-1,2-dicarboxylate (2S,3R,4S,5S)-Ethyl 3-(tert-butyl)-5-(2-(dimethylamino)pyridin-3-yl)-4-nitropyrrolidine-2-carboxylate hydrochloride (Core 11, 1 g, 2.494 mmol) in CH2Cl2 (8.3 mL) was treated with triethylamine (1.1 mL, 7.89 mmol) and then isopropyl chloroformate (1 M solution in toluene) (4.6 mL, 4.60 mmol) at room temperature. The reaction was stirred at room temperature overnight. The volatiles were removed in vacuo, and the crude material was purified by silica gel chromatography, eluting with 5 to 80% ethyl acetate-heptanes. The title compound was obtained, 0.548 g (49% yield).","1,2,5,6",66 66A,"75,77,2,4,67,69","heptanes ethyl acetate (2S,3S,4S,5S)-3-tert-butyl-4-{[(5-tert-butyl-2-methoxyphenyl)methyl]amino}-5-[2-(dimethylamino)pyridin-3-yl]-1-{[(propan-2-yl)oxy]carbonyl}pyrrolidine-2-carboxylic acid silica gel","6,9,78,80","(2S,3R,4S,5S)-2-ethyl 1-isopropyl 3-(tert-butyl)-5-(2-(dimethylamino)pyridin-3-yl)-4-nitropyrrolidine-1,2-dicarboxylate title compound","25,26",triethylamine,"38,39,19,20",toluene CH2Cl2,"32,34,9,12,12,14","isopropyl chloroformate (2S,3R,4S,5S)-Ethyl 3-(tert-butyl)-5-(2-(dimethylamino)pyridin-3-yl)-4-nitropyrrolidine-2-carboxylate hydrochloride Core 11","51,53,44,46",room temperature room temperature,"49,50,81,82,23,24,65,66",stirred obtained treated purified,,,"82,84",0.548 g,"84,85",49%
"Under the protection of nitrogen, 4-iodo-1-methylimidazole (651.66 mg 3.13 mmol) and potassium carbonate (1 g, 7.23 mmol) were added to a mixed solution of compound 214D (1 g, 2.41 mmol) in N,N'-dimethylformamide (6 mL) and water (2 mL) under the protection of nitrogen, the reaction solution was displaced with nitrogen three times and reacted in microwaves at 110 °C for 30 minutes. The thin layer preparation chromatography showed that compound 214D had reacted completely. The reaction was quenched by addition of water (10 mL) and then extracted with ethyl acetate (20 mL * 3). The organic phase was washed with saturated NaCl solution (10 mL * 2), dried over anhydrous sodium sulfate and concentrated under reduced pressure to give the residue which was then purified by column chromatography to give compound 214E (pale yellow solid, 300 mg, the yield was 29.03%).",,,"88,90,110,112,49,50,101,102,4,5,81,82,70,71,42,43",ethyl acetate sodium sulfate nitrogen NaCl nitrogen water 214D nitrogen,"131,132",214E,"11,13",potassium carbonate,"35,36,31,32","water N,N'-dimethylformamide","25,26,5,6",214D 4-iodo-1-methylimidazole,"57,59",110 °C,"47,48,129,130,53,54,18,19,77,78,98,99,107,108,86,87,79,80",displaced give reacted added quenched washed dried extracted addition,"60,62",30 minutes,"135,137",300 mg,"140,141",29.03%
"Example 17 Synthesis of (S)-ethyl-3-phenyl-2((R)-(4-methylphenyl)sulfonylthiazine-3-aminoform yl)propionate (Compound 17) The product (1.65 g, yield: 69%) as a white solid was obtained in accordance with the steps in Example 5, by using 1.35 g (7 mmol) L-phenylalanine ethyl ester as Raw material 2. m.p.91-93°C . 1H-NMR (400MHz,CDCl3) δ: 7.69 (2H, d, J=8.42Hz), 7.30 (5H, m), 7.16 (2H, d, J=8.41Hz), 6.88 (1H, d, J=8.63Hz), 4.77 (2H, m), 4.22 (2H, m), 3.89 (1H, m), 3.29 (1H, m), 3.08 (2H, m), 2.69-0.91 (10H, m). MS-EI (m/z): 477.1512 [M+H]+.","1,2",17,,CDCl3,"7,8,4,6,9,10",17 (S)-ethyl-3-phenyl-2((R)-(4-methylphenyl)sulfonylthiazine-3-aminoform yl)propionate product,,,,,"34,37",L-phenylalanine ethyl ester,,,"29,30,19,20",using obtained,,,"10,12",1.65 g,"13,14",69%
"Second Step: Synthesis of Compound (T-4) Under a nitrogen atmosphere, compound (T-3) (50.0 g), potassium carbonate (72.4 g) and DMF (350 mL) were put in a reaction vessel, and the resulting mixture was stirred at 80° C. for 30 minutes. Thereto, 1-bromopentane (39.0 mL) was added dropwise, and the resulting mixture was further stirred at 80° C. for 2 hours. The resulting reaction mixture was poured into ice water, and an aqueous layer was subjected to extraction with toluene. Combined organic layers were washed with water, and dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (heptane) to obtain compound (T-4) (68.3 g, yield: 99%).","0,1",Second,"105,107,90,92,108,109,8,9,85,86,68,69,78,79",silica gel magnesium sulfate heptane nitrogen water water toluene,"112,113,5,6",T-4 T-4,"14,16",potassium carbonate,"19,20",DMF,"41,42,11,12",1-bromopentane T-3,"55,57,35,37",80° C 80° C,"33,34,110,111,53,54,45,46,23,24,87,88,65,66,103,104,76,77,83,84",stirred obtain stirred added put dried poured purified extraction washed,"58,60,38,40",2 hours 30 minutes,"113,115",68.3 g,"116,117",99%
"Example 1: Preparation of (2S,5R)-2-(7-azaspiro[3.5]nonan-2-ylcarbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate (Compound 1) (1) Preparation of tert-butyl 2-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-7-azaspiro[3.5]non ane-7-carboxylate (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid (767 mg, 2.8 mmol) was dissolved in dichloromethane (35 mL), tert-butyl 2-amino-7-azaspiro[3.5]nonane-7-carboxylate (1.0 g, 4.2 mmol), 1-hydroxylbenzotriazole (567 mg, 4.2 mmol), triethylamine (848 mg, 8.4 mmol) and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (806 mg, 4.2 mmol) were serially added, stirred at 25°C for 16 h. Water (200 mL) and dichloromethane (200 mL) were added, the phases were separated, the organic phase was washed with saturated brine (200 mL), dried over anhydrous sodium sulfate, concentrated, and the crude product was purified by silica gel column chromatography (petroleum ether : ethyl acetate =1:1) to obtain the title compound (1.0 g, yield 71.7 %).","1,2,9,10",1 1,"4,7,102,104,95,97,8,9,99,101,59,60,79,80,85,87,63,64","(2S,5R)-2-(7-azaspiro[3.5]nonan-2-ylcarbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate ethyl acetate silica gel 1 petroleum ether Water brine sodium sulfate dichloromethane","12,15,108,110","tert-butyl 2-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-7-azaspiro[3.5]non ane-7-carboxylate title compound","44,46,33,34,38,39",1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride 1-hydroxylbenzotriazole triethylamine,"24,25",dichloromethane,"27,29,15,17","tert-butyl 2-amino-7-azaspiro[3.5]nonane-7-carboxylate (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid","55,56",25°C,"53,54,106,107,22,23,52,53,82,83,93,94,67,68,76,77",stirred obtain dissolved added dried purified added washed,"57,59",16 h,"110,112",1.0 g,"113,115",71.7 %
"Example 72A Methyl 4-{[(6-bromo-2-phenyl-3-propylquinolin-4-yl)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylate 150 mg (0.40 mmol) of the compound from Example 38A were dissolved in 1.4 ml (19.8 mmol) of thionyl chloride. The reaction mixture was stirred at RT for 2.5 h and then at 60° C. overnight. The reaction mixture was then concentrated under reduced pressure and the residue, after drying under reduced pressure, was taken up in 1 ml of THF. The suspension present was added slowly to a mixture of 0.27 ml (1.54 mmol) of DIPEA and 102 mg (0.46 mmol) of methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride in 1.4 ml of THF, and the reaction mixture was stirred at RT overnight. After addition of ethyl acetate and water, the phases were separated and the aqueous phase was extracted three times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered and concentrated and the residue was purified by preparative HPLC (Method 2). This gave 98 mg (47% of theory, purity 99%) of the title compound","1,2",72A,"110,111,124,126,133,135,107,109",water ethyl acetate sodium sulfate ethyl acetate,"2,4,159,161",Methyl 4-{[(6-bromo-2-phenyl-3-propylquinolin-4-yl)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylate title compound,"80,81,22,24",DIPEA thionyl chloride,"94,95,64,65",THF THF,"10,14,87,90",compound from Example 38A methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride,"30,31,37,39,102,103",RT 60° C RT,"69,70,28,29,58,59,149,150,100,101,15,16,120,121,105,106,131,132",added stirred taken gave stirred dissolved extracted addition dried,"32,34",2.5 h,"150,152",98 mg,"152,153",47%
"Synthesis Example 10: Production of Aromatic Amine Derivative (PH10) In the same manner as in Synthesis Example 8 except for using 2.11 g of the intermediate 6 in place of the intermediate 21 and using 1.00 g of 4-bromobiphenyl in place of bromobenzene, 1.49 g (yield: 56%) of a white solid was obtained, which was identified as the following compound (PH10) by FD-MS analysis: m/z=740 (theoretical value: 740 for C54H32N2O2).","2,3",10,"42,43,31,33",bromobenzene intermediate 21,"50,51,5,8,60,61,8,9",solid Aromatic Amine Derivative PH10 PH10,,,,,"25,27,38,39",intermediate 6 4-bromobiphenyl,,,"20,21,52,53,34,35",using obtained using,,,"43,45",1.49 g,"46,47",56%
"Synthesis Example 16: Synthesis of Compound 59 Compound 59 (5.11 g, a yield of 70%) was obtained according to the same method as Synthesis Example 1 except for using “benzo-2-chloro-4-phenyl-thieno[3,2-d]pyrimidine” (synthesized according to Synthesis Example 1 of Korean Patent Laid-Open Publication KR 2015-0083786A) instead of the bromometabiphenyl in Step 2 of Synthesis Example 1. calcd. C52H30N4S: C, 84.07; H, 4.07; N, 7.54; S, 4.32; found: C, 84.07; H, 4.07; N, 7.54; S, 4.32.","2,3",16,"46,47",bromometabiphenyl,"8,9,6,7",59 59,,,,,"29,30","“benzo-2-chloro-4-phenyl-thieno[3,2-d]pyrimidine”",,,"16,17",obtained,,,"9,11",5.11 g,"14,15",70%
"Step 3 To Compound 3i (15.34g, 81mmol) were added toluene (30mL), sodium bromide (0.83 g, 8.1mmol) and 85 (w/w)% sulfuric acid (26.1mL, 403mmol), and the mixture was stirre d for 1 hour at 70°C. In addition, 85 (w/w)% sulfuric acid (26.1mL, 403mmol) was add ed thereto, and the mixture was stirred for 2 hours at 70°C. After the reaction mixture was cooled in an ice bath, methanol (150 mL) was added thereto, and the mixture wa s refluxed for 2 hours. The reaction mixture was cooled in an ice bath, and extracted with ethyl acetate after addition of water (150mL). The organic layer was successively washed with saturated aqueous sodium hydrocarbonate solution, water, and saturated br ine, dried over anhydrous magnesium sulfate, and the solvent was concentrated under r educed pressure. The obtained residue was solidified with ethyl acetate - hexane to yi eld Compound 4i (11.45g, yield 64%) as an orange solid.","1,2",3,"93,95,115,117,120,122,112,113,108,109,98,99,137,139,109,111,140,141",ethyl acetate br ine magnesium sulfate water aqueous water ethyl acetate sodium hydrocarbonate hexane,"145,146",4i,"11,13,19,21,38,40",sodium bromide sulfuric acid sulfuric acid,"9,10",toluene,"4,5,66,67",3i methanol,"55,56,33,34,77,78",70°C 70°C refluxed,"43,45,8,9,70,71,142,144,50,51,27,29,105,106,117,118,96,97,91,92,135,136",add ed added added yi eld stirred stirre d washed dried addition extracted solidified,"52,54,79,81,30,32",2 hours 2 hours 1 hour,"146,147",11.45g,"148,149",64%
"Example 51A 5-Methyl-2,4-dioxo-3-(2,2,2-trifluoroethyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carbaldehyde 14.33 ml (153.76 mmol) of phosphorus oxychloride were added cautiously, while cooling with an ice bath, to a solution of 4.67 g (15.37 mmol) of the compound from Ex. 45A in 143 ml of DMF. The mixture was stirred at 50° C. for 5 h. Then the reaction mixture was concentrated very substantially on a rotary evaporator. The remaining residue was added to ice-water and stirred. The precipitated product was filtered off with suction, washed to neutrality with water and dried. 4.52 g (99% of theory) of the title compound were obtained.","1,2",51A,"81,82",water water,"91,93,2,3","title compound 5-Methyl-2,4-dioxo-3-(2,2,2-trifluoroethyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carbaldehyde","8,10",phosphorus oxychloride,,,"29,33,37,38",compound from Ex. 45A DMF,"43,45",50° C,"11,12,41,42,94,95,77,78,64,65",added stirred obtained washed added,"46,48",5 h,"84,86",4.52 g,"86,87",99%
"Step B: 2-((S)-2-((S)-1-((S)-2-Ammonio-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamido)-2-phenylethyl)pyridinium dichloride tert-Butyl (S)-3-(4-hydroxyphenyl)-1-oxo-1-((S)-2-((S)-1-phenyl-2-(pyridin-2-yl)ethylcarbamoyl)pyrrolidin-1-yl)propan-2-ylcarbamate (180 mg, 0.32 mmol) was dissolved in a 4 M HCl solution in 1,4-dioxane (3.2 mL, 12.89 mmol). The reaction was stirred at rt for 18 hours. The volatiles were removed under vacuum and the product was triturated in MTBE. The solid was recovered by filtration on a Büchner funnel, washed with MTBE and dried under vacuum. The solid was dissolved in water and freeze dried to afford 150 mg (88%) of the title compound","1,2",B,"58,59,45,46,68,69",MTBE MTBE water,"79,81,2,4",title compound 2-((S)-2-((S)-1-((S)-2-Ammonio-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamido)-2-phenylethyl)pyridinium dichloride,"16,17",HCl,"19,20","1,4-dioxane","4,6",tert-Butyl (S)-3-(4-hydroxyphenyl)-1-oxo-1-((S)-2-((S)-1-phenyl-2-(pyridin-2-yl)ethylcarbamoyl)pyrrolidin-1-yl)propan-2-ylcarbamate,"29,30",rt,"27,28,73,74,11,12,43,44,56,57,66,67",stirred afford dissolved triturated washed dissolved,"31,33",18 hours,"74,76",150 mg,"76,77",88%
"Representative Synthetic Example 2 Step 2-1: 3-(5-Amino-2-methylphenyl)-7-chloro-1-methyl-3,4-dihydropyrimido[4,5-d] pyrimidin-2(1H)-one 7-Chloro-1-methyl-3-(2-methyl-5-nitrophenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one (1.4 g, 4.2 mmol) and ammonium chloride (4.5 g, 84 mmol) were added to a mixed solution of THF/methanol/water (4:2:1, 17.5 mL), then iron powder (2.3 g, 42 mmol) was added, and stirred at 80° C. for 2 hours. When the reaction was completed, the reaction mixture was cooled to room temperature and filtered using a celite pad. The filtrate was extracted with dichloromethane and water. The combined organic layers were dried over anhydrous magnesium sulfate and concentrated to obtain the desired compound (1.1 g, 87.3%) as a pale yellow solid.","3,4,5,6",2 2-1,"74,75,72,73,65,66,83,85",water dichloromethane celite magnesium sulfate,"6,8,90,92","3-(5-Amino-2-methylphenyl)-7-chloro-1-methyl-3,4-dihydropyrimido[4,5-d] pyrimidin-2(1H)-one desired compound","14,16,32,33",ammonium chloride iron,"27,28",water methanol THF,"8,9","7-Chloro-1-methyl-3-(2-methyl-5-nitrophenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one","43,45,59,61",80° C room temperature,"39,40,41,42,21,22,88,89,70,71,80,81,57,58,62,63",added stirred added obtain extracted dried cooled filtered,"46,48",2 hours,"92,94",1.1 g,"94,95",87.3%
"Preparation of tert-butyl 3-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenoxy)azetidine-1-carboxylate Diethyl (E)-diazene-1,2-dicarboxylate (88 mg, 0.20 mmol) was added to a solution of 4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenol (94 mg, 0.20 mmol), tert-butyl 3-hydroxyazetidine-1-carboxylate (35 mg, 0.20 mmol), triphenylphosphine (53 mg, 0.20 mmol) and toluene (2.03 mL). The reaction was then warmed to 110° C. After 15 hours, the reactions as cooled, concentrated under reduced pressure, and purified by flash silica chromatography, elution gradient 0 to 30% ethyl acetate in hexanes, to afford tert-butyl 3-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenoxy)azetidine-1-carboxylate (95 mg, 75%). m/z: ES+ [M+H]+ 621.",,,"69,70,66,68,59,60",hexanes ethyl acetate silica,"72,74,2,4","tert-butyl 3-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenoxy)azetidine-1-carboxylate tert-butyl 3-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenoxy)azetidine-1-carboxylate","27,28,4,6","triphenylphosphine Diethyl (E)-diazene-1,2-dicarboxylate","33,34",toluene,"21,23,16,17","tert-butyl 3-hydroxyazetidine-1-carboxylate 4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenol","42,44",110° C,"11,12,71,72,40,41,56,57",added afford warmed purified,"45,47",15 hours,"74,76",95 mg,"76,77",75%
"(Synthesis of Second Compound for Organic Optoelectric Device) Synthesis Example 17: Synthesis of Compound B-130 20.00 g (42.16 mmol) of 3-bromo-6-phenyl-N-metabiphenylcarbazole, 17.12 g (46.38 mmol) of N-phenylcarbazole-3-boronic ester, and 175 mL of tetrahydrofuran and toluene (1:1) and 75 mL of a 2M-potassium carbonate aqueous solution under a nitrogen atmosphere in a 500 mL round-bottomed flask equipped with a stirrer, 1.46 g (1.26 mmol) of tetrakistriphenyl phosphine palladium (0) was added thereto, and the mixture was heated and refluxed under a nitrogen flow for 12 hours. When a reaction was complete, the reactant was poured into methanol, and a solid produced therein was filtered and then, sufficiently washed with water and methanol and dried. The obtained resulting material was heated with 700 mL of chlorobenzene and dissolved therein, and the solution was filtered with silica gel, and after completely removing the solvent, a solid obtained therefrom was heated with 400 mL of chlorobenzene and dissolved therein and then, recrystallized to obtain 18.52 g of Compound B-130 (a yield of 69%). calcd. C42H32N2: C, 90.54; H, 5.07; N, 4.40; found: C, 90.54; H, 5.07; N, 4.40.","10,11",17,"123,124,95,96,47,48,80,81,110,111,133,135,151,152,108,109",chlorobenzene methanol nitrogen nitrogen methanol silica gel chlorobenzene water,"14,15,164,165",B-130 B-130,"64,68",potassium carbonate tetrakistriphenyl phosphine palladium (0),"43,44,34,35,32,33",aqueous toluene tetrahydrofuran,"20,21,26,28",3-bromo-6-phenyl-N-metabiphenylcarbazole N-phenylcarbazole-3-boronic ester,"77,78",refluxed,"159,160,75,76,69,70,106,107,118,119,131,132,93,94,146,147",obtain heated added washed heated filtered poured heated,"83,85",12 hours,"160,162",18.52 g,"168,169",69%
"Example 3 Preparation of 3-fluoro-2-(4-nitro-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazol-3-yl)-6-(trifluoromethyl)pyridine 106 A two-neck round bottom flask was charged with 3-fluoro-2-(4-nitro-1H-pyrazol-3-yl)-6-(trifluoromethyl)pyridine 104 (20.6 g, 74.6 mM). Anhydrous dioxane (500 ml) was added and the mixture was stirred until it became a clear solution. The reaction flask was degassed and back-filled with nitrogen. Subsequently, NaH (in mineral oil, 60 wt %) (4.47 g, 111.9 mM) was slowly added in portions at room temperature and the greyish suspension was stirred for about 10 minutes. 1,4-dioxaspiro[4.5]decan-8-yl 4-methylbenzenesulfonate (69.9 g, 224 mM) was added portion wise and reaction mixture was refluxed for two days. After cooling down to room temperature, the reaction was quenched with MeOH (100 ml) and the solvents were removed under reduced pressure. Water (300 ml) was added to the crude product and the mixture was extracted with EtOAc (2×300 ml). The organic layers were filtered through Na2SO4 and the crude product was adsorbed on silica gel. The desired product 106 (off-white solid, 18.3 g, 59% yield) was isolated by flash chromatography eluting with Hexane/EtOAc (gradient 0 to 30%).","1,2",3,"45,46,140,141,167,168,148,150,131,132,116,117,105,106",nitrogen Na2SO4 Hexane silica gel EtOAc EtOAc Water MeOH,"153,154,151,153,4,5,5,6","106 desired product 3-fluoro-2-(4-nitro-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazol-3-yl)-6-(trifluoromethyl)pyridine 106","47,48",NaH,"49,51,21,22",mineral oil dioxane,"15,16,14,15,76,78","104 3-fluoro-2-(4-nitro-1H-pyrazol-3-yl)-6-(trifluoromethyl)pyridine 1,4-dioxaspiro[4.5]decan-8-yl 4-methylbenzenesulfonate","98,100,90,91,64,66",room temperature refluxed room temperature,"25,26,43,44,161,162,83,84,12,13,60,61,71,72,103,104,165,166,120,121,95,96,129,130,138,139,146,147",added back-filled isolated added charged added stirred quenched eluting added cooling extracted filtered adsorbed,"92,94,74,76",two days 10 minutes,"156,158",18.3 g,"158,159",59%
"Example 2 (Referenece) 4-amino-2-(2-oxopiperidin-3-yl)isoindoline-1,3-dione (28). To a solution of 3-aminophthalic acid (0.100 g, 0.552 mmol) in DMF (1.1 mL) was added 3-aminopiperidine-2-one (0.063 g, 0.552 mmol) and the reaction was stirred at 90 °C over 18 h. Volatiles were removed in vacuo and the dark-brown crude residue was purified by preparative reverse phase HPLC to give the desired product 28 (0.050 g, 35%) as an off-white powder.","1,2",2,,,"4,5,59,60,3,4","28 28 4-amino-2-(2-oxopiperidin-3-yl)isoindoline-1,3-dione",,,"16,17",DMF,"9,11,21,22",3-aminophthalic acid 3-aminopiperidine-2-one,"32,34",90 °C,"55,56,20,21,30,31",give added stirred,"35,37",18 h,"60,62",0.050 g,"62,63",35%
"Example 14: Synthesis of compound 11140, 1-methyl-N-phenyl-N-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)puperidine-4-carboxamide N-phenyl-N-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)piperidine-4-carboxamide hydrochloride (0.100 g, 0.214 mmol), synthesized in Example 11, and formaldehyde (37.00 % solution in water, 0.024 mL, 0.321 mmol) were dissolved in dichloromethane (10 mL) at room temperature, and sodium triacetoxyborohydride (0.068 g, 0.321 mmol) was added to the solution, followed by stirring at the same temperature for 18 hours. Water was added to the reaction mixture, followed by extraction with ethyl acetate. The organic layer was washed with saturated aqueous sodium chloride solution, dried with magnesium sulfate anhydrous, filtered, and then concentrated under reduced pressure. The concentrate was purified by column chromatography (SiO2, 4 g cartridge; methanol/dichloromethane = from 0% to 15%) and concentrated to give the title compound (0.072 g, 75.6%) as a white solid.","1,2",14,"106,107,70,72,85,87,80,82,79,80,59,60,102,103",methanol ethyl acetate magnesium sulfate sodium chloride aqueous Water SiO2 dichloromethane,"117,119,6,7,5,6","title compound 1-methyl-N-phenyl-N-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)puperidine-4-carboxamide 11140","38,40",sodium triacetoxyborohydride,"31,32,23,24",dichloromethane water,"7,9,18,19","N-phenyl-N-(4-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)piperidine-4-carboxamide hydrochloride formaldehyde","35,37",room temperature,"115,116,45,46,29,30,51,52,68,69,76,77,98,99,83,84,61,62",give added dissolved stirring extraction washed purified dried added,"57,59",18 hours,"119,121",0.072 g,"121,122",75.6%
"Core 3B rac-(2R,3S,4R,5R)-ethyl 3-(tert-butyl)-5-(2-methoxyphenyl)-4-nitropyrrolidine-2-carboxylate To a solution of (E)-ethyl 2-((2-methoxybenzylidene)amino)acetate (26.72 g, 120.94 mmol) and lithium bromide (13.90 g, 131.02 mmol) in tetrahydrofuran (220 mL) at −78° C. was added (E)-3, 3-dimethyl-1-nitrobut-1-ene (13.0 g, 110.78 mmol) in tetrahydrofuran (20 mL) and DBU (1,8-diazabicyclo[5.4.0]undec-7-ene, 22.6 mL, 151.18 mmol) dropwise. The mixture was stirred at −78° C. for 2.5 hours and quenched with saturated aqueous ammonium chloride (100 mL), extracted with ethyl acetate (2×150 mL), washed with brine (2×150 mL), dried over sodium sulfate, filtered and concentrated. The residue was triturated with petroleum ether (100 mL). The solid was collected by filtration and dried in vacuo to provide the title compound rac-(2R,3S,4R,5R)-ethyl 3-(tert-butyl)-5-(2-methoxyphenyl)-4-nitropyrrolidine-2-carboxylate (10.3 g, 29.43 mmol, 28.3% yield).","1,2",3B,"90,92,80,82,62,63,75,76,63,65,69,71",petroleum ether sodium sulfate aqueous brine ammonium chloride ethyl acetate,"109,111,2,4,107,109","rac-(2R,3S,4R,5R)-ethyl 3-(tert-butyl)-5-(2-methoxyphenyl)-4-nitropyrrolidine-2-carboxylate rac-(2R,3S,4R,5R)-ethyl 3-(tert-butyl)-5-(2-methoxyphenyl)-4-nitropyrrolidine-2-carboxylate title compound","41,42,15,17,42,43","DBU lithium bromide 1,8-diazabicyclo[5.4.0]undec-7-ene","37,38,22,23",tetrahydrofuran tetrahydrofuran,"30,32,8,10","(E)-3, 3-dimethyl-1-nitrobut-1-ene (E)-ethyl 2-((2-methoxybenzylidene)amino)acetate","53,55,26,28",−78° C −78° C,"51,52,29,30,105,106,59,60,73,74,67,68,78,79,88,89",stirred added provide quenched washed extracted dried triturated,"56,58",2.5 hours,"113,115,111,113",29.43 mmol 10.3 g,"115,116",28.3%
"Example 41. (R)-3-((3-(methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)piperidine-1-yl)sulfonyl)benzonitrile 70.0 mg of (R)-N-methyl-N-(piperidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine was added to a 5-mL round-bottomed flask, and then dissolved with 1.50 mL of dichloromethane (CH2Cl2). After 64.0 mg of 3-cyanobenzenesulfonyl chloride was added to the solution, the reaction mixture was treated with 0.0790 mL of N,N-diisopropylethylamine and then stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=2:98). The resulting fraction was concentrated under reduced pressure and then further under vacuum. As a result, 70.0 mg of (R)-3-((3-(methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)piperidine-1-yl)sulfonyl)benzonitrile was obtained with a yield of about 59.3%.","1,2",41,"70,71",MeOH CH2Cl2,"90,91,2,3","(R)-3-((3-(methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)piperidine-1-yl)sulfonyl)benzonitrile (R)-3-((3-(methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)piperidine-1-yl)sulfonyl)benzonitrile","43,44","N,N-diisopropylethylamine","22,23,21,22",CH2Cl2 dichloromethane,"6,7,27,29","(R)-N-methyl-N-(piperidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine 3-cyanobenzenesulfonyl chloride","49,51",room temperature,"92,93,16,17,8,9,46,47,38,39,30,31,65,66",obtained dissolved added stirred treated added purified,,,"87,89",70.0 mg,"98,99",59.3%
"Example 2C. 2-(3-((6-Aminohexyl)oxy)benzyl)-8-benzyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one To a solution of tert-butyl (6-(3-((8-benzyl-3-oxo-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-2-yl)methyl)phenoxy)hexyl)carbamate (0.14 g) in CH2Cl2 (15 mL), TFA (1 mL) was added. The orange solution was stirred for 1 hr, then toluene was added, and the solution concentrated to provide the title compound as an amber glass (0.09 g, 80%): ESI MS (m/z) [M+H] (C32H34N4O2) found 507.2.","1,2",2C,"29,30",toluene,"39,41,2,3","title compound 2-(3-((6-Aminohexyl)oxy)benzyl)-8-benzyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one","15,16",TFA,"12,13",CH2Cl2,"7,9","tert-butyl (6-(3-((8-benzyl-3-oxo-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-2-yl)methyl)phenoxy)hexyl)carbamate",,,"19,20,37,38,24,25,31,32",added provide stirred added,"26,28",1 hr,"45,47",0.09 g,"47,48",80%
"EXAMPLE 120 N-[(S)-2-(5-(2-chloro-3-fluorophenyl)-3-{2-[4-(7-methoxy-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl)-propyl]-methanesulphonamide (reaction scheme No. 3 or 4, compound 120) 0.3 ml (3.7 mmol) of methanesulphonyl chloride and 0.5 ml (3.7 mmol) of triethylamine are added at 0° C. to a solution containing 1.5 g (2.5 mmol) of 3-((S)-2-amino-1-methylethyl)-5-(2-chloro-3-fluorophenyl)-1-{2-[4-(7-methoxy-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-1H-pyrimidine-2,4-dione (prepared as in example 119) in 15 ml of dichloromethane. After 30 minutes, dichloromethane is added and the reaction mixture is hydrolysed with 1N aqueous solution of hydrochloric acid. The aqueous phase is extracted again with dichloromethane. The organic phase is dried over anhydrous sodium sulphate, filtered and concentrated. After purification by chromatography, taking up in pentane and filtration, 0.8 g (45%) of N-[(S)-2-(5-(2-chloro-3-fluorophenyl)-3-{2-[4-(7-methoxy-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl)-propyl]-methanesulphonamide is obtained in the form of a white solid.","1,2",120,"76,77,84,86,96,97,64,65,67,69",dichloromethane sodium sulphate pentane aqueous hydrochloric acid,"10,11,2,3,103,104","120 N-[(S)-2-(5-(2-chloro-3-fluorophenyl)-3-{2-[4-(7-methoxy-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl)-propyl]-methanesulphonamide N-[(S)-2-(5-(2-chloro-3-fluorophenyl)-3-{2-[4-(7-methoxy-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl)-propyl]-methanesulphonamide","24,25",triethylamine,"49,50,53,54",dichloromethane dichloromethane,"39,40,16,18","3-((S)-2-amino-1-methylethyl)-5-(2-chloro-3-fluorophenyl)-1-{2-[4-(7-methoxy-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-1H-pyrimidine-2,4-dione methanesulphonyl chloride","28,30",0° C,"55,56,26,27,105,106,90,91,73,74,61,62,93,94,81,82",added added obtained purification extracted hydrolysed taking dried,"51,53",30 minutes,"99,101",0.8 g,"101,102",45%
"To a solution of 5-Bromo-4-methoxy-pyridin-2-ylamine (53 g, 0.261 mol, 1.0 eq.) in EtOH:H2O=4:1 (500 mL) is added chloro-acetaldehyde (24.6 g, 0.31 mol), then NaHCO3 (26.3 g, 0.313 mol) is added. The resultant mixture is heated to 90° C. for 4 h. After cooling to r.t., the organic solvent is evaporated. The residue is extracted with DCM (200 mL×3). The organic layers are combined, dried over Na2SO4, filtered and concentrated. The crude product is purified by silica gel chromatography (DCM:MeOH=50:1) to afford compound 6-Bromo-7-methoxy-imidazo[1,2-a]pyridine (39 g, 66%) as a brown solid.",,,"55,56,78,79,65,66,75,77",MeOH DCM DCM Na2SO4 silica gel,"82,83","6-Bromo-7-methoxy-imidazo[1,2-a]pyridine","23,24",NaHCO3,"12,13",H2O EtOH,"4,5,17,18",5-Bromo-4-methoxy-pyridin-2-ylamine chloro-acetaldehyde,"44,45,36,38",r.t. 90° C,"29,30,16,17,34,35,80,81,73,74,42,43,63,64,53,54",added added heated afford purified cooling dried extracted,"39,41",4 h,"83,85",39 g,"85,86",66%
"Synthesis of compound 2-c At 0°C, triethyl phosphonoacetate (1.4mL, 5mmol) and sodium hydride (240mg, 6mmol) were added into a solution of compound 2-d (470mg, 2mmol) in THF (lOmL), the mixture was further stirred for 1h. The mixture was warmed to room temperature, followed by adding saturated aqueous solution of NH4Cl (300mL), extracted with EA (50mL×3). The organic phases were combined, washed in turn with water (10mL×3) and saturated brine (10mL), dried over anhydrous sodium sulfate, filtered, evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA = 5:1) to give light yellow solid 2-c (380mg, yield 62%).",,,"46,47,68,69,73,75,53,54,85,86,64,65,49,50,88,89",aqueous brine EA sodium sulfate EA silica water NH4Cl PE,"3,4,96,97",2-c 2-c,"11,13",sodium hydride,"26,27",THF,"6,8,22,23",triethyl phosphonoacetate 2-d,"40,42,5,6",room temperature 0°C,"16,17,92,93,32,33,51,52,38,39,83,84,44,45,60,61,70,71",added give stirred extracted warmed purified adding washed dried,"34,35",1h,"97,98",380mg,"99,100",62%
"Embodiment 33B 6-Fluoro-1-(p-toluenesulfonyl)indole-2-carboxylic acid 6-Fluoro-1-(p-toluenesulfonyl) indole (39.80 g, 132.06 mmol) was dissolved in tetrahydrofuran (400 mL) at -70 °C, and n-butyllithium (2.5 mol, 52.82 mL) was added to the mixture and stirred for 1 hour. Dry ice (58.11 g, 1.32 mmol) was slowly added to the mixture and stirred for 1.5 hours. TLC showed the reaction was complete, saturated NH4Cl solution (200 mL) was added to the mixture, extracted with EA (200 mL × 2), the pH of the aqueous phase was adjusted to 1 with concentrated hydrochloric acid, and then extracted with DCM (200 mL × 3) and concentrated to deliver the title compound (yellow solid, 32.75 g, yield 74.40%).","1,2",33B,"59,60,70,71,93,94,87,89",NH4Cl EA DCM hydrochloric acid,"2,4,103,105",6-Fluoro-1-(p-toluenesulfonyl)indole-2-carboxylic acid title compound,"20,21",n-butyllithium,"13,14",tetrahydrofuran,"35,37,4,6",Dry ice 6-Fluoro-1-(p-toluenesulfonyl) indole,"17,19",-70 °C,"11,12,48,49,43,44,101,102,26,27,31,32,68,69,91,92,64,65",dissolved stirred added deliver added stirred extracted extracted added,"33,35,50,52",1 hour 1.5 hours,"107,109",32.75 g,"110,111",74.40%
"Example 38 N-(1-methyl-3-(pyridin-2-yl)-1H-pyrazol-4-yl)-5'-(pyrrolidin-1-yl)-[2,3'-bipyridine]-6-carboxamide (I-36) An NMP (1 mL) solution of 5'-fluoro-N-(1-methyl-3-(pyridin-2-yl)-1H-pyrazol-4-yl)-[2,3'-bipyridine]-6-carboxamide (22.5 mg, 0.06 mmol) and pyrrolidine (0.1 mL) was heated at 120-150° C. for 4 days until reaction went to completion, as monitored by LC-MS. Solvent was removed in vacuo, after silica gel chromatography and further trituration from Hexanes-EtOAc, title compound was obtained as a yellow solid: 14.9 mg (58% yield);","1,2",38,"49,50,42,44",Hexanes EtOAc silica gel,"3,4,2,3,50,52","I-36 N-(1-methyl-3-(pyridin-2-yl)-1H-pyrazol-4-yl)-5'-(pyrrolidin-1-yl)-[2,3'-bipyridine]-6-carboxamide title compound",,,"5,6",NMP,"10,11,16,17","5'-fluoro-N-(1-methyl-3-(pyridin-2-yl)-1H-pyrazol-4-yl)-[2,3'-bipyridine]-6-carboxamide pyrrolidine","22,24",120-150° C,"20,21,53,54,44,45,47,48",heated obtained chromatography trituration,"25,27",4 days,"58,60",14.9 mg,"60,61",58%
"Step 3 (E)-3-(4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-7,8-dimethoxy-3-methyl-1,2,3,4-t etrahydroisoquinolin-1-yl)phenyl)acrylic acid (E)-methyl 3-(4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-7,8-dimethoxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylate 35c (18 mg, 0.04 mmol) was dissolved in 4 mL of a mixture of tetrahydrofuran and methanol (V/V=1:1), then 0.5 mL of 1M sodium hydroxide solution was added. The reaction was stirred for 10 hours at room temperature. 1M hydrochloric acid was added dropwise to adjust the pH to 6. The mixture was extracted with ethyl acetate (50 mL). The organic phase was washed with saturated sodium chloride solution (50 mL), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by thin-layer chromatography with elution system A to obtain the title compound (E)-3-(4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-7,8-dimethoxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylic acid 35 (5 mg, yield 28%) as a light yellow solid.","1,2",3,"62,64,73,75,81,83,46,48",ethyl acetate sodium chloride sodium sulfate hydrochloric acid,"107,109,2,5,111,112,109,111","title compound (E)-3-(4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-7,8-dimethoxy-3-methyl-1,2,3,4-t etrahydroisoquinolin-1-yl)phenyl)acrylic acid 35 (E)-3-(4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-7,8-dimethoxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylic acid","30,32",sodium hydroxide,"23,24,21,22",methanol tetrahydrofuran,"5,7,7,8","(E)-methyl 3-(4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-7,8-dimethoxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylate 35c","43,45",room temperature,"13,14,105,106,34,35,38,39,70,71,60,61,49,50,78,79",dissolved obtain added stirred washed extracted added dried,"40,42",10 hours,"112,114",5 mg,"115,116",28%
"Step 5 (E)-methyl 3-(3,5-difluoro-4-((1S,3R/1R,3S)-7-fluoro-2-(2-fluoro-2-methylpropyl)-6-hydroxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylate 2-fluoro-5-(2-((2-fluoro-2-methylpropyl)amino)propyl)phenol 16e (300 mg, 1.233 mmol) was dissolved in 5 mL of methanol, then (E)-methyl 3-(3,5-difluoro-4-formylphenyl) acrylate 1e (418 mg, 1.896 mmol) and acetic acid (740 mg, 12.33 mmol) were added. The resulting mixture was heated to 80°C and stirred for 48 hours. After the reaction was stopped, the reaction solution was cooled to room temperature. A solution of 1M sodium bicarbonate was added to the reaction solution to adjust the pH to 7-8. The mixture was extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography with elution system B to obtain the title compound (E)-methyl 3-(3,5-difluoro-4-((1S,3R/1R,3S)-7-fluoro-2-(2-fluoro-2-methylpropyl)-6-hydroxy-3-me thyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylate 16f (300 mg, yield 54%) as a yellow oil.","1,2",5,"93,95,110,112,83,85,64,66",sodium sulfate silica gel ethyl acetate sodium bicarbonate,"126,127,2,4,121,123,123,126","16f (E)-methyl 3-(3,5-difluoro-4-((1S,3R/1R,3S)-7-fluoro-2-(2-fluoro-2-methylpropyl)-6-hydroxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylate title compound (E)-methyl 3-(3,5-difluoro-4-((1S,3R/1R,3S)-7-fluoro-2-(2-fluoro-2-methylpropyl)-6-hydroxy-3-me thyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylate","27,29",acetic acid,"16,17",methanol,"4,5,18,21,5,6,21,22","2-fluoro-5-(2-((2-fluoro-2-methylpropyl)amino)propyl)phenol (E)-methyl 3-(3,5-difluoro-4-formylphenyl) acrylate 16e 1e","41,42,58,60",80°C room temperature,"119,120,43,44,11,12,34,35,39,40,56,57,108,109,90,91,81,82,67,68",obtain stirred dissolved added heated cooled purified dried extracted added,"45,47",48 hours,"127,129",300 mg,"130,131",54%
"Step 2: preparation of sodium (7-oxo-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl) sulfate (Example 11) Using the procedure described in example 9 (step 2), the intermediate 6-allyloxy-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-7-one (11a) (105 mg, 0.427 mmol) was converted into sodium (7-oxo-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl) sulfate (example 11) (69 mg,0.224 mmol, 52%) as a light yellow solid after lyophilization.","1,2",2,,,"32,34,29,32,7,9,4,7","example 11 sodium (7-oxo-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl) sulfate Example 11 sodium (7-oxo-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl) sulfate",,,,,"21,22,20,21","11a 6-allyloxy-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-7-one",,,"27,28",converted,,,"34,36",0.224 mmol 69 mg,"37,38",52%
"Example 48A Methyl 4-({[6-bromo-2-(2-fluorophenyl)-3-methylquinolin-4-yl]carbonyl}amino)bicyclo[2.2.2]octane-1-carboxylate At RT, 15 mg (0.07 mmol) of methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride, 32 mg (0.08 mmol) of HATU and 0.04 ml (0.22 mmol) of DIPEA were added to a solution of 20 mg (0.06 mmol) of the compound from Example 6A in 0.6 ml of DMF, and the mixture was stirred at 60° C. overnight. After cooling to RT, water and ethyl acetate were added to the mixture and the aqueous phase was extracted three times with ethyl acetate. The combined organic phases were washed with saturated aqueous sodium carbonate solution and dried over sodium sulfate, and the solvents were removed on a rotary evaporator. The residue was purified by column chromatography (silica gel, mobile phase cyclohexane/ethyl acetate 2:1). This gave 19 mg (64% of theory, purity 99%) of the title compound","1,2",48A,"118,119,90,92,89,90,79,81,96,98,114,116,63,65,61,62",cyclohexane sodium carbonate aqueous ethyl acetate sodium sulfate silica gel ethyl acetate ethyl acetate water,"132,134,2,4",title compound Methyl 4-({[6-bromo-2-(2-fluorophenyl)-3-methylquinolin-4-yl]carbonyl}amino)bicyclo[2.2.2]octane-1-carboxylate,"19,20,26,27",HATU DIPEA,"47,48",DMF,"39,43,11,14",compound from Example 6A methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride,"5,6,60,61,54,56",RT RT 60° C,"122,123,52,53,28,29,94,95,110,111,58,59,86,87,66,67,75,76",gave stirred added dried purified cooling washed added extracted,,,"123,125",19 mg,"125,126",64%
"720 mg of tert-butyl (S)-(1-benzylpyrrolidine-3-yl)carbamate was added to a 100-mL round-bottomed flask. After 11.5 mL of tetrahydrofuran and 623 mg of lithium aluminum hydride (LiAlH4) were sequentially added thereto, the reaction mixture was refluxed for about 4 hours and then cooled at 0°C. 1.16 mL of deionized water was slowly added to the reaction mixture while cooling. After the reaction mixture was stirred for about 5 minutes, 1.16 mL of a 15% sodium hydroxide (NaOH) aqueous solution was added thereto. The reaction mixture was further stirred for about 5 minutes, and then 3.80 mL of deionized water was added thereto to terminate the reaction. The reaction mixture was filtered through a Celite™ 545 filter agent. The resulting filtrate was distilled under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2:NH4OH=5:90:5). As a result, 440 mg of (S)-1-benzyl-N-methylpyrrolidine-3-amine was obtained with a yield of about 89.9%. 440 mg of (S)-1-benzyl-N-methylpyrrolidine-3-amine was added to a 25-mL round-bottomed flask, and then 9.00 mL of deionized water and 373 mg of 6-chloro-7-deazapurine were sequentially added thereto. After 639 mg of potassium carbonate (K2CO3) was added to the reaction mixture, the reaction mixture was refluxed for about 36 hours and then cooled at room temperature. The reaction mixture was extracted three times with 40.0 mL of dichloromethane (CH2Cl2) to collect an organic phase. The collected organic phase was concentrated under reduced pressure, and the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=2:98). As a result, 544 mg of (S)-N-(1-benzylpyrrolidine-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine was obtained with a yield of about 76.6%. 534 mg of (S)-N-(1-benzylpyrrolidine-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine was added to a 25-mL round-bottomed flask and then dissolved with 5.00 mL of methanol. After 534 mg of a 10w/w% palladium/carbon (Pd/C) was added thereto, a hydrogen-containing balloon was installed on the reaction flask. The reaction mixture was vigorously stirred overnight and then filtered through a Celite™ 545 filter agent. The resulting filtrate was concentrated under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=2:98). The resulting fraction was concentrated under reduced pressure and then further under vacuum. As a result, 250 mg of (S)-N-methyl-N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine was obtained with a yield of about 66.1%. 150 mg of (S)-N-methyl-N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine was added to a 5-mL round-bottomed flask and then dissolved with 2.25 mL of n-butanol. After 0.0730 mL of ethyl cyanoacetate was added thereinto, the reaction mixture was treated with 0.0520 mL of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), and then heated at about 80°C for about 24 hours. After termination of the reaction, the reaction solution was distilled under reduced pressure to remove the solvent. The resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=2:98). The resulting fraction was concentrated under reduced pressure and then further under vacuum. As a result, 140 mg of (S)-3-(3-(methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)pyrrolidine-1-yl)-3-oxopropanenitrile was obtained with a yield of about 71.4%.",,,"96,97,134,135,111,113,436,437,75,76,47,48,332,333,309,311,72,74,216,217,217,218,74,75,242,243",water CH2Cl2 MeOH Celite™ 545 NH4OH CH2Cl2 MeOH aqueous water MeOH Celite™ 545 CH2Cl2 sodium hydroxide CH2Cl2 dichloromethane CH2Cl2 NaOH MeOH,"352,353,141,142,249,250,456,457","(S)-N-methyl-N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine (S)-1-benzyl-N-methylpyrrolidine-3-amine (S)-N-(1-benzylpyrrolidine-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine (S)-3-(3-(methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)pyrrolidine-1-yl)-3-oxopropanenitrile","282,284,24,25,399,400,181,183,398,399,21,24,289,290,284,285,183,184","10w/w% palladium/carbon LiAlH4 DBU potassium carbonate 1,8-diazabicyclo[5.4.0]undec-7-ene lithium aluminum hydride hydrogen Pd/C K2CO3","16,17,167,168,276,277,379,380",tetrahydrofuran water methanol n-butanol,"364,365,3,5,172,173,261,262,153,154,384,386","(S)-N-methyl-N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine tert-butyl (S)-(1-benzylpyrrolidine-3-yl)carbamate 6-chloro-7-deazapurine (S)-N-(1-benzylpyrrolidine-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine (S)-1-benzyl-N-methylpyrrolidine-3-amine ethyl cyanoacetate","42,43,194,195,203,205,33,34,405,406",0°C refluxed room temperature refluxed 80°C,"292,293,143,144,185,186,393,394,366,367,251,252,402,403,286,287,175,176,27,28,271,272,6,7,458,459,387,388,263,264,374,375,354,355,155,156,201,202,50,51,40,41,98,99,237,238,108,109,327,328,85,86,209,210,78,79,62,63,431,432,306,307,129,130",installed obtained added treated added obtained heated added added added dissolved added obtained added added dissolved obtained added cooled added cooled added purified filtered purified stirred extracted added stirred purified filtered purified,"65,67,408,410,88,90,197,199,36,38",5 minutes 24 hours 5 minutes 36 hours 4 hours,"138,140,453,455,349,351,246,248",440 mg 140 mg 250 mg 544 mg,"464,465,149,150,360,361,257,258",71.4% 89.9% 66.1% 76.6%
"Example I-11 Synthesis of Compound 69 Synthesis of Compound 66 To a mixture of compound 65 (145.0 mg, 1.0 mmol) in DMF (6 mL), maleic anhydride (89.8 mg, 0.9 mmol) was dropwise added slowly. The mixture was heated to reflux for 12 hours. After cooled to room temperature, solid product precipitated was filtered and washed with CH2Cl2 (20 mL×3) to afford the compound 66 (110.2 mg, 45.1%) as a white solid. LC-MS m/z (ES+), 244.02 (M+H)+.","1,2",I-11,"5,6,56,57",69 CH2Cl2,"63,64,9,10",66 66,,,"21,22",DMF,"15,16,24,26",65 maleic anhydride,"46,48,39,40",room temperature reflux,"37,38,60,61,32,33,54,55,44,45",heated afford added washed cooled,"41,43",12 hours,"64,66",110.2 mg,"66,67",45.1%
"Example 7 Synthesis of 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methylsulfonyl-methoxypyridin-2-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]cquinolin-2-one (Compound Example 201) i. 8-(1,3-Dimethylpyrazol-4-yl)-1-(3-fluoro-5-hydroxy-2-pyridyl)-7-methoxy-3-methyl-imidazo[4,5-c]quinolin-2-one (80 mg, 0.18 mmol, 98%), N,N-dimethylformamide (5 ml), potassium carbonate (50 mg, 0.36 mmol) and chloro(methylsulfanyl)methane (110 mg, 1.09 mmol, 95%) were initially introduced in a 25 ml round-bottomed flask. The solution was stirred overnight at 25° C. The reaction was then terminated by addition of 50 ml of water. The solution was extracted four times with 30 ml of ethyl acetate each time, and the organic phases were combined. The mixture was evaporated in vacuo. The residue was pre-purified on silica gel with MeOH:Et0Ac (6:94), giving 80 mg (85%) of 8-(1,3-dimethylpyrazol-4-yl)-1-[3-fluoro-5-(methylsulfanyl methoxy)-2-pyridyl]-7-methoxy-3-methyl-imidazo[4,5-c]quinolin-2-one as yellow solid.","1,2,8,9",7 i,"6,8,70,72,59,60,91,93,94,95,4,5","Et0Ac Example 201 ethyl acetate water silica gel MeOH 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methylsulfonyl-methoxypyridin-2-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]cquinolin-2-one","101,103","8-(1,3-dimethylpyrazol-4-yl)-1-[3-fluoro-5-(methylsulfanyl methoxy)-2-pyridyl]-7-methoxy-3-methyl-imidazo[4,5-c]quinolin-2-one","18,20",potassium carbonate,"15,16","N,N-dimethylformamide","9,10,25,26","8-(1,3-Dimethylpyrazol-4-yl)-1-(3-fluoro-5-hydroxy-2-pyridyl)-7-methoxy-3-methyl-imidazo[4,5-c]quinolin-2-one chloro(methylsulfanyl)methane","46,48",25° C,"33,34,96,97,43,44,89,90,63,64,54,55",introduced giving stirred pre-purified extracted addition,,,"97,99",80 mg,"99,100",85%
"Step 4: 2-[bromo(d2)methyl]-5-methylpyrimidine To a solution of (5-methylpyrimidin-2-yl)(d2)methanol [Example 9, Step 3] (1.5 g, 11.9 mmol, 1.00 equiv) in DCM (20 mL) was added PPh3 (3.12 g, 11.9 mmol, 1.00 equiv) and NBS (2.12 g, 11.9 mmol, 1.00 equiv) at 0° C. The resulting solution was stirred for 1 h at 0° C. The reaction was then quenched by the addition of H2O (20 mL). The resulting solution was extracted with DCM (3×20 mL). The organic layers were dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:2) to afford 700 mg (31.3%) of 2-[bromo(d2)methyl]-5-methylpyrimidine as a yellow oil.","1,2",4,"62,63,93,95,71,72,81,83,97,99",H2O silica gel DCM petroleum ether sodium sulfate ethyl acetate,"107,108,2,3",2-[bromo(d2)methyl]-5-methylpyrimidine 2-[bromo(d2)methyl]-5-methylpyrimidine,"32,33,24,25",NBS PPh3,"19,20",DCM,"7,8",(5-methylpyrimidin-2-yl)(d2)methanol,"51,53,40,42",0° C 0° C,"23,24,102,103,46,47,69,70,57,58,78,79,90,91",added afford stirred extracted quenched dried applied,"48,50",1 h,"103,105",700 mg,"105,106",31.3%
"Example 12 Synthesis of 1-(3-fluoro-5-methoxypyridin-4-yl)-8-(1-fluoromethyl-1H-pyrazol-4-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]quinolin-2-one (Compound Example 140) 1-(3-Fluoro-5-methoxy-4-pyridyl)-7-methoxy-3-methyl-8-(1 H-pyrazol-4-yl)imidazo[4,5-c]-quinolin-2-one (60 mg, 0.14 mmol, 97%), potassium carbonate (57.6 mg, 0.42 mmol) and N,N-dimethylformamide (5 ml) were initially introduced in a sealed 30 ml reaction vessel. The mixture was stirred at room temperature for 5 minutes and cooled to 0° C. Bromofluoro-methane (165 mg, 1.39 mmol, 95%) was added, the mixture was warmed to room temperature and stirred for a further hour. The reaction was then terminated by addition of 50 mL of water. The solution was extracted three times with 30 mL of ethyl acetate each time, the organic phases were combined and evaporated in vacuo. The crude product was purified by means of preparative HPLC, giving 5 mg (8%) of 1-(3-fluoro-5-methoxypyridin-4-yl)-8-(1-fluoromethyl-1H-pyrazol-4-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]quinolin-2-one as white solid.","1,2",12,"82,83,93,95",water ethyl acetate,"4,5,6,8,121,122","1-(3-fluoro-5-methoxypyridin-4-yl)-8-(1-fluoromethyl-1H-pyrazol-4-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]quinolin-2-one Example 140 1-(3-fluoro-5-methoxypyridin-4-yl)-8-(1-fluoromethyl-1H-pyrazol-4-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]quinolin-2-one","15,17",potassium carbonate,"22,23","N,N-dimethylformamide","8,10,50,51","1-(3-Fluoro-5-methoxy-4-pyridyl)-7-methoxy-3-methyl-8-(1 H-pyrazol-4-yl)imidazo[4,5-c]-quinolin-2-one Bromofluoro-methane","48,50,63,65,40,42",0° C room temperature room temperature,"38,39,57,58,66,67,27,28,61,62,46,47,116,117,86,87,77,78",stirred added stirred introduced warmed cooled giving extracted addition,"69,71,43,45",further hour 5 minutes,"117,119",5 mg,"119,120",8%
"Intermediate Synthesis 3: Synthesis of Intermediate 3 Under an argon atmosphere, a mixture of 52.4 g (203.7 mmol) of the intermediate 2 in 700 ml of dimethylformamide was stirred. After adding 36.2 g (203.7 mmol) of N-bromosuccinimide, the mixture was further stirred at room temperature for 12 h. After the reaction, the mixture was extracted with toluene in a separatory funnel. The organic layer was dried over anhydrous magnesium sulfate, filtered, and then concentrated. The concentrate residue was purified by silica gel column chromatography to obtain 43.1 g (yield: 63%) of a white solid, which was identified as the following intermediate 3 by FD-MS analysis.","2,3",3,"68,70,80,82,56,57,9,10",magnesium sulfate silica gel toluene argon,"6,7,101,102",3 3,"36,37",N-bromosuccinimide,"26,27",dimethylformamide,"21,22",2,"43,45",room temperature,"28,29,41,42,85,86,30,31,54,55,78,79,65,66",stirred stirred obtain adding extracted purified dried,"46,48",12 h,"86,88",43.1 g,"89,90",63%
"c. PREPARATION OF (S)-2-(3-(BENZO[D][1,3]DIOXOL-5-YL)UREIDO)-3-(3,5-DIFLUOROPHENYL)-N-((6S,8AS,14AS,20S,21S,23AS)-6,21-DIMETHYL-5,8,14,19,23-PENTAOXOOCTADECAHYDRO-1H,5H,14H,19H-PYRIDO[2,1-I]DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-20-YL)PROPANAMIDE (COMPOUND 17) Compound 17 was synthesized from compound C (90 mg, 0.129 mmol), 5-isocyanatobenzo[d][1,3]dioxole (25.3 mg, 0.155 mmol) and triethylamine (85 μL, 0.620 mmol) as a white-off solid (45 mg, 42%) following the general synthesis pathway described herein above;","0,1",c,,,"5,6,3,4,7,8","17 (S)-2-(3-(BENZO[D][1,3]DIOXOL-5-YL)UREIDO)-3-(3,5-DIFLUOROPHENYL)-N-((6S,8AS,14AS,20S,21S,23AS)-6,21-DIMETHYL-5,8,14,19,23-PENTAOXOOCTADECAHYDRO-1H,5H,14H,19H-PYRIDO[2,1-I]DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-20-YL)PROPANAMIDE 17","23,24",triethylamine,,,"12,13,17,18","C 5-isocyanatobenzo[d][1,3]dioxole",,,"9,10",synthesized,,,"32,34",45 mg,"34,35",42%
"Example 85 (3-Aminopyrazol-1-yl)-[4-(6-fluoro-1H-indol-3-yl)phenyl]methanone This compound was prepared from Intermediate 3 and 3-aminopyrazole according to the procedure described in Example 1. Purification was performed using preparative HPLC to afford the title compound (5 mg, 15%). Data: LCMS (B) Rt: 11.261 min; m/z 321.1 (M+H)+.","1,2",85,,,"4,5,2,3,29,31",compound (3-Aminopyrazol-1-yl)-[4-(6-fluoro-1H-indol-3-yl)phenyl]methanone title compound,,,,,"9,10,11,12",3 3-aminopyrazole,,,"6,7,27,28",prepared afford,,,"31,33",5 mg,"33,34",15%
"Step 3 The compound 40 (181 mg, 0.590 mmol) was dissolved in dioxane (4 mL). 2-Chloro-3-trifluoromethylphenol (151 mg, 0.767 mmol) and cesium carbonate (288 mg, 0.885 mmol) were added to the solution. The mixture was stirred under microwave irradiation at 100°C for 4.5 hours. Water was added to the mixture. The mixture was washed by ethyl acetate. The organic layer was washed by brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure. The obtained residue was purified by silica-gel column chromatography (hexane-ethyl acetate) to give the compound 41 (132 mg, yield 47.9%).","1,2",3,"83,84,55,57,86,87,44,45,68,70,63,64",silica-gel ethyl acetate hexane Water sodium sulfate ethyl acetate brine,"92,93",41,"21,23",cesium carbonate,"12,13",dioxane,"4,5,15,16",40 2-Chloro-3-trifluoromethylphenol,"40,41",100°C,"28,29,89,90,38,39,10,11,65,66,61,62,46,47,81,82,53,54",added give irradiation dissolved dried washed added purified washed,"42,44",4.5 hours,"93,95",132 mg,"96,97",47.9%
"Step 4: preparation of intermediate N-allyloxy-2-nitro-N-(4,5,6,7-tetrahydrothiazolo[4,5-c]pyridin-7-yl)benzenesulfonamide (6d) To a solution of tert-butyl 7-[allyloxy-(2-nitrophenyl)sulfonyl-amino]-6,7-dihydro-4H-thiazolo[4,5-c]pyridine-5-carboxylate (6c) (20 g, 40.28 mmol) in anhydrous DCM (37 mL) under inert atmosphere at 0°C was dropwise added TFA (37 mL, 483 mmol). After stirring for 2 h at rt, the reaction mixture was cooled at 0°C and neutralized with ammonium hydroxide solution 28% until pH 8. The mixture was diluted with water and extracted with DCM. The organic layer was dried over Na2SO4, concentrated in vacuo to give N-allyloxy-2-nitro-N-(4,5,6,7-tetrahydrothiazolo[4,5-c]pyridin-7-yl)benzenesulfonamide (6d) (14.68 g, 37.02 mmol, 92%) as a yellow solid.","1,2",4,"53,55,69,70,65,66,76,77",ammonium hydroxide DCM water Na2SO4,"83,84,82,83,6,7,5,6","6d N-allyloxy-2-nitro-N-(4,5,6,7-tetrahydrothiazolo[4,5-c]pyridin-7-yl)benzenesulfonamide 6d N-allyloxy-2-nitro-N-(4,5,6,7-tetrahydrothiazolo[4,5-c]pyridin-7-yl)benzenesulfonamide","31,32",TFA,"20,21",DCM,"11,13,13,14","tert-butyl 7-[allyloxy-(2-nitrophenyl)sulfonyl-amino]-6,7-dihydro-4H-thiazolo[4,5-c]pyridine-5-carboxylate 6c","49,50,27,28,42,43",0°C 0°C rt,"37,38,30,31,81,82,63,64,67,68,47,48,74,75,51,52",stirring added give diluted extracted cooled dried neutralized,"39,41",2 h,"84,86,86,88",14.68 g 37.02 mmol,"88,89",92%
"Step 4 The compound I-1251 (650 mg, 1.44 mmol) was dissolved in tetrahydrofuran (6.5 mL). Triethylamine (0.30 mL, 2.17 mmol) and ethyl chloroformate (0.206 mL, 2.17 mmol) were added to the solution. The mixture was stirred at room temperature for 30 minutes. Insoluble materials were filtered off. Under ice cooling, the filtrate was added to the aqueous solution of sodium borohydride (mixture of sodium borohydride (82 mg, 2.17 mmol) and water (6.5 mL)). The mixture was stirred for 1 hour. Water was added to the reaction mixture. The mixture was extracted with ethyl acetate. The organic layer was washed by brine, and dried over sodium sulfate. The solvent was evaporated under reduced pressure. The obtained residue was purified by silica-gel column chromatography (ethyl acetate-n-hexane) to give the compound I-1256 (332 mg, yield 52%).","1,2",4,"119,120,100,101,80,81,122,124,92,94,104,106",silica-gel brine n-hexane Water ethyl acetate ethyl acetate sodium sulfate,"128,129",I-1256,"15,16,21,23,63,65,59,61",Triethylamine ethyl chloroformate sodium borohydride sodium borohydride,"70,71,12,13,56,57",water tetrahydrofuran aqueous,"4,5",I-1251,"37,39",room temperature,"35,36,28,29,125,126,76,77,10,11,53,54,102,103,82,83,117,118,90,91,98,99",stirred added give stirred dissolved added dried added purified extracted washed,"78,80,40,42",1 hour 30 minutes,"129,131",332 mg,"132,133",52%
"Step 6. 5-(2-Fluoro-6-methylphenyl)-1H-pyrazolo[4,3-b]pyridine-6-carbonitrile To a solution of 5-(2-fluoro-6-methylphenyl)-1-trityl-1H-pyrazolo[4,3-b]pyridine-6-carbonitrile (406.1 mg, 0.821 mmol) in DCM (10.0 ml) was added TFA (5.0 ml). The reaction was stirred at room temperature for 30 min, and then concentrated. The residue was dissolved in DCM and washed with sat. NaHCO3(aq). The organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified on silica gel (40 g, 0-100% EtOAc in DCM) to give the desired product as a white solid (140.1 mg, 68%).","1,2",6,"39,40,44,45,66,67,61,63,52,53,68,69",DCM aq NaHCO3 EtOAc silica gel Na2SO4 DCM,"72,74,2,3","desired product 5-(2-Fluoro-6-methylphenyl)-1H-pyrazolo[4,3-b]pyridine-6-carbonitrile","18,19",TFA,"13,14",DCM,"7,8","5-(2-fluoro-6-methylphenyl)-1-trityl-1H-pyrazolo[4,3-b]pyridine-6-carbonitrile","26,28",room temperature,"17,18,70,71,24,25,41,42,37,38,59,60,49,50",added give stirred washed dissolved purified dried,"29,31",30 min,"78,80",140.1 mg,"80,81",68%
"Step 5. 3-(4-Aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-N-((1s,4s)-4-hydroxy-4-methylcyclohexyl-1-d)-4-methylbenzenesulfonamide To a solution of (1s,4s)-4-amino-1-methylcyclohexan-4-d-1-ol hydrochloride (7.1 mg, 0.043 mmol), triethylamine (18 μL, 0.128 mmol), and DMAP (0.5 mg, 4 μmol) in DMA (350 μL) at 0° C. was added 3-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-4-methylbenzenesulfonyl chloride (14 mg, 0.043 mmol) in a single portion. The reaction mixture was allowed to come to rt, stirring for 2 h. The reaction mixture was again cooled to 0° C., and the reaction was quenched with MeOH. Purification via preparative HPLC on a C-18 column (pH 10, 26-38% MeCN/0.1% NH4OH (aq) over 5 min, 60 mL/min) afforded the title compound as a white solid (4.1 mg, 23%). LCMS for C19H24DN6O3S (M+H)+: calculated m/z=418.2; found 418.1.","1,2",5,"84,85,83,84,85,86,71,72",NH4OH MeCN aq MeOH,"2,3,93,95","3-(4-Aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-N-((1s,4s)-4-hydroxy-4-methylcyclohexyl-1-d)-4-methylbenzenesulfonamide title compound","19,20,13,14",DMAP triethylamine,"25,26",DMA,"33,35,7,9","3-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-4-methylbenzenesulfonyl chloride (1s,4s)-4-amino-1-methylcyclohexan-4-d-1-ol hydrochloride","29,31,51,52,63,65",0° C rt 0° C,"32,33,91,92,52,53,72,73,69,70,61,62",added afforded stirring Purification quenched cooled,"54,56",2 h,"99,101",4.1 mg,"101,102",23%
"[Example 36] Synthesis of compound I-1286 The compound I-0937 (100 mg, 0.342 mmol) was dissolved in dioxane (2 mL). A Lawesson's reagent (180 mg, 0.444 mmol) was added to the solution. The mixture was stirred at 100°C for 1 hour. Pyridine (541 mg, 6.83 mmol) and cyanamide (71.8 mg, 1.709 mmol) were added to the reaction mixture. The mixture was stirred at 60°C for 1 hour. Ethyl acetate and 1 mol/L hydrochloric acid solution were added to the reaction mixture. The mixture was extracted with ethyl acetate. The organic layer was dried over sodium sulfate, and filtered. The Solvent was evaporated under reduced pressure . The obtained residue was purified by silica-gel column chromatography (ethyl acetate-n-hexane) to give the compound I-1286 (25.5 mg, yield 16%).","1,2",36,"114,116,71,73,85,87,66,68,111,112,93,95",ethyl acetate hydrochloric acid n-hexane ethyl acetate Ethyl acetate silica-gel sodium sulfate,"5,6,120,121",I-1286 I-1286,"40,41,20,22",Pyridine Lawesson's reagent,"16,17",dioxane,"46,47,8,9",cyanamide I-0937,"36,37,62,63",100°C 60°C,"27,28,14,15,52,53,117,118,34,35,60,61,91,92,109,110,83,84,75,76",added dissolved added give stirred stirred dried purified extracted added,"64,66,38,40",1 hour 1 hour,"121,123",25.5 mg,"124,125",16%
"Example 76 (E)-3-(4-((1R,3R/1S,3S)-6-(1-ethyl-1H-pyrazol-4-yl)-2-(2-fluoro-2-methylpropyl)-3-met hyl-1,2,3,4-tetrahydrobenzofuro[2,3-c]pyridin-1-yl)-3,5-difluorophenyl)acrylic acid Step 1 1-(5-bromobenzofuran-3-yl)propan-2-one 5-bromobenzofuran-3(2H)-one 76a (5 g, 23.471 mmol, prepared by a method disclosed in the patent application ""2008068974""), acetonyltriphenylphosphonium chloride (12.5 g, 35.206 mmol), and N,N-diisopropylehtylamine (9.1 g, 70.413 mmol) were dissolved in 60 mL of dimethylbenzene. The mixture was warmed up to 120°C and stirred for 12 hours, then the reaction was stopped. The reaction solution was cooled to room temperature and concentrated under reduced pressure. The residue was purified by silica gel column chromatography with elution system B to obtain the title compound 1-(5-bromobenzofuran-3-yl)propan-2-one 76b (3.1 g, yield 53%) as a yellow oil.","6,7,1,2",1 76,"78,80,2,5","silica gel (E)-3-(4-((1R,3R/1S,3S)-6-(1-ethyl-1H-pyrazol-4-yl)-2-(2-fluoro-2-methylpropyl)-3-met hyl-1,2,3,4-tetrahydrobenzofuro[2,3-c]pyridin-1-yl)-3,5-difluorophenyl)acrylic acid","92,93,91,92,7,8,89,91",76b 1-(5-bromobenzofuran-3-yl)propan-2-one 1-(5-bromobenzofuran-3-yl)propan-2-one title compound,"31,32","N,N-diisopropylehtylamine","42,43",dimethylbenzene,"9,10,8,9,24,26",76a 5-bromobenzofuran-3(2H)-one acetonyltriphenylphosphonium chloride,"49,50,66,68",120°C room temperature,"51,52,87,88,46,47,37,38,64,65,76,77",stirred obtain warmed dissolved cooled purified,"53,55",12 hours,"93,95",3.1 g,"96,97",53%
"184.9: 5-(2-chloro-3-fluorophenyl)-3-(2-methylsulphanyl-ethyl)-1-{2-[4-(7-methylsulphanyl-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-1H-pyrimidine-2,4-dione 185 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 107 mg (1 mmol) of 1-oxy-pyridin-2-ol are added to 0.3 g (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methylsulphanyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL of N,N-dimethylformamide. The reaction mixture is stirred for 5 min and then 281 mg (1 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one (prepared as described in 184.4) and 0.15 mL (1 mmol) of triethylamine are added. The reaction mixture is stirred at room temperature for 12 hours and then diluted with dichloromethane and water. The aqueous phase is extracted three times with dichloromethane, the organic phases are combined and washed with a saturated aqueous solution of sodium hydrogen carbonate and then with a saturated aqueous solution of sodium chloride. After drying over magnesium sulphate, the solution is filtered and then concentrated under vacuum. The crude residue obtained is purified by silica gel chromatography eluted with a heptane/ethyl acetate mixture 7/3. 520 mg (100%) of 5-(2-chloro-3-fluorophenyl)-3-(2-methylsulphanyl-ethyl)-1-{2-[4-(7-methylsulphanyl-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-1H-pyrimidine-2,4-dione is obtained in the form of a white solid.","0,1",184.9,"112,114,78,79,141,142,101,104,76,77,87,88,135,137,98,99,117,119,109,110",sodium chloride water ethyl acetate heptane sodium hydrogen carbonate dichloromethane dichloromethane silica gel aqueous magnesium sulphate aqueous,"149,150,1,2","5-(2-chloro-3-fluorophenyl)-3-(2-methylsulphanyl-ethyl)-1-{2-[4-(7-methylsulphanyl-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-1H-pyrimidine-2,4-dione 5-(2-chloro-3-fluorophenyl)-3-(2-methylsulphanyl-ethyl)-1-{2-[4-(7-methylsulphanyl-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-1H-pyrimidine-2,4-dione","7,9,58,59,15,16",1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride triethylamine 1-oxy-pyridin-2-ol,"30,31","N,N-dimethylformamide","46,47,24,26","7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one [5-(2-chloro-3-fluorophenyl)-3-(2-methylsulphanyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid","67,69",room temperature,"17,18,65,66,151,152,60,61,35,36,74,75,83,84,133,134,94,95,115,116",added stirred obtained added stirred diluted extracted purified washed drying,"70,72,37,39",12 hours 5 min,"145,147",520 mg,"147,148",100%
"Step 2. methyl 4-((3-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-4-methylphenyl)sulfonamido)cubane-1-carboxylate To a solution of methyl-4-aminocubane-1-carboxylate (96 mg, 0.54 mmol), Et3N (0.30 mL, 2.2 mmol), and DMAP (6.6 mg, 0.054 mmol) in DCM (0.5 mL) was added 3-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-4-methylbenzenesulfonyl chloride (175 mg, 0.541 mmol) and the resulting solution was stirred at ambient temperature for 6 h. The crude reaction mixture was purified by CombiFlash chromatography (25 g silica gel column, eluting with 0-15% methanol/dichloromethane) to afford the desired product (93 mg, 38%). LCMS for C22H20N6O4S (M+H)+: calculated m/z=465.5; found 465.2.","1,2",2,"65,66,59,61",methanol silica gel dichloromethane,"69,71,2,4","desired product methyl 4-((3-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-4-methylphenyl)sulfonamido)cubane-1-carboxylate","13,14,19,20",Et3N DMAP,"25,26",DCM,"30,32,8,9","3-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-4-methylbenzenesulfonyl chloride methyl-4-aminocubane-1-carboxylate","43,45",ambient temperature,"29,30,41,42,67,68,53,54",added stirred afford purified,"46,48",6 h,"71,73",93 mg,"73,74",38%
"Example 3 (E)-3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-6-hydroxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylic acid Step 1 3-(2-((2-fluoro-2-methylpropyl)amino)propyl)phenol 3-(2-aminopropyl)phenol 3a (220 mg, 2.3 mmol, prepared by a method disclosed in the patent application ""WO2009068177""), 2-fluoro-2-methylpropyl trifluoromethanesulfonate 1b (651 mg, 2.9 mmol) and N,N-diisopropylethylamine (559 mg, 4.365 mmol) were dissolved in 5 mL of 1,4-dioxane. The resulting mixture was heated to 90°C and stirred for 12 hours under an argon atmosphere. The reaction was stopped, and the reaction solution was concentrated under reduced pressure. The residue was purified by silica gel column chromatography with elution system A to obtain the title compound 3-(2-((2-fluoro-2-methylpropyl)amino)propyl)phenol 3b (113 mg, yield 35%) as a brown liquid.","1,2,5,6",3 1,"77,79,57,58,2,4","silica gel argon (E)-3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-6-hydroxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)phenyl)acrylic acid","91,92,90,91,88,90,6,7",3b 3-(2-((2-fluoro-2-methylpropyl)amino)propyl)phenol title compound 3-(2-((2-fluoro-2-methylpropyl)amino)propyl)phenol,"31,32","N,N-diisopropylethylamine","42,43","1,4-dioxane","23,25,8,9,25,26,7,8",2-fluoro-2-methylpropyl trifluoromethanesulfonate 3a 1b 3-(2-aminopropyl)phenol,"49,50",90°C,"51,52,86,87,37,38,47,48,75,76",stirred obtain dissolved heated purified,"53,55",12 hours,"92,94",113 mg,"95,96",35%
"Preparation of (6S,8R)-6-(4-bromo-2-methoxyphenyl)-7-(2,2-difluoropropyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline Sodium nitrite (0.049 g, 0.72 mmol) as a solution in water (0.750 mL) was added dropwise to a cooled solution of (1S,3R)-1-(4-bromo-2-methoxyphenyl)-2-(2,2-difluoropropyl)-3,5-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-amine (0.30 g, 0.68 mmol) in propionic acid (2.5 mL) at −15° C., and the reaction was stirred for 1 hour under these conditions. Ice-cold EtOAc (10 mL) was added followed by saturated aqueous NaHCO3 (10 mL) in portions. The layers were separated, and the the organic layer was washed with saturated aqueous NaHCO3. The combined aqueous layers were extracted with EtOAc, and all organic layers were combined, dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue was purified by flash silica chromatography, elution gradient 20 to 70% ethyl acetate in hexanes, to afford (6S,8R)-6-(4-bromo-2-methoxyphenyl)-7-(2,2-difluoropropyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline (0.23 g, 75%) as a gum.",,,"58,59,77,78,108,109,76,77,115,117,85,86,57,58,94,95,49,50,118,119",NaHCO3 NaHCO3 silica aqueous ethyl acetate EtOAc aqueous Na2SO4 EtOAc hexanes,"121,122,2,3","(6S,8R)-6-(4-bromo-2-methoxyphenyl)-7-(2,2-difluoropropyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline (6S,8R)-6-(4-bromo-2-methoxyphenyl)-7-(2,2-difluoropropyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline","30,32,3,5",propionic acid Sodium nitrite,"13,14",water,"24,25","(1S,3R)-1-(4-bromo-2-methoxyphenyl)-2-(2,2-difluoropropyl)-3,5-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-amine","35,37",−15° C,"41,42,120,121,17,18,53,54,92,93,73,74,105,106,83,84",stirred afford added added dried washed purified extracted,"43,45",1 hour,"122,124",0.23 g,"124,125",75%
"[Synthesis Example 2] Synthesis of Compound 3 [Reaction Scheme 2-1] Synthesis of [Intermediate 2-a] In a 500-mL reactor, Intermediate 1-e (20 g, 55 mmol) and tetrahydrofuran (200 mL) were placed and stirred together. After the mixture was cooled to −78° C., 1.6M N-butyllithium (41 mL, 66 mmol) was dropwise added and stirred for 1 hour. Iodine (16.7 g, 66 mmol) was added, followed by heating to room temperature and stirring for 2 hours. An aqueous sodium thiosulfate solution was added and an organic layer was extracted. Purification by column chromatography afforded Intermediate 2-a (20.4 g): yield 91%","2,3",2,"74,75,75,77,6,7",aqueous sodium thiosulfate 3,"91,93,12,14",Intermediate 2-a Intermediate 2-a,"55,56,42,43",Iodine N-butyllithium,"25,26",tetrahydrofuran,"18,20",Intermediate 1-e,"39,41,66,68",−78° C room temperature,"51,52,31,32,69,70,61,62,90,91,64,65,29,30,37,38,49,50,79,80",stirred stirred stirring added afforded heating placed cooled added added,"53,55,71,73",1 hour 2 hours,"93,95",20.4 g,"96,97",91%
"Example 59 5-Methyl-6-[6-(3-methyl-3H-imidazol-4-yl)-pyridin-2-yl methyl]-[1,2,5]oxadiazolo[3,4-b]pyridin-7-ylamine Obtained by starting from 6-(6-Chloro-pyridin-2-ylmethyl)-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-7-ylamine (example 3) and (1-Methyl-1H-imidazol-5-yl)boronic acid pinacol ester. The mixture is purified by RP-HPLC (modifier: ammonium hydroxide). Yield: 15 mg (25% of theory)","1,2",59,"23,25",ammonium hydroxide,"2,4","5-Methyl-6-[6-(3-methyl-3H-imidazol-4-yl)-pyridin-2-yl methyl]-[1,2,5]oxadiazolo[3,4-b]pyridin-7-ylamine",,,,,"8,9,12,16,9,11","6-(6-Chloro-pyridin-2-ylmethyl)-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-7-ylamine (1-Methyl-1H-imidazol-5-yl)boronic acid pinacol ester example 3",,,"6,7,4,5,19,20",starting Obtained purified,,,"26,28",15 mg,"28,29",25%
"Synthesis Example 12: Synthesis of Compound 358 Compound 358 was synthesized in the same manner as in Synthesis Example 9, except that 5,9-dibromo-dibenzo[c,g]fluoren-7-one was used instead of 5,9-dibromo-benzo[c]fluoren-7-one in Synthesis of Intermediate Compound (iii). Yield: 0.63 g (0.51 mmol, 73%). HR-EIMS (m/z) [M+] calcd for C92H66N4 1226.5287; found, 1250.5294.","2,3",12,"27,28,33,34","5,9-dibromo-benzo[c]fluoren-7-one iii","8,9,6,7",358 358,,,,,"22,23","5,9-dibromo-dibenzo[c,g]fluoren-7-one",,,"10,11,24,25",synthesized used,,,"35,37,37,39",0.63 g 0.51 mmol,"39,40",73%
"Synthesis of Intermediate Compound (ii) The Intermediate Compound (i) was dissolved in tetrahydrofuran (0.05 M, solvent), cooled to a temperature of 0° C., and then stirred for 0.5 hours. Then, methylmagnesium bromide (1.05 equiv.) was slowly added thereto dropwise and then additionally stirred at room temperature for 6 hours. An organic layer was obtained by performing an extraction process on the reaction mixture three times by using ethyl acetate and water. The obtained organic layer was dried by using magnesium sulfate, and the solvent was evaporated therefrom. The obtained residue was separated and purified by silica gel column chromatography to obtain Intermediate Compound (ii). The obtained compound was identified by using 1H NMR, 13C NMR, and HR-EIMS. Yield: 2.62 g (4.94 mmol, 68%). HR-EIMS (m/z) [M+1+] calcd for C36H27NO2 530.2042; found, 530.2351.",,,"95,97,67,69,70,71,79,81",silica gel ethyl acetate water magnesium sulfate,"103,104,4,5",ii ii,,,"12,13",tetrahydrofuran,"30,32,8,9",methylmagnesium bromide i,"44,46,21,23",room temperature 0° C,"16,17,42,43,100,101,36,37,10,11,25,26,57,58,93,94,76,77",cooled stirred obtain added dissolved stirred extraction purified dried,"27,29,47,49",0.5 hours 6 hours,"120,122,118,120",4.94 mmol 2.62 g,"122,123",68%
"Step B: 3-(2,4-Difluorophenyl)-1-(pyrazin-2-yl)-1H-[thieno[2,3-c]pyrazole-5-carboxylic acid Ethyl 3-(2,4-difluorophenyl)-1-(pyrazin-2-yl)-1H-thieno[2,3-c]pyrazole-5-carboxylate (54.0 mg, 0.140 mmol) was dissolved in tetrahydrofuran (900 µl) and methanol (600 µl) at 25 °C. 1M sodium hydroxide (559 µl, 0.559 mmol) was added and the reaction mixture heated to 50 °C, and stirred for 12 h. The reaction was stopped, cooled to room temperature, quenched by addition of concentrated hydrochloric acid (46.2 µL), and concentrated under reduced pressure. The title compound with 4 equivalents of sodium chloride (87.2 mg, 0.139 mmol, 99 % yield) was recovered as a light yellow/white solid. LC-MS [M+1] = 359.2.","1,2",B,"74,76,58,60",sodium chloride hydrochloric acid,"68,70,2,4","title compound 3-(2,4-Difluorophenyl)-1-(pyrazin-2-yl)-1H-[thieno[2,3-c]pyrazole-5-carboxylic acid","24,26",sodium hydroxide,"17,18,13,14",methanol tetrahydrofuran,"4,6","Ethyl 3-(2,4-difluorophenyl)-1-(pyrazin-2-yl)-1H-thieno[2,3-c]pyrazole-5-carboxylate","51,53,21,23,38,40",room temperature 25 °C 50 °C,"84,85,36,37,11,12,41,42,31,32,49,50,53,54",recovered heated dissolved stirred added cooled quenched,"43,45",12 h,"76,78,78,80",87.2 mg 0.139 mmol,"80,82",99 %
"Step 2 (E)-methyl3-(4-((1S,3R/1R,3S)-6-acetoxy-2-(2-fluoro-2-methylpropyl)-7-formyl-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-3,5-difluorophenyl)acrylate (E)-methyl 3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-7-formyl-6-hydroxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl) phenyl)acrylate 77a (300 mg, 0.65 mmol) and sodium acetate (160 mg, 1.95 mmol) were dissolved in 9 mL of acetic anhydride. The reaction mixture was warmed up to 150°C and stirred for 12 hours. The reaction solution was cooled to room temperature and concentrated under reduced pressure. The residue was purified by silica gel column chromotography with elution system B to obtain the title compound (E)-methyl 3-(4-((1S,3R/1R,3S)-6-acetoxy-2-(2-fluoro-2-methylpropyl)-7-formyl-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-3,5-difluorophenyl)acrylate 77b (150 mg, yield 47.5%) as a colorless oil.","1,2",2,"57,59",silica gel,"68,70,2,3,72,73,70,72","title compound (E)-methyl3-(4-((1S,3R/1R,3S)-6-acetoxy-2-(2-fluoro-2-methylpropyl)-7-formyl-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-3,5-difluorophenyl)acrylate 77b (E)-methyl 3-(4-((1S,3R/1R,3S)-6-acetoxy-2-(2-fluoro-2-methylpropyl)-7-formyl-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-3,5-difluorophenyl)acrylate","12,14",sodium acetate,,,"6,7,3,6,24,26","77a (E)-methyl 3-(3,5-difluoro-4-((1S,3R/1R,3S)-2-(2-fluoro-2-methylpropyl)-7-formyl-6-hydroxy-3-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl) phenyl)acrylate acetic anhydride","33,34,45,47",150°C room temperature,"19,20,35,36,66,67,30,31,55,56,43,44",dissolved stirred obtain warmed purified cooled,"37,39",12 hours,"73,75",150 mg,"76,77",47.5%
"Step 5. 3-Bromo-N-(4-methoxybenzyl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-amine A mixture of 3-bromo-8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyrazine (0.35 g, 1.2 mmol), N,N-diisopropylethylamine (0.40 mL, 2.3 mmol), and 4-methoxybenzylamine (0.17 mL, 1.3 mmol) in iPrOH (5.0 mL) was heated at 110° C. for 15 min in a microwave. The resulting white suspension was washed with water (3×). The resulting white solid was dried in vacuo overnight to afford the title compound as a white solid (0.53 g, 99%).","1,2",5,"44,45",water,"2,3,58,60","3-Bromo-N-(4-methoxybenzyl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-amine title compound","11,12","N,N-diisopropylethylamine","23,24",iPrOH,"6,7,17,18","3-bromo-8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyrazine 4-methoxybenzylamine","29,31",110° C,"56,57,27,28,42,43",afford heated washed,"32,34",15 min,"64,66",0.53 g,"66,67",99%
"Example 15: Synthesis of (S)-3-aminoquinuclidine.monosulfate Toluene solution (33.99 g) containing (S)-3-aminoquinuclidine (4.05 g: 32.1 mmol) was charged into a 50 mL-flask equipped with a mechanical stirrer, a thermometer, and a cooling line, and 95% sulfuric acid (3.32 g: 32.2 mmol) was added thereto while stirring on ice. Precipitated crystals were filtered, and then dried under reduced pressure at 60° C., to obtain (S)-3-aminoquinuclidine.monosulfate (6.12 g (27.3 mmol, yield=85%) as a white crystal. Endothermic peak top temperature in DSC: 86° C., 188° C., 297° C. Elemental analysis: C7H14N2.H2SO4 Theoretical value: C, 37.49%, H, 7.19%, N, 12.49%, S 14.29% Actual measured value: C, 36.6%, H, 7.1%, N, 12.2%, S 14.2%","1,2",15,,,"62,63,4,5",(S)-3-aminoquinuclidine.monosulfate (S)-3-aminoquinuclidine.monosulfate,"34,36",sulfuric acid,"5,6",Toluene,"10,11",(S)-3-aminoquinuclidine,"58,60",60° C,"41,42,16,17,61,62,53,54",added charged obtain dried,,,"65,67,63,65",27.3 mmol 6.12 g,,85%
"Step 3. 3-(4-Aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-N-(4-cyanobicyclo[2.1.1]hexan-1-yl)benzenesulfonamide A microwave vial was charged with N-(4-cyanobicyclo[2.1.1]hexan-1-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide (70.0 mg, 0.180 mmol), 7-bromoimidazo[2,1-f][1,2,4]triazin-4-amine (46 mg, 0.22 mmol, Synthonix) and THF (1.8 mL), followed by the addition of 1 M aq. K2CO3 (0.54 mL, 0.54 mmol). The reaction mixture was degassed and heated to 90° C. for 3.5 hours. Upon cooling to room temperature, the reaction mixture was partitioned between water and EtOAc. The aqueous layer was extracted with two further portions of EtOAc. The combined organic extracts were dried over sodium sulfate, filtered and concentrated. The product was purified by flash chromatography, eluting with a gradient from 0-100% EtOAc in hexanes to afford a white solid (68 mg, 95%). LCMS for C18H18N7O2S (M+H)+: calculated m/z=396.1, found 396.1.","1,2",3,"82,84,61,62,102,103,74,75,100,101,63,64",sodium sulfate water hexanes EtOAc EtOAc EtOAc,"107,108,2,3","solid 3-(4-Aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-N-(4-cyanobicyclo[2.1.1]hexan-1-yl)benzenesulfonamide","32,33",K2CO3,"31,32,21,22",aq THF,"14,15,9,10","7-bromoimidazo[2,1-f][1,2,4]triazin-4-amine N-(4-cyanobicyclo[2.1.1]hexan-1-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide","45,47,53,55",90° C room temperature,"104,105,7,8,27,28,43,44,80,81,59,60,90,91,51,52,68,69",afford charged addition heated dried partitioned purified cooling extracted,"48,50",3.5 hours,"108,110",68 mg,"110,111",95%
"Step 3. 2-Bromo-1-fluoro-5-iodo-3-methylbenzene To a solution of 4-bromo-3-fluoro-5-methylaniline (7.28 g, 36 mmol) in acetonitrile (190 mL) cooled to 0° C. in an ice bath was added sulfuric acid (4.75 mL, 89 mmol) dissolved in H2O (10 mL). After stirring for 5 minutes, a solution of sodium nitrite (4.92 g, 71.4 mmol) in water (10 mL) was added dropwise, and the reaction mixture was stirred for an additional 15 minutes at 0° C. Potassium iodide (23.7 g, 143 mmol) in water (20 mL) was then added, and the ice-bath was removed. After warming to r.t., the reaction was stirred for an additional 20 minutes before the reaction was quenched via the addition of aqueous Na2S2O3. The mixture was then extracted with ethyl acetate and the combined organic phases were washed with brine, dried over magnesium sulfate, and concentrated under reduced pressure. The crude product was purified by Biotage Isolera™ (10.3 g, 94%).","1,2",3,"133,135,113,114,112,113,130,131,120,122",magnesium sulfate Na2S2O3 aqueous brine ethyl acetate,"142,143,2,3",product 2-Bromo-1-fluoro-5-iodo-3-methylbenzene,"72,74,26,28,45,47",Potassium iodide sulfuric acid sodium nitrite,"52,53,13,14,79,80,34,35",water acetonitrile water H2O,"7,8",4-bromo-3-fluoro-5-methylaniline,"18,20,70,72,93,94",0° C 0° C r.t.,"25,26,84,85,56,57,32,33,97,98,16,17,91,92,144,145,38,39,63,64,128,129,131,132,107,108,118,119",added added added dissolved stirred cooled warming purified stirring stirred washed dried quenched extracted,"40,42,101,103,67,69",5 minutes 20 minutes 15 minutes,"148,150",10.3 g,"150,151",94%
"(3) Preparation of tert-butyl 8-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-3-azabicyclo[ 3.2.1]octane-3-carboxylate (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid (0.56 g, 2.03 mmol), tert-butyl 8-amino-3-azabicyclo[3.2.1]octane-3-carboxylate (0.46 g, 2.03 mmol), 1-hydroxylbenzotriazole (0.3 g, 2.22 mmol), 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.8 g, 4.17 mmol) and triethylamine (0.4 g, 3.9 mmol) were dissolved in dichloromethane (10 mL), stirred and reacted under nitrogen gas protection at 25 °C for 16 h. The reaction solution was concentrated, and the obtained crude product was separated and purified by silica gel column chromatography (petroleum ether : ethyl acetate =1:1) to obtain the title compound as a colorless gum (0.52 g, yield 53.1 %).","0,1",3,"45,46,76,78,73,75,69,71",nitrogen ethyl acetate petroleum ether silica gel,"82,84,3,6","title compound tert-butyl 8-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-3-azabicyclo[ 3.2.1]octane-3-carboxylate","30,31,18,19,23,25",triethylamine 1-hydroxylbenzotriazole 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride,"38,39",dichloromethane,"6,8,12,14","(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid tert-butyl 8-amino-3-azabicyclo[3.2.1]octane-3-carboxylate","49,51",25 °C,"43,44,80,81,36,37,67,68",reacted obtain dissolved purified,"52,54",16 h,"88,90",0.52 g,"91,93",53.1 %
"Example 22A Methyl 3-ethyl-1-(2-methoxyethyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylate Analogously to the method described in Ex. 19A, 2.05 g (6.56 mmol) of the compound from Ex. 17A were used to obtain 2.11 g (98% of theory) of the title compound It was possible here to dispense with chromatographic purification of the product.","1,2",22A,,,"33,35,2,4","title compound Methyl 3-ethyl-1-(2-methoxyethyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylate",,,,,"18,22",compound from Ex. 17A,,,"25,26,23,24",obtain used,,,"26,28",2.11 g,"28,29",98%
"Example 104 1-Methyl-3-[4-(3-methylisoxazol-5-yl)butyl]pyrido[3,2-d]pynmidine-2,4-dione Step 1 1-Methyl-3-[4-(3-methylisoxazol-5-yl)butyl]pyrido[3,2-d]pyrimidine-2,4-dione 1-Methylpyrido[3,2-d]pyrimidine-2,4-dione (30.0 mg, 169 mmol), 5-(4-bromobutyl)-3-methyl-isoxazole (40.6 mg, 186 mmol) and potassium carbonate (58.5 mg, 423 mmol) were dissolved in N,N-dimethylformamide (4 mL), potassium iodide (2.8 mg, 0.017 mmol) was added and the reaction was stirred to reflux at 120°C for 3 hours. The reaction solution was directly filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by preparative HPLC to give 1-methyl-3-[4-(3-methylisoxazol-5-yl)butyl]pyrido[3,2-d]pyrimidine-2,4-dione (7.2 mg) with a yield of 13%.","4,5,1,2",1 104,,,"2,3,73,74,5,6","1-Methyl-3-[4-(3-methylisoxazol-5-yl)butyl]pyrido[3,2-d]pynmidine-2,4-dione 1-methyl-3-[4-(3-methylisoxazol-5-yl)butyl]pyrido[3,2-d]pyrimidine-2,4-dione 1-Methyl-3-[4-(3-methylisoxazol-5-yl)butyl]pyrido[3,2-d]pyrimidine-2,4-dione","29,31,17,19",potassium iodide potassium carbonate,"26,27","N,N-dimethylformamide","6,7,11,12","1-Methylpyrido[3,2-d]pyrimidine-2,4-dione 5-(4-bromobutyl)-3-methyl-isoxazole","43,44,45,46",reflux 120°C,"24,25,36,37,72,73,41,42",dissolved added give stirred,"47,49",3 hours,"74,76",7.2 mg,"80,81",13%
"Synthesis of Compound 55 Bromoacetyl bromide (150.0 mg, 0.75 mmol) was added to a solution of compound 54 (573.7 mg, 0.5 mmol) in DMF (10 mL) at 0° C. The resulting mixture was stirred at 0° C. for 10 minutes and then allowed to stir at room temperature for another 3 hours. The mixture was added water (20 mL) and extracted by ethyl acetate (20 mL×3). The combined organic layers were concentrated, and the residue was purified by pre-HPLC to give compound 55 (421 mg, 66.4%) as a yellow powder. LC-MS m/z (ES+), 1270.38 (M+H)+.",,,"56,57,62,64",water ethyl acetate,"3,4,82,83",55 55,,,"23,24",DMF,"17,18,4,6",54 Bromoacetyl bromide,"27,29,35,37,46,48",0° C 0° C room temperature,"44,45,33,34,80,81,11,12,55,56,60,61",stir stirred give added added extracted,"38,40,50,52",10 minutes 3 hours,"83,85",421 mg,"85,86",66.4%
"Intermediate 10: 1,6-Diamino-2-chloro-3-iodopyridin-1-ium 2,4,6-trimethylbenzenesulfonate Step A: 6-Chloro-5-iodopyridin-2-amine. To a solution of 6-chloropyridin-2-amine (50.0 g, 389 mmol) in DMF (700 mL) was added N-iodosuccinimide (105 g, 467 mmol). The brown solution was stirred at rt for 12 h. The mixture was poured into water (2.1 L) and filtered. The filter cake was washed with water (2×500 mL) and then dried under vacuum. Purification (FCC, SiO2; 5-20% EtOAc/petroleum ether) afforded the title compound (83 g, 75%) as a pink solid.","5,6,1,2",A 10,"65,66,53,54,2,4,63,64,42,43","petroleum ether EtOAc water 1,6-Diamino-2-chloro-3-iodopyridin-1-ium 2,4,6-trimethylbenzenesulfonate SiO2 water","69,71,6,7",title compound 6-Chloro-5-iodopyridin-2-amine,"22,23",N-iodosuccinimide,"17,18",DMF,"11,12",6-chloropyridin-2-amine,"33,34",rt,"67,68,21,22,31,32,61,62,40,41,51,52",afforded added stirred Purification poured washed,"35,37",12 h,"71,73",83 g,"73,74",75%
"[EXAMPLE 6] Synthesis of compounds 1-037 and 1-038 Step 1 Synthesis of compound 37b The compound 37a (5.00 g, 31.9 mmol) was dissolved in tetrahydrofuran (50 ml). Under ice cooling, a solution of diphenyldiazomethane (8.04 g, 41.4 mmol) in tetrahydrofuran (10 ml) was added to the solution. The mixture was stirred overnight at room temperature and then concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, followed by elution with hexane/ethyl acetate. Fractions containing the desired compound were concentrated under reduced pressure to afford the compound 37b (9.86 g, 96%).","9,10,1,2",1 6,"7,8,74,75,5,6,66,68",1-038 hexane 1-037 silica gel ethyl acetate,"90,91,13,14",37b 37b,,,"39,40,24,25",tetrahydrofuran tetrahydrofuran,"33,34,16,17",diphenyldiazomethane 37a,"53,55",room temperature,"50,51,87,88,22,23,43,44,72,73,64,65",stirred afford dissolved added elution subjected,,,"91,93",9.86 g,"93,94",96%
"Example Compound 49 2-((3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)amino)-2-oxoethyl 2-(m-tolyl)acetate 2-(3-tolyl)acetic acid (26.8 mg, 0.2 mmol) was dissolved in DCM (3.4 mL) and added DCC (34.1 mg, 0.2 mmol) and DMAP (4.0 mg, 0.03 mmol) followed by N-(3,5-dimethyl-1-phenyl-1 H-pyrazol-4-yl)-2-hydroxyacetamide (38.2 mg, 0.2 mmol), synthesized as reported in Example 1. The obtained suspension was filtered over cotton to remove the bulk of DCU and purified by column chromatography (75% EtOAc in PE) to afford 59 mg (99%) of the title compound",,,"56,57,63,64,65,66",DCU EtOAc PE,"3,5,73,75,2,3","2-((3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)amino)-2-oxoethyl 2-(m-tolyl)acetate title compound 49","25,26,19,20",DMAP DCC,"14,15",DCM,"5,7,32,34","2-(3-tolyl)acetic acid N-(3,5-dimethyl-1-phenyl-1 H-pyrazol-4-yl)-2-hydroxyacetamide",,,"67,68,18,19,30,31,12,13,58,59,48,49",afford added followed dissolved purified filtered,,,"68,70",59 mg,"70,71",99%
"Example 55 7-Butyl-3-methyl-1-(4-(3-methylisoxazol-5-yl)butyl)-1H-punne-2,6(3H,7H)-dione Step 1 7-Butyl-3-methyl-1H-purine-2,6(3H,7H)-dione 3-Methyl-1H-purine-2,6(3H,7H)-dione (4.00 g, 24.1 mmol) was dissolved in methanol (30 mL). An aqueous solution (15 mL) of potassium hydroxide (1.48 g, 26.5 mmol) was added and the mixture was heated to 80°C and stirred for 1.5 hours. After cooling to 50°C, 1-iodobutane (5.76 g, 31.3 mmol) was added and the reaction was stirred at 50°C for 24 hours. Then the reaction was cooled to room temperature, filtered, and the filter cake was washed successively with water (30 mL) and methanol (30 mL), and dried to give 7-butyl-3-methyl-1H-purine-2,6(3H,7H)-dione (2.80 g, as a white solid) with a yield of 52%.","4,5,1,2",1 55,"2,3,81,82,85,86","7-Butyl-3-methyl-1-(4-(3-methylisoxazol-5-yl)butyl)-1H-punne-2,6(3H,7H)-dione water methanol","5,6,92,93","7-Butyl-3-methyl-1H-purine-2,6(3H,7H)-dione 7-butyl-3-methyl-1H-purine-2,6(3H,7H)-dione","23,25",potassium hydroxide,"14,15,18,19",methanol aqueous,"47,48,6,7","1-iodobutane 3-Methyl-1H-purine-2,6(3H,7H)-dione","60,61,37,38,70,72,46,47",50°C 80°C room temperature 50°C,"53,54,30,31,39,40,35,36,44,45,91,92,58,59,12,13,68,69,78,79",added added stirred heated cooling give stirred dissolved cooled washed,"62,64,41,43",24 hours 1.5 hours,"93,95",2.80 g,"103,104",52%
"Step 2. 2-(4-Bromo-3,5-difluorophenyl)acetonitrile To a mixture of 4-(4-bromo-3,5-difluorophenyl)isoxazole (489.4 mg, 1.882 mmol) and potassium fluoride (584.8 mg, 10.07 mmol) was added DMF (5.0 ml) followed by water (5.0 ml). The reaction was heated to 90° C. for 3 h. After cooling to room temperature, the mixture was diluted with CH2Cl2, and washed with brine. The organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified on silica gel (40 g, 0-100% EtOAc in hexanes) to give the desired product as an off-white solid (363.4 mg, 83%).","1,2",2,"49,50,61,62,77,78,70,72,53,54,75,76",CH2Cl2 Na2SO4 hexanes silica gel brine EtOAc,"2,3,81,83","2-(4-Bromo-3,5-difluorophenyl)acetonitrile desired product","13,15",potassium fluoride,"21,22,26,27",DMF water,"7,8","4-(4-bromo-3,5-difluorophenyl)isoxazole","34,36,42,44",90° C room temperature,"20,21,32,33,79,80,58,59,68,69,40,41,51,52,47,48",added heated give dried purified cooling washed diluted,"37,39",3 h,"87,89",363.4 mg,"89,90",83%
"Step 2. 6-Bromo-1-trityl-1H-pyrazolo[4,3-b]pyridine 4-oxide To a solution of 6-bromo-1-trityl-1H-pyrazolo[4,3-b]pyridine (3.240 g, 7.36 mmol) in DCM (60.0 ml) was added m-CPBA (5.83 g, 26.0 mmol) portionwise. After stirring at room temperature for 16 h, the reaction mixture was treated with a solution of sodium thiosulfate (30.0 g, 190 mmol) in water (100 ml). The organic phase was washed with 2 M K2CO3 (aq), dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified on silica gel (120 g, 0-100% EtOAc in DCM) to give the desired product as a white foamy solid (3.22 g, 96%).","1,2",2,"81,82,74,76,60,61,61,62,79,80,49,50,65,66,42,44",DCM silica gel K2CO3 aq EtOAc water Na2SO4 sodium thiosulfate,"2,4,85,87","6-Bromo-1-trityl-1H-pyrazolo[4,3-b]pyridine 4-oxide desired product","19,20",m-CPBA,"14,15",DCM,"8,9","6-bromo-1-trityl-1H-pyrazolo[4,3-b]pyridine","28,30",room temperature,"26,27,18,19,83,84,72,73,62,63,56,57,37,38",stirring added give purified dried washed treated,"31,33",16 h,"92,94",3.22 g,"94,95",96%
"Synthesis Example 15: Synthesis of Compound 361 Compound 361 was synthesized in the same manner as in Synthesis Example 1, except that 4,4'-dimethoxydiphenylamine was used instead of biphenyl-3-yl(dibenzofuran-4-yl)amine in Synthesis of Intermediate Compound (i). Yield: 0.89 g (0.70 mmol, 45%). HR-EIMS (m/z) [M+] calcd for C84H74N4O8 1266.5507; found, 1266.5515.","2,3",15,"33,34,27,28",i biphenyl-3-yl(dibenzofuran-4-yl)amine,"8,9,6,7",361 361,,,,,"22,23","4,4'-dimethoxydiphenylamine",,,"10,11,24,25",synthesized used,,,"37,39,35,37",0.70 mmol 0.89 g,"39,40",45%
"Example 2. Preparation of SM-2: 1,1-Difluoro-2-oxo-2-(1-adamantylamino) ethanesulfonyl fluoride A 100 mL flask was charged with C2Cl2 (20 mL) under nitrogen stream at 0° C. and then 2-(fluorosulfonyl)difluoroacetyl fluoride (8.49 g, 47.1 mmol, 1.2 eq.) was added and the mixture was stirred for 10 minutes at 0° C. A CH2Cl2 (20 mL) solution of 1-adamantylamine (5.94 g, 39.3 mmol, 1.0 eq.) and Pyridine (3.10 g, 39.3 mmol, 1.0 eq.) was added drop-wise to the mixture over 15 minutes and subsequently the mixture was stirred for 4 hours at 0° C. to room temperature. CH2Cl2 (40 mL) and 1N HCl (40 mL) were added to the final reaction mixture and then the lower layer was separated and washed with 1N HCl (40 mL) and brine (40 mL). The solution was dried over anhydrous MgSO4 and filtrated and then CH2Cl2 was removed in an evaporator. The target compound as yellow solid (11.77 g) in 96.2% yield was obtained.","1,2",2,"118,119,92,93,122,123,19,20,97,98,131,132,136,137",HCl CH2Cl2 brine nitrogen HCl MgSO4 CH2Cl2,"5,8,4,5,143,145","1,1-Difluoro-2-oxo-2-(1-adamantylamino) ethanesulfonyl fluoride SM-2 target compound","61,62",Pyridine,"15,16,48,49",C2Cl2 CH2Cl2,"53,54,26,28",1-adamantylamine 2-(fluorosulfonyl)difluoroacetyl fluoride,"22,24,87,89,90,92,45,47",0° C 0° C room temperature 0° C,"35,36,69,70,154,155,40,41,82,83,13,14,128,129,115,116,138,139,101,102",added added obtained stirred stirred charged dried washed removed added,"84,86,75,77,42,44",4 hours 15 minutes 10 minutes,"148,150",11.77 g,"151,152",96.2%
"EXAMPLE 78 5-(2-chloro-3-methanesulphonyl-phenyl)-3-isopropyl-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione (reaction scheme No. 3, compound 78) A solution containing 2 mg (2 μmol) of ammonium molybdate tetrahydrate in 76 μl (0.7 mmol) of hydrogen peroxide is added to 22 mg (40 μmol) of 5-(2-chloro-3-methylsulphanyl-phenyl)-3-isopropyl-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione (prepared as described in example 76.4), in 0.9 ml of ethanol. The reaction mixture is stirred at room temperature for 2 hours, it is hydrolysed with a saturated aqueous solution of sodium hydrogen carbonate and then extracted with ethyl acetate. The organic phase is washed twice with 10% aqueous solution of sodium thiosulphate, once with water, dried over magnesium sulphate, filtered and concentrated under vacuum. The product precipitates in diethyl ether and then the solvent is removed under nitrogen and the white solid obtained is dried under vacuum. 18 mg (76%) of 5-(2-chloro-3-methanesulphonyl-phenyl)-3-isopropyl-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione is obtained in the form of a white solid.","1,2",78,"92,93,88,90,95,97,65,66,85,86,68,71,106,108,115,116,75,77",water sodium thiosulphate magnesium sulphate aqueous aqueous sodium hydrogen carbonate diethyl ether nitrogen ethyl acetate,"2,3,129,130,8,9","5-(2-chloro-3-methanesulphonyl-phenyl)-3-isopropyl-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione 5-(2-chloro-3-methanesulphonyl-phenyl)-3-isopropyl-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione 78","17,20,26,28",ammonium molybdate tetrahydrate hydrogen peroxide,"47,48",ethanol,"36,37","5-(2-chloro-3-methylsulphanyl-phenyl)-3-isopropyl-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione","54,56",room temperature,"29,30,52,53,131,132,113,114,73,74,81,82,61,62,93,94,104,105",added stirred obtained removed extracted washed hydrolysed dried precipitates,"57,59",2 hours,"125,127",18 mg,"127,128",76%
"Example 12A tert-Butyl 3-ethyl-1-(2-methoxyethyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylate Analogously to the method described in Ex. 11A, 2.50 g (8.05 mmol) of the compound from Ex. 7A, 3.94 g (12.1 mmol) of caesium carbonate and 1.68 g (12.1 mmol) of 2-bromoethyl methyl ether were used to obtain 2.13 g (71% of theory) of the title compound In a departure from the method described above, a Biotage cartridge containing 50 g of silica gel was used here for the MPLC purification, and the product was finally purified by stirring in a mixture of 60 ml of pentane and 0.5 ml of dichloromethane.","1,2",12A,"90,91,66,68,95,96",pentane silica gel dichloromethane,"49,51,2,4","title compound tert-Butyl 3-ethyl-1-(2-methoxyethyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylate","27,29",caesium carbonate,,,"35,38,18,22",2-bromoethyl methyl ether compound from Ex. 7A,,,"41,42,80,81,74,75",obtain purified purification,,,"42,44",2.13 g,"44,45",71%
"Synthesis of compound 1-b Compound 1-c (1.88g, 10mmol) and N-bromosuccinimide (2.7g, 15mmol) were dissolved in acetic acid (40mL), the mixture was cooled to room temperature after reacting at 80°C for 24hrs. Part of acetic acid was removed under reduced pressure, the residue was filtered through celite, the filtrate cake was washed with DCM (200mL). The filtrate was in turn washed with saturated sodium sulfite solution (200mL), dried over anhydrous sodium sulfate, filtered, evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA = 50:1) to give colorless solid 1-b (2.5g, yield 94%).",,,"81,82,62,64,33,35,45,46,52,53,69,71,84,85",silica sodium sulfite acetic acid EA celite DCM sodium sulfate PE,"3,4,91,92",1-b 1-b,"9,10,15,17",N-bromosuccinimide acetic acid,,,"5,6",1-c,"28,29,23,25",80°C room temperature,"13,14,21,22,26,27,88,89,36,37,66,67,59,60,50,51,79,80,43,44",dissolved cooled reacting give removed dried washed washed purified filtered,"30,31",24hrs,"92,93",2.5g,"94,95",94%
"Methyl 3-cyano-4-(trifluoromethyl)benzoate (IV-25): To a suspension of IV-24 (272 mg, 1.24 mmol) in conc. HCl (770 μL) cooled to 0° C. with stirring was added dropwise a solution of sodium nitrite (86 mg, 1.24 mmol) in water (700 μL) at such a rate to maintain a temperature below 5° C. After addition the reaction was stirred for 40 min then neutralized to pH 6 by the addition of Na2CO3 while still maintaining a temperature below 5° C. In a separate flask, a solution of potassium cyanide (372 mg, 5.70 mmol) in water (2 mL) was added portionwise to a stirred biphasic solution of copper (II) sulfate pentahydrate (372 mg, 1.49 mmol) in water (2 mL) and toluene (2 mL) at 0° C. then heated to 70° C. To this was added the diazonium salt solution dropwise while maintaining its temp at 0° C. After addition, the reaction was stirred at 70° C. for 1 h, cooled to room temp, and then separated between EtOAc (30 mL) and water (30 mL). The organic layer was washed with brine (10 mL), dried (Na2SO4), and concentrated to afford a crude dark brown oil that was purified by chromatography (ethyl acetate/hexanes, 1:9) to yield the desired product as a yellow oil (153 mg, 54%).",,,"167,168,180,181,163,164,68,69,176,177,195,197",water Na2SO4 EtOAc Na2CO3 hexanes brine ethyl acetate,"189,190,2,3,201,203,0,2",oil IV-25 desired product Methyl 3-cyano-4-(trifluoromethyl)benzoate,"13,15,103,107,29,31",conc. HCl copper (II) sulfate pentahydrate sodium nitrite,"112,113,116,117,36,37,91,92",water toluene water water,"132,134,84,86,7,8",diazonium salt potassium cyanide IV-24,"75,77,125,127,19,21,150,152,141,143,120,122,157,159,48,50",5° C 70° C 0° C 70° C 0° C 0° C room temp 5° C,"199,200,55,56,17,18,123,124,184,185,130,131,148,149,95,96,24,25,174,175,192,193,155,156,161,162,66,67,179,180",yield stirred cooled heated afford added stirred added added washed purified cooled separated addition dried,"57,59,153,155",40 min 1 h,"207,209",153 mg,"209,210",54%
"(Example 20) The first step The synthesis of Compound 90 To a solution of Compound 30 (400mg, 0.907mmol) in DMF (8.00 mL) were added cyanogen bromide (152 mg, 1.36 mmol) and potassium carbonate (188 mg, 1.36 mmol), and the mixture was stirred at room temperature for 16 hours. Cyanogen bromide (48.0mg, 0.454mmol) and potassium carbonate (62.7mg, 0.454mmol) was added thereto, and the mixture was stirred at room temperature for 3 hours. The reaction mixture was extracted with ethyl acetate after addition of ice water. The organic layer was washed with saturated brine, and dried with anhydrous sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (hexane-ethyl acetate) to yield compound 90 (346mg, yield 82%).","3,4,1,2",first 20,"116,117,91,92,96,98,83,84,77,79,112,114",hexane brine sodium sulfate ethyl acetate water ethyl acetate silica gel,"9,10,121,122",90 90,"31,33,53,55",potassium carbonate potassium carbonate,"19,20",DMF,"48,50,15,16,24,26",Cyanogen bromide 30 cyanogen bromide,"43,45,66,68",room temperature room temperature,"58,59,23,24,41,42,64,65,119,120,110,111,75,76,88,89,93,94,80,81",added added stirred stirred yield purified extracted washed dried addition,"69,71,46,48",3 hours 16 hours,"122,123",346mg,"124,125",82%
"The third step To a mixed solution of Compound 7 (600mg, 1.37mmol) in ethanol (10.0 mL) and water (2.00 mL) were added ammonium chloride (1.09 g, 20.5 mmol) and iron powder (572mg, 10. 3 mmol), and the mixture was stirred for 90 minutes at 90 °C. The reaction mixture was cooled to room temperature, and filtered through celite. The filtrate was extracted with ethyl acetate after addition of ice water, a saturated aqueous ammonium chloride solution and saturated aqueous sodium bicarbonate solution. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and the solvent was concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (hexane-ethyl acetate) to yield Compound 8 (420mg, yield 75.1%).","1,2",third,"69,70,63,65,109,111,79,81,93,95,72,73,78,79,73,75,89,90,57,58,112,113",water ethyl acetate silica gel sodium bicarbonate sodium sulfate aqueous aqueous ammonium chloride ethyl acetate brine celite hexane,"117,118",8,"29,30,22,24",iron ammonium chloride,"17,18,13,14",water ethanol,"9,10",7,"44,46,52,54",90 °C room temperature,"115,116,21,22,39,40,61,62,107,108,50,51,55,56,90,91,86,87,66,67",yield added stirred extracted purified cooled filtered dried washed addition,"41,43",90 minutes,"118,119",420mg,"120,121",75.1%
"Synthesis Example 12: Production of Aromatic Amine Derivative (PH12) In the same manner as in Synthesis Example 8 except for using 2.11 g of the intermediate 6 in place of the intermediate 21 and using 1.18 g of 2-bromo-9,9-dimethylfluorene in place of bromobenzene, 1.30 g (yield: 49%) of a white solid was obtained, which was identified as the following compound (PH12) by FD-MS analysis: m/z=780 (theoretical value: 780 for C57H36N2O2).","2,3",12,"42,43,31,33",bromobenzene intermediate 21,"60,61,5,8,8,9",PH12 Aromatic Amine Derivative PH12,,,,,"25,27,38,39","intermediate 6 2-bromo-9,9-dimethylfluorene",,,"20,21,52,53,34,35",using obtained using,,,"43,45",1.30 g,"46,47",49%
"Example 12. Preparation of PAG-3 A 50 mL flask was charged with 2-hydroxy-2-trifluoromethylacetophenone (SM-9, 0.98 g, 4.80 mmol, 1.0 eq.) and THF (12 mL) under nitrogen stream and the mixture was stirred for 10 minutes at −30° C. nBuLi (1.6 M, 1.5 mL, 2.40 mmol, 1.0 eq.) was added drop-wise to the mixture over 10 minutes and the mixture was stirred for 30 minutes at −20° C. This solution was then added to a cold (−20° C.) solution of methyl 2,2-difluoro-2-(fluorosulfonyl)acetate (Sigma-Aldrich, 0.92 g, 4.80 mmol, 1.0 eq.) in THF (12 mL) over 5 minutes and the mixture was stirred for 2.5 hours while warming from −20° C. to 20° C. 1N HCl (24 mL) was added to the final reaction mixture and then Et2O (72 mL) was added. The upper layer was separated and washed with 1N HCl (24 mL), the lower layer was extracted with Et2O (48 mL), and the organic layers were combined. This solution was washed with brine (24 mL) twice and was subsequently dried over anhydrous MgSO4 and filtered. Solvents were removed in an evaporator and the crude product was purified by column chromatography (hexane/AcOEt) to obtain the target PAG as a colorless oil (0.02 g, 1.3% yield).","1,2",12,"124,125,25,26,112,113,161,162,138,139,189,190,147,148,171,172",Et2O nitrogen HCl brine HCl hexane Et2O MgSO4 AcOEt,"194,195,4,5",PAG PAG-3,"38,39",nBuLi,"21,22,89,90",THF THF,"12,13,13,14,79,81","2-hydroxy-2-trifluoromethylacetophenone SM-9 methyl 2,2-difluoro-2-(fluorosulfonyl)acetate","36,38,75,77,109,111,65,67,106,108",−30° C −20° C 20° C −20° C −20° C,"99,100,60,61,71,72,48,49,10,11,31,32,191,192,145,146,135,136,128,129,168,169,159,160,116,117,185,186",stirred stirred added added charged stirred obtain extracted washed added dried washed added purified,"93,95,33,35,54,56,62,64,101,103",5 minutes 10 minutes 10 minutes 30 minutes 2.5 hours,"199,201",0.02 g,"201,202",1.3%
"Example 52-2 : Preparation of 6-(2'-amino-3'-fluoro-5-methoxy-[2,4'-bipyridin]-6-yl-N4,N4-dimethylpyrimidin-2,4-diamine (LXXV) 6-(6-Bromo-3-methoxypyridin-2-yl)-N4,N4-dimethylpyrimidin-2,4-diamine (214.49 mg, 661.65 µmol) and 2-[3-fluoro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2-pyridinyl]-imidodicarbonic acid-1,3-bis(1,1-dimethylethyl)ester (580 mg, 1.32 mmol) obtained in Preparation Example 1 were dissolved in dioxane (6 mL). To the resulting solution were added dropwise potassium phosphate (K3PO4) (421.34 mg, 1.98 mmol) dissolved in distilled water (3 mL) and tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) (38.26 mg, 33.08 µmol). The solution was refluxed with heat for 24 hrs, cooled, and evaporated under reduced pressure to concentrate. The solution was diluted with distilled water and dichloromethane and then the resulting solid was filtered, washed with diethylether, and dried to give the title compound (96 mg, 41 %).","1,2",52-2,"82,83,80,81,92,93",dichloromethane water diethylether,"6,7,5,6,98,100","LXXV 6-(2'-amino-3'-fluoro-5-methoxy-[2,4'-bipyridin]-6-yl-N4,N4-dimethylpyrimidin-2,4-diamine title compound","37,39,51,52,52,53,47,48,39,40",potassium phosphate tetrakis(triphenylphosphine)palladium(0) Pd(PPh3)4 water K3PO4,"27,28",dioxane,"13,15,7,8","2-[3-fluoro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2-pyridinyl]-imidodicarbonic acid-1,3-bis(1,1-dimethylethyl)ester 6-(6-Bromo-3-methoxypyridin-2-yl)-N4,N4-dimethylpyrimidin-2,4-diamine","60,61",refluxed,"35,36,44,45,25,26,62,63,96,97,90,91,77,78",added dissolved dissolved heat give washed diluted,"64,66",24 hrs,"100,102",96 mg,"102,104",41 %
"Example 14. Preparation of N-(3-fluorophenyl)-N-(3-(4-(piperazine-1-carbonyl)phenyl)prop-2-ynyl)pentaneamide (LMT-885) A final product, N-(3-fluorophenyl)-N-(3-(4-(piperazine-1-carbonyl)phenyl)prop-2-ynyl)pentaneamide, was obtained (94 mg, 58% yield) by the same method as described in Example 12 using the tert-butyl 4-(4-(3-(N-(3-fluorophenyl)pentaneamido)prop-1-ynyl)benzoyl)piperazine-1-carboxylate (200 mg, 0.383 mmol) obtained in Example 13.","1,2",14,,,"5,6,4,5,9,10,8,9",LMT-885 N-(3-fluorophenyl)-N-(3-(4-(piperazine-1-carbonyl)phenyl)prop-2-ynyl)pentaneamide N-(3-fluorophenyl)-N-(3-(4-(piperazine-1-carbonyl)phenyl)prop-2-ynyl)pentaneamide product,,,,,"27,29",tert-butyl 4-(4-(3-(N-(3-fluorophenyl)pentaneamido)prop-1-ynyl)benzoyl)piperazine-1-carboxylate,,,"11,12",obtained,,,"12,14",94 mg,"14,15",58%
"Step 7 Synthesis of Compound 177 To Compound 176 (1.77 g, 2.33 mmol) in THF (8.85 mL) solution was added 1 mol/L of TBAF in THF solution (6.96 mL, 6.96 mmol), and the mixture was stirred at 60°C for 3 hours. After cooling, ethyl acetate and saturated ammonium chloride solution were added thereto, and the mixture was extracted with ethyl acetate. The organic layer was washed sequentially with aqueous saturated ammonium chloride solution and saturated brine, and dried over anhydrous sodium sulfate. After concentration under reduced pressure, the residue was purified by silica gel column chromatography (hexane - ethyl acetate) to obtain Compound 177 (1.13 g, 80% yield).","1,2",7,"43,45,80,82,47,49,92,94,59,61,68,69,75,76,70,72,98,100,96,97",ethyl acetate sodium sulfate ammonium chloride silica gel ethyl acetate aqueous brine ammonium chloride ethyl acetate hexane,"103,104,5,6",177 177,"23,24",TBAF,"25,26,14,15",THF THF,"8,9",176,"37,38",60°C,"19,20,101,102,35,36,57,58,51,52,77,78,65,66,90,91",added obtain stirred extracted added dried washed purified,"39,41",3 hours,"104,106",1.13 g,"106,107",80%
"A mixture of pentaerythrityl tetrabromide (7.75 g, 20.0 mmol), ethyl 3-hydroxybenzoate (10.80 g, 65 mmol), potassium carbonate (13.80 g, 100 mmol) and DMF (50 mL) was stirred under argon and heated at 110° C. for 20 h. After cooling to room temperature, the mixture was poured into ice/water (200 mL) and extracted with hexane/ethyl acetate (1:1, 400 mL). The extract was washed with water (200 mL), dried over magnesium sulfate, and the solvent was removed under reduced pressure. The crude product was purified by column chromatography using silica gel and hexane/ethyl acetate (9:1) as an eluent to give pure Compound B1, diethyl 3,3'-((2-(bromomethyl)-2-((3-(ethoxycarbonyl)phenoxy)methyl)propane-1,3-diyl)bis(oxy))dibenzoate, (5.22 g, 40% yield).",,,"28,29,87,89,63,64,68,70,53,54,90,91",argon ethyl acetate silica gel water magnesium sulfate ethyl acetate water hexane hexane,"100,101,101,103","B1 diethyl 3,3'-((2-(bromomethyl)-2-((3-(ethoxycarbonyl)phenoxy)methyl)propane-1,3-diyl)bis(oxy))dibenzoate","15,17",potassium carbonate,"22,23",DMF,"9,11,3,5",ethyl 3-hydroxybenzoate pentaerythrityl tetrabromide,"32,34,40,42",110° C room temperature,"30,31,26,27,97,98,45,46,38,39,61,62,51,52,82,83,66,67",heated stirred give poured cooling washed extracted purified dried,"35,37",20 h,"103,105",5.22 g,"105,106",40%
"Synthesis of Compound 54 Compound 53 (41.2 mg, 0.1 mmol) was dissolved in 10 mL DMF and cooled to 0° C. in an ice bath. Et3N (6.9 μL, 0.05 mmol) and the compound 8 (73.7 mg, 0.1 mmol) were added dropwise to the solution and left to stir for 30 minutes. The solution was allowed to warm to room temperature and stirred for another 5 hours. The mixture was concentrated under reduced pressure, and the residue was purified by pre-HPLC to give compound 54 (73 mg, 63.6%) as a white powder. LC-MS m/z (ES+), 1148.47 (M+H)+.",,,,,"3,4,83,84",54 54,"25,26",Et3N,"15,16",DMF,"33,34,5,6",8 53,"58,60,19,21",room temperature 0° C,"17,18,56,57,11,12,81,82,39,40,61,62,47,48",cooled warm dissolved give added stirred stir,"64,66,49,51",5 hours 30 minutes,"84,86",73 mg,"86,87",63.6%
"Step 5 To a solution of Compound 18i (6.2g, 10.5mmol) in tetrahydrofuran (15mL) was added 1mol / L tetrabutylammonium fluoride tetrahydrofuran solution (27mL, 27.0mmol), and the mixture was stirred for 1 hour at 60°C. The reaction mixture was extracted with ethyl acetate after addition of saturated aqueous sodium hydrogencarbonate solution. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and the solvent was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (hexane-ethyl acetate) to yield Compound 19i (4.2 g, 96%) as a colorless foam compound.","1,2",5,"77,79,57,58,61,63,81,82,47,49,46,47,40,42",silica gel brine magnesium sulfate hexane sodium hydrogencarbonate aqueous ethyl acetate ethyl acetate,"86,87",19i,"18,20",tetrabutylammonium fluoride,"11,12,20,21",tetrahydrofuran tetrahydrofuran,"7,8",18i,"33,34",60°C,"14,15,28,29,84,85,54,55,38,39,75,76,58,59,43,44",added stirred yield washed extracted purified dried addition,"30,32",1 hour,"87,89",4.2 g,"89,90",96%
"Step 4: Synthesis of 4-(4-(4-((4-(dimethylamino)phenyl)ethynyl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide To a solution of 4-(4-(4-((4-(dimethylamino)phenyl)ethynyl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-methyl-2-(methylsulfonyl)-N-((tetrahydro-2H-pyran-2-yl)oxy)butanamide (200 mg, 1 eq) in MeOH (6 ml) was added with HCl solution in MeOH (1.25N, 0.83 ml, 3 eq) and stirred for 2 hr at room temperature. The solvent was removed under reduced pressure and the residue was diluted with water (6 ml), adjusted the pH to 7.0. The water was concentrated in vacuo and the resulting residue was purified with column chromatography to prepare the title compound (40 mg, 24%).","1,2",4,"60,61,51,52",water water,"4,5,77,79","4-(4-(4-((4-(dimethylamino)phenyl)ethynyl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide title compound","21,22",HCl,"24,25,15,16",MeOH MeOH,"9,10","4-(4-(4-((4-(dimethylamino)phenyl)ethynyl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-methyl-2-(methylsulfonyl)-N-((tetrahydro-2H-pyran-2-yl)oxy)butanamide","36,38",room temperature,"31,32,75,76,19,20,70,71,62,63,49,50",stirred prepare added purified concentrated diluted,"33,35",2 hr,"79,81",40 mg,"81,82",24%
"Example 20 Synthesis of (R)-1-(3-(dimethylamino)piperidin-1-yl)-3-(1-(2,2,2-trifluoroethyl)-1H-imidazol-2-yl)propan-1-one Hydrochloride A solution of hydrogen chloride in diethyl ether (2.0 N, 0.309 mL, 0.618 mmol) was added to a solution of (R)-1-(3-(dimethylamino)piperidin-1-yl)-3-(1-(2,2,2-trifluoroethyl)-1H-imidazol-2-yl)propan-1-one (0.0790 g, 0.238 mmol) in diethyl ether (3.0 mL) at 0° C. The reaction liquid was stirred at the same temperature for 1 hour and then stirred at room temperature for 30 minutes. The white solid precipitated was filtered and collected, washed with diethyl ether and dried at room temperature to obtain (R)-1-(3-(dimethylamino)piperidin-1-yl)-3-(1-(2,2,2-trifluoroethyl)-1H-imidazol-2-yl)propan-1-one hydrochloride (0.0349 g, 0.0861 mmol, 36%)(hereinafter referred to as the compound of Example 20) as a white solid.","1,2",20,"70,72",diethyl ether,"90,94,4,6,79,81","compound of Example 20 (R)-1-(3-(dimethylamino)piperidin-1-yl)-3-(1-(2,2,2-trifluoroethyl)-1H-imidazol-2-yl)propan-1-one Hydrochloride (R)-1-(3-(dimethylamino)piperidin-1-yl)-3-(1-(2,2,2-trifluoroethyl)-1H-imidazol-2-yl)propan-1-one hydrochloride","9,11",hydrogen chloride,"32,34,12,14",diethyl ether diethyl ether,"26,27","(R)-1-(3-(dimethylamino)piperidin-1-yl)-3-(1-(2,2,2-trifluoroethyl)-1H-imidazol-2-yl)propan-1-one","75,77,37,39,55,57",room temperature 0° C room temperature,"53,54,43,44,21,22,78,79,73,74,68,69",stirred stirred added obtain dried washed,"58,60,49,51",30 minutes 1 hour,"83,85,81,83",0.0861 mmol 0.0349 g,"85,86",36%
"Example 6 Preparation of N2-(8-(azetidin-3-yl)-7-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-5-c hloro-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (Compound 6) (1) Preparation of tert-butyl 3-((methylsulfonyl)oxy)azetidin-1-carboxylate Tert-butyl 3-hydroxyazetidin-1-carboxylate (2.0 g, 11.5 mmol) was dissolved in 50mL tetrahydrofuran, and triethylamine (2.34 g, 23.1 mmol) was added. Under the condition of ice water bath, methanesulfonyl chloride (1.58 g, 13.8 mmol) was added slowly. The resultant mixture was warmed to room temperature, and further reacted for 4 h. After the reaction, the solvent was removed by rotary evaporation, and to the residue,50mL waterwas added. After extraction with ethyl acetate (3×50mL), the organic phases were combined, dried with anhydrous sodium sulphate, and filtrated. The solvent was removed by rotary evaporation to obtain the product (2.67 g, yield: 92%).","1,2,8,9",6 1,"81,83,76,77,92,94,7,8,4,6","ethyl acetate water sodium sulphate 6 N2-(8-(azetidin-3-yl)-7-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-5-c hloro-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine","11,13,106,107",tert-butyl 3-((methylsulfonyl)oxy)azetidin-1-carboxylate product,"25,26",triethylamine,"23,24",tetrahydrofuran,"39,41,13,15",methanesulfonyl chloride Tert-butyl 3-hydroxyazetidin-1-carboxylate,"54,56",room temperature,"104,105,46,47,58,59,31,32,20,21,52,53,77,78,79,80,89,90",obtain added reacted added dissolved warmed added extraction dried,"60,62",4 h,"107,109",2.67 g,"110,111",92%
"(2) Preparation of (2S,5R)-2-((2-azaspiro[3.3]heptan-6-yl)carboxamido)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate (2S,5R)-2-((2-(tert-butyloxycarbonyl)-2-azaspiro[3.3]heptan-6-yl)carboxamido)-7-oxo-1,6-dia zabicyclo[3.2.1]octan-6-ylsulfuric acid tetra(n-butyl)ammonium salt (3.4 g, 4.85 mmol) was added in dichloromethane (16 mL), cooled to 0°C, trifluoroacetic acid (8 mL) was added. Reaction was performed at 0°C for 0.5 h, LC-MS was used to detect the end of reaction. Solvent was removed by vacuum distillation, and acetonitrile (150 mL) was added under ultrasonic to get a large amount of with precipitate. After suck filtration, the filter cake was washed with acetonitrile (20 mL×3), dried in vacuum to obtain the title compound (1.52 g, 86.9 %).","0,1",2,"54,55,78,79",acetonitrile acetonitrile,"3,6,87,89","(2S,5R)-2-((2-azaspiro[3.3]heptan-6-yl)carboxamido)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate title compound","24,26",trifluoroacetic acid,"18,19",dichloromethane,"6,11","(2S,5R)-2-((2-(tert-butyloxycarbonyl)-2-azaspiro[3.3]heptan-6-yl)carboxamido)-7-oxo-1,6-dia zabicyclo[3.2.1]octan-6-ylsulfuric acid tetra(n-butyl)ammonium salt","34,35,23,24",0°C 0°C,"16,17,21,22,32,33,85,86,29,30,76,77,58,59",added cooled performed obtain added washed added,"36,38",0.5 h,"89,91",1.52 g,"91,93",86.9 %
"Reference Example 9 Synthesis of (E)-methyl 3-(1-isopropyl-1H-imidazol-2-yl)acrylate Methyl (triphenylphosphoranylidene)acetate (0.932 g, 2.79 mmol) was added to a solution of 1-isopropyl-1H-imidazole-2-carbaldehyde (0.350 g, 2.53 mmol) in dichloromethane (7.6 mL) at room temperature. The reaction liquid was stirred for 16 hours and then concentrated under reduced pressure. The residue was washed with a mixed solvent of n-hexane/dichloromethane=20/1 and the washing solution was concentrated. The residue was purified by column chromatography (silica gel, n-hexane/ethyl acetate) to obtain (E)-methyl 3-(1-isopropyl-1H-imidazol-2-yl)acrylate (0.362 g, 1.86 mmol, 74%) as a white solid.","2,3",9,"70,71,68,70,54,55",ethyl acetate n-hexane silica gel n-hexane dichloromethane,"5,7,74,76",(E)-methyl 3-(1-isopropyl-1H-imidazol-2-yl)acrylate (E)-methyl 3-(1-isopropyl-1H-imidazol-2-yl)acrylate,,,"25,26",dichloromethane,"19,20,7,9",1-isopropyl-1H-imidazole-2-carbaldehyde Methyl (triphenylphosphoranylidene)acetate,"29,31",room temperature,"73,74,14,15,35,36,64,65,48,49",obtain added stirred purified washed,"37,39",16 hours,"76,78,78,80",0.362 g 1.86 mmol,"80,81",74%
"Synthesis of compound 6-a Under N2 atmosphere, ethyl 2-bromoisobutyrate (190mg, 1mmol) and potassium carbonate (138mg, 1mmol) were added to a solution of compound 6-b (75mg, 0.3mmol) in acetonitrile (4mL), the mixture was reacted for 3hrs at 80°C. The mixture was cooled to room temperature, concentrated under reduced pressure. The residue was filtered through celite, the filtrate cake was washed with EA (50mL). The filtrate was in turn washed with water (8mL×3) and saturated brine (10mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA = 3:1) to give yellow liquid 6-a (56 mg, yield 52%).",,,"93,94,90,91,69,70,73,74,60,61,53,54,5,6,78,80",PE silica water brine EA celite EA N2 magnesium sulfate,"3,4,100,101",6-a 6-a,"12,14",potassium carbonate,"27,28",acetonitrile,"7,9,23,24",ethyl 2-bromoisobutyrate 6-b,"42,44,36,37",room temperature 80°C,"97,98,32,33,17,18,40,41,88,89,51,52,75,76,58,59,67,68",give reacted added cooled purified filtered dried washed washed,"34,35",3hrs,"101,103",56 mg,"104,105",52%
"(Reference Example 18) Synthesis of 1-propyl-1H-imidazole: Sodium hydride (55%, 0.966 g, 22.1 mmol) was added to a solution of imidazole (1.37 g, 20.1 mmol) in tetrahydrofuran (50.0 mL) at room temperature. The reaction liquid was stirred at the same temperature for 1 hour, and then, 1-bromopropane (5.48 mL, 60.3 mmol) was added at room temperature. The reaction liquid was stirred at the same temperature for 16 hours. The reaction liquid was filtered through Celite and washed with tetrahydrofuran, and then the filtrate and the washing solution were concentrated under reduced pressure. The residue was purified by flash column chromatography (silica gel, chloroform/methanol) to obtain 1-propylimidazole (2.07 g, 18.8 mmol, 93%) as a colorless oil.","2,3",18,"99,101,73,74,101,102,77,78",silica gel Celite methanol chloroform tetrahydrofuran,"104,105,5,6",1-propylimidazole 1-propyl-1H-imidazole,"6,8",Sodium hydride,"25,26",tetrahydrofuran,"19,20,45,46",imidazole 1-bromopropane,"29,31,53,55",room temperature room temperature,"103,104,14,15,35,36,51,52,59,60,75,76,94,95,71,72",obtain added stirred added stirred washed purified filtered,"65,67,41,43",16 hours 1 hour,"107,109,105,107",18.8 mmol 2.07 g,"109,110",93%
"(Reference Example 5) Synthesis of 1-(4-(dimethylamino)piperidin-1-yl)ethanone: Pyridine (0.922 mL, 9.75 mmol) and acetic anhydride (0.946 mL, 11.7 mmol) were added to a solution of 4-dimethylaminopiperidine (1.00 g, 7.79 mmol) in dichloromethane (7.8 mL) at 0°C and the reaction liquid was stirred at room temperature for 16 hours. A saturated aqueous solution of sodium hydrogencarbonate was added to the reaction liquid, and the reaction liquid was extracted with chloroform. The organic layer was washed with a 10% aqueous solution of sodium chloride, dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure. The residue was purified by flash column chromatography (NH silica gel, chloroform/methanol) to obtain 1-(4-(dimethylamino)piperidin-1-yl)ethanone (0.869 g, 6.78 mmol, 87%) as a colorless oil.","2,3",5,"84,86,52,54,106,107,49,50,79,81,104,106,67,68,76,77",sodium sulfate sodium hydrogencarbonate methanol chloroform aqueous sodium chloride silica gel chloroform aqueous,"109,110,5,6",1-(4-(dimethylamino)piperidin-1-yl)ethanone 1-(4-(dimethylamino)piperidin-1-yl)ethanone,"6,7",Pyridine,"30,31",dichloromethane,"24,25,12,14",4-dimethylaminopiperidine acetic anhydride,"34,35,42,44",0°C room temperature,"19,20,108,109,40,41,72,73,65,66,55,56,81,82,98,99",added obtain stirred washed extracted added dried purified,"45,47",16 hours,"110,112,112,114",0.869 g 6.78 mmol,"114,115",87%
"Preparation of MTC-BnCl (MW 298.7) A flask was charged with MTC-C6F5 (10 g, 30.6 mmol), p-chloromethyl benzyl alcohol (4.8 g, 30.6 mmol), PROTON SPONGE (2 g, 9.3 mmol) and THF (30 mL). The reaction mixture was stirred for 12 hours then added directly to a silica gel column. The product was isolated using diethyl ether as the eluent to yield 7.45 g (81%) white crystalline powder.",,,"45,47,53,55",silica gel diethyl ether,"2,3,49,50",MTC-BnCl product,"22,24",PROTON SPONGE,"29,30",THF,"15,18,10,11",p-chloromethyl benzyl alcohol MTC-C6F5,,,"36,37,59,60,8,9,41,42,51,52",stirred yield charged added isolated,"38,40",12 hours,"60,62",7.45 g,"62,63",81%
"(step 2) Synthesis of tert-butyl N-[(2-chloro-4-pyridyl)methyl]carbamate To (2-chloro-4-pyridyl)methylamine (14 g, 0.10 mol) was added dichloromethane (120 mL) for dissolution, triethylamine (28 mL, 0.20 mol) and di-tert-butyl dicarbonate (26 g, 0.12 mol) were added, and the mixture was stirred at room temperature for 2 hr. The solvent was evaporated from the reaction mixture and the obtained residue was purified by silica gel column chromatography (petroleum ether/ethyl acetate) to give the title compound (22 g, 0.091 mmol, 91%).","1,2",2,"63,65,59,61",petroleum ether silica gel ethyl acetate,"69,71,4,6",title compound tert-butyl N-[(2-chloro-4-pyridyl)methyl]carbamate,"19,20",triethylamine,"14,15",dichloromethane,"7,8,25,27",(2-chloro-4-pyridyl)methylamine di-tert-butyl dicarbonate,"39,41",room temperature,"37,38,13,14,67,68,32,33,57,58",stirred added give added purified,"42,44",2 hr,"73,75,71,73",0.091 mmol 22 g,"75,76",91%
"EXAMPLE 116 N-[(S)-2-(5-(2-chloro-3-fluorophenyl)-3-{2-[4-(7-methoxy-5-methyl-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl)-propyl]acetamide (reaction scheme No. 4, compound 116) 116.1: 2-(5-methoxy-2-nitrophenyl)-propionitrile A solution containing 1 g (5.2 mmol) of (5-methoxy-2-nitrophenyl)-acetonitrile (prepared as in example 115.1) and 0.6 ml (8.9 mmol) of iodomethane in 5 ml of N,N-dimethylformamide is added at 0° C. to a solution containing 208 mg (5.2 mmol) of sodium hydride in 7 ml (91 mmol) of N,N-dimethylformamide. After 1 hour, the mixture is diluted with ethyl acetate and then with water. The aqueous phase is extracted three times with ethyl acetate, the organic phase is washed with water and then brine. After drying over magnesium sulphate, the solution is filtered and then concentrated under vacuum. After purification by silica gel chromatography, 663 mg (62%) of 2-(5-methoxy-2-nitrophenyl)-propionitrile is obtained in the form of a clear oil.","1,2,9,10",116 116.1,"8,9,90,91,97,99,73,74,68,70,111,113,82,84,2,3,93,94","116 water magnesium sulphate water ethyl acetate silica gel ethyl acetate N-[(S)-2-(5-(2-chloro-3-fluorophenyl)-3-{2-[4-(7-methoxy-5-methyl-2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl)-propyl]acetamide brine","118,119,10,11",2-(5-methoxy-2-nitrophenyl)-propionitrile 2-(5-methoxy-2-nitrophenyl)-propionitrile,"51,53",sodium hydride,"36,37,59,60","N,N-dimethylformamide N,N-dimethylformamide","19,20,31,32",(5-methoxy-2-nitrophenyl)-acetonitrile iodomethane,"40,42",0° C,"120,121,38,39,78,79,66,67,109,110,88,89,95,96",obtained added extracted diluted purification washed drying,"61,63",1 hour,"114,116",663 mg,"116,117",62%
"Example 8-2 : Preparation of 2'-amino-6'-(2-aminopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol (LXIII) 6-(2-amino-pyrimidin-4-yl)-3'-fluoro-5-methoxy-[2,4']bipyridin-2'-ylamine (LXII) (210 mg, 0.672 mmol) was mixed with pyridine hydrochloride (Pyridine HCl) (790 mg, 6.720 mmol) and the mixture was stirred at 170 °C for 1 hr. The mixture was cooled to room temperature, neutralized with 2 N sodium hydroxide (NaOH) solution, and diluted with ethylacetate (EA). Then, the organic solvent was dried over anhydrous magnesium sulfate (MgSO4), filtered and evaporated under reduced pressure to concentrate to give the title compound (170 mg, 85 %).","1,2",8-2,"65,66,48,49,53,54,63,65,54,55,46,48",MgSO4 NaOH ethylacetate magnesium sulfate EA sodium hydroxide,"77,79,6,7,5,6","title compound LXIII 2'-amino-6'-(2-aminopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol","18,20,16,18",Pyridine HCl pyridine hydrochloride,,,"8,9,7,8","LXII 6-(2-amino-pyrimidin-4-yl)-3'-fluoro-5-methoxy-[2,4']bipyridin-2'-ylamine","30,32,40,42",170 °C room temperature,"75,76,28,29,14,15,51,52,38,39,42,43,60,61",give stirred mixed diluted cooled neutralized dried,"33,35",1 hr,"79,81",170 mg,"81,83",85 %
"Step 1-5, preparation of {1-[6-(3-carbamoyl-5-fluoro-phenyl)-7-chloro-3-(3-fluoro-5-methyl-phenyl)-cinnolin-4-yl]-piperidin-4-yl}-carbamic acid tert-butyl ester: A mixture of {1-[6-bromo-7-chloro-3-(3-fluoro-5-methyl-phenyl)-cinnolin-4-yl]-piperidin-4-yl}-carbamic acid tert-butyl ester (50 mg, 0.09 mmol), 3-carbamoyl-5-fluorobenzeneboronic acid (25 mg, 0.14 mmol), PdCl2(t-Bu2PPhNMe2)2 (6.5 mg, 0.009 mmol), and K2CO3 (25 mg, 0.18 mmol) in dioxane/H2O (10/1=2 mL/0.2 mL) was degassed with N2 for 5 min, and then sealed. The reaction mixture was stirred for 1 h at 80° C. and cooled to room temperature. The reaction was filtered through a pad of celite, and the volatile solvent was removed under vacuum. The residue was directly purified by column chromatography to afford the title compound (30 mg, 54%). MS (M+H)+=608.3.","1,2",1-5,"44,45,75,76",N2 celite,"4,8,95,97",{1-[6-(3-carbamoyl-5-fluoro-phenyl)-7-chloro-3-(3-fluoro-5-methyl-phenyl)-cinnolin-4-yl]-piperidin-4-yl}-carbamic acid tert-butyl ester title compound,"31,32,25,26",K2CO3 PdCl2(t-Bu2PPhNMe2)2,"37,38",H2O dioxane,"19,21,11,15",3-carbamoyl-5-fluorobenzeneboronic acid {1-[6-bromo-7-chloro-3-(3-fluoro-5-methyl-phenyl)-cinnolin-4-yl]-piperidin-4-yl}-carbamic acid tert-butyl ester,"65,67,60,62",room temperature 80° C,"42,43,55,56,93,94,70,71,63,64",degassed stirred afford filtered cooled,"46,48,57,59",5 min 1 h,"97,99",30 mg,"99,100",54%
"Example 8. Preparation of Monomer M-3 A 50 mL flask was charged with 2-hydroxy-2-trifluoromethylacetophenone (SM-4, 1.36 g, 6.40 mmol, 1.0 eq.) and THF (16 mL) under nitrogen stream. The mixture was stirred for 10 minutes at −30° C. n-BuLi (4.0 mL, 6.40 mmol, 1.0 eq. 1.6 M) was added dropwise to the mixture over the course of 10 minutes and the mixture was stirred for 60 minutes at −30° C. This solution was then transferred to an addition flask and added dropwise over the course of 15 minutes to a stirring solution of THF (16 mL) and 2-(2,2-difluoro-2-(fluorosulfonyl)acetamido)ethyl methacrylate (SM-2, 1.85 g, 6.40 mmol, 1.0 eq.) at −30° C. under a nitrogen stream. This reaction mixture was subsequently stirred for 2.5 hours at −30° C. to 10° C. 1N HCl (32 mL) was added to the final reaction mixture which was then extracted with Et2O (96 mL) followed by 1N HCl (32 mL). The lower aqueous layer was saved and extracted with an additional portion of Et2O (64 mL). The organic layers were then combined and washed with twice with brine (32 mL portions) and the solution dried over MgSO4. Solvents were removed by an evaporator and the crude material purified by column chromatograph (hexane/CH2Cl2) to give the target PAG monomer as colorless oil (0.32 g, 10.6% yield).","1,2",8,"166,167,150,151,180,181,204,205,144,145,111,112,189,190,129,130,26,27",Et2O HCl brine hexane Et2O nitrogen CH2Cl2 MgSO4 HCl nitrogen,"5,6,208,211",M-3 target PAG monomer,"38,39",n-BuLi,"93,94,22,23",THF THF,"13,14,97,99,99,100,14,15","2-hydroxy-2-trifluoromethylacetophenone 2-(2,2-difluoro-2-(fluorosulfonyl)acetamido)ethyl methacrylate SM-2 SM-4","126,128,123,125,68,70,36,38,107,109",10° C −30° C −30° C −30° C −30° C,"206,207,63,64,31,32,11,12,80,81,118,119,48,49,187,188,160,161,200,201,133,134,176,177,142,143",give stirred stirred charged added stirred added dried extracted purified added washed extracted,"57,59,65,67,33,35,120,122,86,88",10 minutes 60 minutes 10 minutes 2.5 hours 15 minutes,"214,216",0.32 g,"216,217",10.6%
"Example 16 To a suspension of 6-(2-aminothiazol-4-yl)-3,4-dihydroquinolin-2(1H)-one (0.100 g, 0.408 mmol) and oxazole-5-carboxylic acid (0.051 g, 0.448 mmol), and pyridine (0.15 mL, 1.832 mmol) in acetonitrile (4 mL) in a sealed tube was added propylphosphonic anhydride solution (50 wt % in ethyl acetate, 0.85 mL, 1.431 mmol). The sealed tube was heated to 48.5° C. for 4 days and the precipitation formed. After cooling, the solid was collected by filtration and washed with cold dichloromethane to give N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)oxazole-5-carboxamide (0.121 g, 87%) as a beige solid.","1,2",16,"74,75",dichloromethane,"77,78","N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)oxazole-5-carboxamide","19,20,34,36",pyridine propylphosphonic anhydride,"41,43,25,26",ethyl acetate acetonitrile,"6,7,12,14","6-(2-aminothiazol-4-yl)-3,4-dihydroquinolin-2(1H)-one oxazole-5-carboxylic acid","53,55",48.5° C,"33,34,76,77,51,52,71,72",added give heated washed,"56,58",4 days,"78,80",0.121 g,"80,81",87%
"Example 26 Step 1: Preparation of benzyl 3-oxocyclobutane-carboxylate 3-Oxocyclobutanecarboxylic acid(3.0 g, 26.3 mmol), benzyl bromide(6.7 g, 39.4 mmol) and potassium carbonate(7.3 g, 52.6 mmol) was dissolved in acetone(30 mL), and then heated to reflux for 10 hours. After TLC showed that the reaction was completed, the reaction mixture was concentrated under reduce pressure to remove the solvent, added water (20 mL), and extracted with ethyl acetate (150 mL×2). The combined organic phase was washed with saturated salt water(50 mL), dried with anhydrous sodium sulfate, filtered and concentrated under vacuum. The residue was purified through silica gel column chromatography (petroleum ether/ethyl acetate=10:1) to give benzyl 3-oxocyclobutane-carboxylate (2.5 g, 41.9% yield) as a colorless liquid.","3,4,1,2",1 26,"82,84,64,66,98,100,58,59,94,96,77,78",sodium sulfate ethyl acetate petroleum ether water ethyl acetate silica gel water,"6,8,103,105",benzyl 3-oxocyclobutane-carboxylate benzyl 3-oxocyclobutane-carboxylate,"19,21",potassium carbonate,"27,28",acetone,"8,10,13,15",3-Oxocyclobutanecarboxylic acid benzyl bromide,"33,34",reflux,"31,32,102,103,25,26,57,58,73,74,62,63,79,80,92,93",heated give dissolved added washed extracted dried purified,"35,37",10 hours,"105,107",2.5 g,"107,108",41.9%
"Step 2: Preparation of (S)-7-amino-5-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazoline-2-yl)ethyl)amino)-1-(4-methoxybenzyl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one 52 mg of (S)-7-amino-5-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazoline-2-yl)ethyl)amino)-1-(4-methoxybenzyl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one was prepared as a white solid by using 65 mg (0.10 mmol) of (S)-5-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazoline-2-yl)ethyl)amino)-1-(4-methoxybenzyl)-3-methyl-7-(methylthio)-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one prepared in step 1 according to the same manner as described in step 4 of Example 15 (0.09 mmol, yield: 73%).","1,2",2,,,"4,5,8,9","(S)-7-amino-5-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazoline-2-yl)ethyl)amino)-1-(4-methoxybenzyl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one (S)-7-amino-5-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazoline-2-yl)ethyl)amino)-1-(4-methoxybenzyl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one",,,,,"22,23","(S)-5-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazoline-2-yl)ethyl)amino)-1-(4-methoxybenzyl)-3-methyl-7-(methylthio)-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one",,,"16,17,10,11",using prepared,,,"40,42,5,7",0.09 mmol 52 mg,"43,44",73%
"Synthesis Example 5 To an acetonitrile solution (50 mL) containing compound 2 (100 mg, 0.4 mmol) were added iodine (113 mg, 0.44 mmol) and iodobenzene diacetate (143 mg, 0.44 mmol). Next, the mixture was stirred at room temperature for 3 hours. The reaction solution was diluted with a sodium thiosulfate aqueous solution and was then extracted using ethyl acetate to recover an organic layer. The organic layer was washed with water and saturated saline and dried over anhydrous sodium sulfate. After the organic solvent was removed under reduced pressure, the remainder was purified by flash column chromatography (using an eluent ratio of hexane : ethyl acetate = 10 : 1) to give compound 5 as a red solid (167 mg,84%).","2,3",5,"78,80,57,59,73,74,70,71,102,103,48,50,50,51,104,106",sodium sulfate ethyl acetate saline water hexane sodium thiosulfate aqueous ethyl acetate,"113,114",5,"18,19,24,26",iodine iodobenzene diacetate,"5,6",acetonitrile,"11,12",2,"36,38",room temperature,"111,112,34,35,17,18,92,93,55,56,45,46,75,76,68,69",give stirred added purified extracted diluted dried washed,"39,41",3 hours,"118,120",167 mg,,84%
"2-(((tert-Butyldimethylsilyl)oxy)methyl)-5,8-dichloro-1-(2,6-dichlorophenyl)-1,6-naphthyridin-4(1H)-one (Intermediate 7) Step 1: 2,4,5-Trichloronicotinaldehyde To a solution of 2,4,5-trichloropyridine (5 g, 27.4 mmol) in 150 ml of THF was added LDA (2 M in heptane, 20.56 ml, 41.1 mmol) at −78° C. The mixture was stirred at −78° C. for 1 hour. Then methyl formate (8.23 g, 137 mmol) in THF (20 mL) was added quickly into the reaction mixture followed by stirring at −78° C. for 1 hour. The reaction mixture was quenched with aqueous saturated NH4Cl solution and extracted with EtOAc three times. The combined organic layers were dried over anhydrous Na2SO4 and, volatiles were removed under reduced pressure. The residue was purified with silica-gel chromatography (10-100% EtOAc in heptane) to afford the desired compound as a solid (4.2 g, 73%).","4,5",1,"95,96,111,112,0,1,113,114,79,80,77,78,84,85,108,109,1,3","Na2SO4 EtOAc 2-(((tert-Butyldimethylsilyl)oxy)methyl)-5,8-dichloro-1-(2,6-dichlorophenyl)-1,6-naphthyridin-4(1H)-one heptane NH4Cl aqueous EtOAc silica-gel Intermediate 7","5,6,117,119","2,4,5-Trichloronicotinaldehyde desired compound","22,23",LDA,"52,53,19,20,26,27",THF THF heptane,"45,47,10,11","methyl formate 2,4,5-trichloropyridine","39,41,32,34,66,68",−78° C −78° C −78° C,"115,116,56,57,64,65,37,38,21,22,106,107,75,76,82,83,92,93",afford added stirring stirred added purified quenched extracted dried,"69,71,42,44",1 hour 1 hour,"122,124",4.2 g,"124,125",73%
"Step 1: Synthesis of 4-(4-(4-(5-aminopent-1-yn-1-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-methyl-2-(methylsulfonyl)-N-((tetrahydro-2H-pyran-2-yl)oxy)butanamide To a solution of 5-(4-(1-(3-methyl-3-(methylsulfonyl)-4-oxo-4-(((tetrahydro-2H-pyran-2-yl)oxy)amino)butyl)-1,2,3,6-tetrahydropyridin-4-yl)phenyl)pent-4-yn-1-yl methanesulfonate (Example 19, step 3) (200 mg, 1 eq) in 1,4-dioxane (0.67 ml) was added with ammonia (0.5M in 1,4-dioxane, 6.7 ml, 10 eq). The mixture was refluxed for 12 hr and cooled room temperature, and the solvent was concentrated in vacuo. The residue was purified with column chromatography to prepare the title compound (80 mg, 46%).","1,2",1,,,"62,64,4,5","title compound 4-(4-(4-(5-aminopent-1-yn-1-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-methyl-2-(methylsulfonyl)-N-((tetrahydro-2H-pyran-2-yl)oxy)butanamide","26,27",ammonia,"20,21,29,30","1,4-dioxane 1,4-dioxane","9,11","5-(4-(1-(3-methyl-3-(methylsulfonyl)-4-oxo-4-(((tetrahydro-2H-pyran-2-yl)oxy)amino)butyl)-1,2,3,6-tetrahydropyridin-4-yl)phenyl)pent-4-yn-1-yl methanesulfonate","43,45",room temperature,"37,38,60,61,24,25,42,43",refluxed prepare added cooled,"39,41",12 hr,"64,66",80 mg,"66,67",46%
"EXAMPLE 42 3-methyl-5-(6-methyl-pyridin-2-yl)-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione (reaction scheme No. 3, compound 42) 42.1: 1-benzhydryl-3-methyl-5-(6-methyl-1-oxy-pyridin-2-yl)-1H-pyrimidine-2,4-dione 15 mg (0.1 mmol) of palladium(II) acetate and 20 mg (0.1 mmol) of tri-tert-butylphosphonium tetrafluoroborate are added to a solution of 500 mg (1.4 mmol) of 1-benzhydryl-5-bromo-3-methyl-1H-pyrimidine-2,4-dione (prepared as described in example 2.2), 294 mg (2.7 mmol) of 2-picoline-N-oxide, and 279 mg (2 mmol) of potassium carbonate in 10 ml of toluene, previously degassed with nitrogen for 10 minutes. The reaction mixture is heated at 110° C. in a sealed tube for 40 hours. It is filtered on Celite and the filtrate is concentrated under vacuum. The crude residue is chromatographed on silica gel eluted with a dichloromethane/acetone mixture 70/30. 220 mg (41%) of 1-benzhydryl-3-methyl-5-(6-methyl-1-oxy-pyridin-2-yl)-1H-pyrimidine-2,4-dione is obtained in the form of an off-white solid.","1,2,9,10",42 42.1,"66,67,8,9,89,90,108,109,2,3,103,105","nitrogen 42 Celite dichloromethane 3-methyl-5-(6-methyl-pyridin-2-yl)-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione silica gel acetone","10,11,115,116","1-benzhydryl-3-methyl-5-(6-methyl-1-oxy-pyridin-2-yl)-1H-pyrimidine-2,4-dione 1-benzhydryl-3-methyl-5-(6-methyl-1-oxy-pyridin-2-yl)-1H-pyrimidine-2,4-dione","24,26,56,58,16,18",tri-tert-butylphosphonium tetrafluoroborate potassium carbonate palladium(II) acetate,"62,63",toluene,"37,38,49,50","1-benzhydryl-5-bromo-3-methyl-1H-pyrimidine-2,4-dione 2-picoline-N-oxide","76,78",110° C,"74,75,64,65,27,28,117,118,87,88,101,102",heated degassed added obtained filtered chromatographed,"68,70,83,85",10 minutes 40 hours,"111,113",220 mg,"113,114",41%
"Step 4: Preparation of methyl 6-(4-(tert-butyl)phenoxy)-2-(1-(N-(2-methoxy-2- oxoethyl)-4-toluenesulfonylamino)ethyl) nicotinate A 100 mL eggplant flask was sequentially charged with methyl 2-(1-bromoethyl)-6-(4-(tert-butyl)phenoxy) nicotinate (2.48 g,6.32 mmol) prepared in step 3, p-toluenesulfonylglycine methyl ester (1.53 g, 6.32 mmol) and potassium carbonate (1.75 g,12.64 mmol) and sodium iodide (95 mg, 0.63 mmol) and 15 ml of N, N-dimethylformamide for dissolving them. The mixture was stirred at 50 °C for 10 hours. Thin layer chromatography [V (petroleum ether) / V (ethyl acetate) = 2/1] detected that the reaction was basically completed, and the reaction solution was partitioned between ethyl acetate and water, extracted with ethyl acetate (50 mL × 3). The organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, and filtered. The filtrate was mixed with crude silica gel, and subjected to flash column chromatography on silica gel column, eluting with V (petroleum ether) / V (ethyl acetate) = 4/1. The fraction was evaporated to dryness to obtain 0.93 g of methyl 6-(4-(tert-butyl)phenoxy)-2-(1-(N-(2-methoxy-2-oxoethyl)-4-toluenesulfonylamino) ethyl) nicotinate, 26.49%.","1,2",4,"70,72,92,94,141,143,135,137,116,118,74,76,145,147,112,113,95,96,98,100,126,128",petroleum ether ethyl acetate petroleum ether silica gel sodium sulfate ethyl acetate ethyl acetate brine water ethyl acetate silica gel,"160,164,4,8",methyl 6-(4-(tert-butyl)phenoxy)-2-(1-(N-(2-methoxy-2-oxoethyl)-4-toluenesulfonylamino) ethyl) nicotinate methyl 6-(4-(tert-butyl)phenoxy)-2-(1-(N-(2-methoxy-2- oxoethyl)-4-toluenesulfonylamino)ethyl) nicotinate,"35,37,41,43",potassium carbonate sodium iodide,"51,53","N, N-dimethylformamide","17,20,27,30",methyl 2-(1-bromoethyl)-6-(4-(tert-butyl)phenoxy) nicotinate p-toluenesulfonylglycine methyl ester,"61,63",50 °C,"156,157,59,60,54,55,15,16,66,69,109,110,129,130,96,97,90,91,113,114,123,124",obtain stirred dissolving charged Thin layer chromatography washed subjected extracted partitioned dried mixed,"64,66",10 hours,"157,159",0.93 g,"164,165",26.49%
"Step 3 3,7-Dimethyl-1-(3-(3-methylisoxazol-5-yl)propyl)-1H-purine-2,6(3H,7H)-dione 3-(3-Methylisoxazol-5-yl)propyl methanesulfonate (100 mg, 0.450 mmol) was dissolved in anhydrous N,N-methylformamide (5 mL). Potassium carbonate (126 mg, 0.900 mmol), potassium iodide (8.0 mg, 0.045 mmol) and 2,6-hydroxy-3,7-dimethylpurine (98.0 mg, 0.550 mmol) were added at room temperature under nitrogen atmosphere. The reaction solution was heated to 130°C and stirred for 3 hours. Water (40 mL) was added to quench the reaction, and the reaction solution was extracted with ethyl acetate (30 mL x 3). The organic phases were combined, washed with saturated sodium chloride solution (30 mL x 2), dried over anhydrous magnesium sulfate, filtered and the filtrate was concentrated under reduced pressure. The resulting product was purified by preparative HPLC to give 3,7-dimethyl-1-(3-(3-methylisoxazol-5-yl)propyl)-1H-purine-2,6(3H,7H)-dione (23.0 mg) with a yield of 16%.","1,2",3,"70,72,40,41,54,55,94,96,84,86",ethyl acetate nitrogen Water magnesium sulfate sodium chloride,"115,116,2,3","3,7-dimethyl-1-(3-(3-methylisoxazol-5-yl)propyl)-1H-purine-2,6(3H,7H)-dione 3,7-Dimethyl-1-(3-(3-methylisoxazol-5-yl)propyl)-1H-purine-2,6(3H,7H)-dione","16,18,22,24",Potassium carbonate potassium iodide,"13,14","N,N-methylformamide","3,5,29,30","3-(3-Methylisoxazol-5-yl)propyl methanesulfonate 2,6-hydroxy-3,7-dimethylpurine","37,39,48,49",room temperature 130°C,"114,115,50,51,46,47,10,11,35,36,91,92,58,59,81,82,68,69",give stirred heated dissolved added dried added washed extracted,"52,54",3 hours,"116,118",23.0 mg,"122,123",16%
"Step 2: Preparation of (S)-7-amino-5-(2-(5-chloro-4-oxo-3-(pyridine-3-yl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)pyrimido[4,5-d]pyrimidine-4(1H)-one 20 mg of (S)-7-amino-5-(2-(5-chloro-4-oxo-3-(pyridine-3-yl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)pyrimido[4,5-d]pyrimidine-4(1H)-one was prepared as a white solid according to the same manner as described in step 4 of Example 15 except that (S)-5-(2-(5-chloro-4-oxo-3-(pyridine-3-yl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)-7-(methylthio)pyrimido[4,5-d]pyrimidine-4(1H)-one was used (0.043 mmol, yield: 86%).","1,2",2,,,"8,9,4,5","(S)-7-amino-5-(2-(5-chloro-4-oxo-3-(pyridine-3-yl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)pyrimido[4,5-d]pyrimidine-4(1H)-one (S)-7-amino-5-(2-(5-chloro-4-oxo-3-(pyridine-3-yl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)pyrimido[4,5-d]pyrimidine-4(1H)-one",,,,,"30,31","(S)-5-(2-(5-chloro-4-oxo-3-(pyridine-3-yl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)-7-(methylthio)pyrimido[4,5-d]pyrimidine-4(1H)-one",,,"10,11,32,33",prepared used,,,"5,7,33,35",20 mg 0.043 mmol,"36,37",86%
"A solution of [4-chloro-2-(methylsulfanyl)pyrimidin-5-yl]methanol (CAS#1044145-59-6, 6.6 g, 35 mmol), (±)-(1R*,2R*)-2-amino-1-methylcyclopentanol (1b, 4.4 g, 46 mmol) and triethylamine (14.5 mL, 104 mmol) in ACN (86 mL) was stirred in a 50° C. oil bath for 16 h. The reaction solution was evaporated to dryness. Water (25 mL), sat. aq NaCl (25 mL) and sat. aq NaHCO3 (25 mL) were added to the residue, and the mixture extracted with EtOAc (200 mL×3). The combined organics were dried over sodium sulfate, and concentrated to dryness. The residue (9.3 g light yellow gum) was suspended in EtOAc (50 mL) with sonication to produce a thick white slurry. This slurry was heated at 60° C. with stirring. Heptane (˜150 mL) was added slowly to the heated suspension, then the mixture allowed to cool to room temperature overnight. The resulting solid was collected by filtration, rinsed with heptane (30 mL), and dried to give (±)-(1R*,2R*)-2-{[5-(hydroxymethyl)-2-(methylsulfanyl)pyrimidin-4-yl]amino}-1-methylcyclopentanol (1c, 6.91 g, 74%) as a white solid.",,,"54,55,43,44,47,48,112,113,76,78,53,54,67,68,92,93,141,142,48,49",NaHCO3 Water aq Heptane sodium sulfate aq EtOAc EtOAc heptane NaCl,"149,150,148,149","1c (±)-(1R*,2R*)-2-{[5-(hydroxymethyl)-2-(methylsulfanyl)pyrimidin-4-yl]amino}-1-methylcyclopentanol","16,17",triethylamine,"22,23",ACN,"9,10,3,4,4,5,10,11","(±)-(1R*,2R*)-2-amino-1-methylcyclopentanol [4-chloro-2-(methylsulfanyl)pyrimidin-5-yl]methanol CAS#1044145-59-6 1b","108,110,129,131,29,31",60° C room temperature 50° C,"147,148,26,27,106,107,74,75,58,59,139,140,116,117,127,128,65,66,90,91",give stirred heated dried added rinsed added cool extracted suspended,"34,36",16 h,"150,152",6.91 g,"152,153",74%
"Example 10A tert-Butyl 1-(2-methoxyethyl)-5-methyl-2,4-dioxo-3-(2-phenylethyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylate 1.85 g (5.69 mmol) of caesium carbonate were added to a solution of 2.0 g (5.18 mmol) of the compound from Ex. 6A in 60 ml of DMF, and the mixture was stirred at RT for 10 min. 863 mg (6.21 mmol) of 2-bromomethyl methyl ether were then added, and the mixture was heated to 100° C. for 30 min. The mixture was then evaporated to dryness on a rotary evaporator. The remaining residue was taken up in ethyl acetate and washed successively with water and saturated sodium chloride solution. After drying over anhydrous magnesium sulphate, the mixture was filtered and the filtrate was evaporated. The crude product was purified by MPLC (Puriflash column with 80 g of silica gel, cyclohexane/ethyl acetate 10:1). Filtration, evaporation and drying of the residue under high vacuum gave 2.22 g (96% of theory) of the title compound","1,2",10A,"122,124,88,89,98,100,82,84,91,93,124,125",silica gel water magnesium sulphate ethyl acetate sodium chloride cyclohexane ethyl acetate,"145,147,2,4","title compound tert-Butyl 1-(2-methoxyethyl)-5-methyl-2,4-dioxo-3-(2-phenylethyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylate","9,11",caesium carbonate,"31,32",DMF,"47,50,23,27",2-bromomethyl methyl ether compound from Ex. 6A,"59,61,38,39",100° C RT,"36,37,52,53,57,58,12,13,137,138,95,96,113,114,85,86,79,80",stirred added heated added gave drying purified washed taken,"62,64,40,42",30 min 10 min,"138,140",2.22 g,"140,141",96%
"Method B: A microwave vial was charged with 6-iodo-8-methyl-2-propyl-[1,2,4]triazolo[1,5-a]pyridine (Intermediate 66, 269 mg, 0.89 mmol), methyl 2,2-difluoro-2-(fluorosulfonyl)acetate (0.28 mL, 2.23 mmol), CuI (425 mg, 2.23 mmol), DMPU (0.61 mL, 5.06 mmol), and DMF (5.6 mL). The vial was evacuated under vacuum and backfilled with Na (×3), and then capped and sealed. The reaction was then stirred in a microwave reactor at 130° C. for 45 min. The mixture was cooled to room temperature and filtered over a pad of Celite®, eluting with MeOH. After concentrating the filtrate in vacuo, the residue was dissolved in EtOAc and washed with sat. aq. NH4Cl. The aqueous layer was extracted with EtOAc (×2), and the combined organics washed with brine (×3), dried over Na2SO4 and filtered. The filtrate was concentrated in vacuo. Purification (FCC, SiO2; 0-50% EtOAc/hexanes) afforded the title compound (137 mg, 63%).","1,2",B,"44,45,82,83,107,108,100,101,79,80,115,116,99,100,119,120,132,133,130,131,94,95",Na MeOH EtOAc NH4Cl hexanes Celite® brine aq Na2SO4 EtOAc SiO2 EtOAc,"135,137",title compound,"26,27,21,22",DMPU CuI,"32,33",DMF,"9,11,15,17,8,9","Intermediate 66 methyl 2,2-difluoro-2-(fluorosulfonyl)acetate 6-iodo-8-methyl-2-propyl-[1,2,4]triazolo[1,5-a]pyridine","71,73,61,63",room temperature 130° C,"133,134,6,7,55,56,42,43,113,114,80,81,96,97,74,75,92,93,105,106,117,118,128,129,69,70",afforded charged stirred backfilled washed eluting washed filtered dissolved extracted dried Purification cooled,"64,66",45 min,"137,139",137 mg,"139,140",63%
"Step 1 (5-Bromopyridin-3-yl)methanol (49) To a stirred solution of methyl 5-bromonicotinate (10 g, 43.47 mmol) in methanol (100 mL) NaBH4 (6.5 g, 260.0 mmol) was added portion wise at 0° C. The reaction mixture was allowed warm to room temperature and stirred at 50° C. for 16 h. The solvents were removed by rotary evaporation. The residue was diluted with ice-cold water (100 mL) and the aqueous layer was extracted with EtOAc (3×150 mL); the combined organic layer was washed with brine (2×150 mL), dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure to afford (5-bromopyridin-3-yl)methanol (6.5 g, yield: 74%, LC/MS: 99%) as an off-white solid. NMR (CDCl3, 400 MHz): δ 8.58 (d, J=2.0 Hz, 1H), 8.48 (d, J=2.0 Hz, 1H), 7.90 (t, J=2.0 Hz, 1H), 4.73 (s, 2H), 2.47 (bs, 1H).","1,2",1,"87,88,61,62,71,72,81,82,108,109",Na2SO4 water EtOAc brine CDCl3,"3,4,96,97,2,3",49 (5-bromopyridin-3-yl)methanol (5-Bromopyridin-3-yl)methanol,"19,20,16,17",NaBH4 methanol,,,"9,11",methyl 5-bromonicotinate,"43,45,29,31",50° C 0° C,"25,26,95,96,41,42,58,59,69,70,79,80,84,85",added afford stirred diluted extracted washed dried,"46,48",16 h,"102,103,97,99",99% 6.5 g,"100,101",74%
"Synthesis of 2-butylthiochroman-4-one (10b) 340 mg trans-2-heptenic acid (2.65 mmol) was solved in 1.0 ml dry DCM in a Schleck tube with a septum under nitrogen. 0.27 ml Thiophenol (2.65 mmol) was added and the mixture was cooled with an ice-bath. Under nitrogen 2.5 ml trifluoromethanesulfonic acid was added and the mixture stirred at 0°C for 5 min. After that, the mixture was heated in an oil bath at 130 °C with a reflux cooler for 5 min. the reaction was allowed to cool to room temperature and was poured on ice. DCM was added and the phases separated. The water phase was washed with DCM and the combined organic phases washed twice with sat. NaHCO3 sol. and Brine. The organic phases was dried with MgSO4, filtered and the solved evaporated. The product was purified by column chromatography on silica 60 with PE/DCM 1:1. The product was obtained as slightly yellow oil (m = 198 mg, 34 %). Rf = 0.43 (PE/DCM 1:1).",,,"142,143,42,43,115,116,125,126,118,119,92,93,161,162,25,26,139,140,105,106",PE nitrogen DCM DCM NaHCO3 MgSO4 Brine DCM PE nitrogen silica DCM,"3,4,145,146,2,3",10b product 2-butylthiochroman-4-one,"45,47",trifluoromethanesulfonic acid,"16,17",DCM,"6,8,28,29",trans-2-heptenic acid Thiophenol,"69,71,54,55,85,87",130 °C 0°C room temperature,"147,148,48,49,11,12,63,64,52,53,32,33,94,95,111,112,123,124,134,135,83,84,103,104",obtained added solved heated stirred added added washed dried purified cool washed,"56,58,76,78",5 min 5 min,"154,156",198 mg,"156,158",34 %
"(6)Preparation of 6-bromo-7-methyl-5-nitro-2,3-dihydrobenzo[b][1,4]dioxin 7-Methyl-5-nitro-2,3-dihydrobenzo[b][1,4]dioxin (13 g, 66.61 mmol)was dissolved in 200mL N,N-dimethyl formamide, and N-bromosuccinimide (23.7g, 133.2 mmol)was added in batch. The resultant mixture was heated to 60°C, and the reaction was carried out overnight. After the reaction, 200mL water was added, and the resultant mixture was extracted with ethyl acetate (3×200mL). The organic phases were combined, the solvent was removed by rotary evaporation, and the residue was subjected to silica gel column chromatography (petroleum ether: ethyl acetate=5:1) to obtain the product (12 g, yield: 66%).","0,1",6,"39,40,49,51,74,76,70,72,76,78",water ethyl acetate petroleum ether silica gel ethyl acetate,"2,3,81,82","6-bromo-7-methyl-5-nitro-2,3-dihydrobenzo[b][1,4]dioxin product","14,15",N-bromosuccinimide,"11,13","N,N-dimethyl formamide","3,4","7-Methyl-5-nitro-2,3-dihydrobenzo[b][1,4]dioxin","27,28",60°C,"25,26,79,80,8,9,18,19,47,48,68,69,41,42",heated obtain dissolved added extracted subjected added,,,"82,84",12 g,"85,86",66%
"Example 44A Methyl 4-{[(6-chloro-3-methyl-2-phenylquinolin-4-yl)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylate At RT, 258 mg (1.41 mmol) of methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate, 402 mg (1.06 mmol) of HATU and 182 mg (1.41 mmol) of DIPEA were added to a solution of 210 mg (0.71 mmol) of 6-chloro-3-methyl-2-phenylquinoline-4-carboxylic acid in 5 ml of DMF. The mixture was then stirred at 60° C. for 1 h. After cooling to RT, the mixture was added to 20 ml of a 10% strength citric acid solution. The resulting precipitate was filtered off, washed with water and dried under reduced to pressure. This gave 326 mg (97% of theory, purity 98%) of the title compound","1,2",44A,"70,72,81,82",citric acid water,"99,101,2,4",title compound Methyl 4-{[(6-chloro-3-methyl-2-phenylquinolin-4-yl)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylate,"18,19,25,26",HATU DIPEA,"43,44",DMF,"11,13,37,39",methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate 6-chloro-3-methyl-2-phenylquinoline-4-carboxylic acid,"58,59,50,52,5,6",RT 60° C RT,"89,90,27,28,48,49,79,80,56,57,62,63",gave added stirred washed cooling added,"53,55",1 h,"90,92",326 mg,"92,93",97%
"Intermediate 10B 5-bromo-3-(((tert-butyldimethylsilyl)oxy)methyl)-2-methoxypyridine (5-Bromo-2-methoxypyridin-3-yl)methanol (1.876 g, 8.60 mmol), tert-butyldimethylsilyl chloride (1.556 g, 10.32 mmol), and imidazole (0.879 g, 12.91 mmol) were stirred in dichloromethane (35 mL) overnight at room temperature. Methanol (3 mL) was added to quench the tert-butyldimethylsilyl chloride, and the reaction mixture was stirred at room temperature for 10 minutes. The mixture was diluted with dichloromethane and washed twice with saturated aqueous sodium bicarbonate and once with brine. The organic layer was dried over sodium sulfate, filtered and concentrated to afford 5-bromo-3-(((tert-butyldimethylsilyl)oxy)methyl)-2-methoxypyridine (2.71 g, 8.16 mmol, 95% yield).","1,2",10B,"69,70,63,64,76,78,57,58,30,31,38,40,64,66",brine aqueous sodium sulfate dichloromethane Methanol tert-butyldimethylsilyl chloride sodium bicarbonate,"2,3,83,84",5-bromo-3-(((tert-butyldimethylsilyl)oxy)methyl)-2-methoxypyridine 5-bromo-3-(((tert-butyldimethylsilyl)oxy)methyl)-2-methoxypyridine,"15,16",imidazole,"23,24",dichloromethane,"8,10,3,4",tert-butyldimethylsilyl chloride (5-Bromo-2-methoxypyridin-3-yl)methanol,"28,30,47,49",room temperature room temperature,"21,22,82,83,55,56,34,35,59,60,45,46,74,75",stirred afford diluted added washed stirred dried,"50,52",10 minutes,"86,88,84,86",8.16 mmol 2.71 g,"88,89",95%
"Example 54-2 : Preparation of 4-chloro-6-(5-methoxy-[2,4'-bipyridin]-6-yl)pyrimidin-2-amine 4-(6-Bromo-3-methoxypyridin-2-yl)-6-chloropyrimidin-2-amine (26 mg, 82.39 µmol) and pyridin-4-ylboronic acid (12.15 mg, 98.87 µmol) were dissolved in dioxane (300 µL). To the resulting solution were added dropwise potassium phosphate (K3PO4) (52.47 mg, 247.18 µmol) dissolved in distilled water (100 µL) and tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) (4.76 mg, 4.12 µmol). The solution was refluxed with heat for 24 hrs, cooled, evaporated under reduced pressure to concentrate, and diluted with distilled water and dichloromethane. The resulting solid was filtered, washed with diethylether, and dried to give the title compound (7.6 mg, 29 %).","1,2",54-2,"71,72,81,82,73,74",water diethylether dichloromethane,"5,6,87,89","4-chloro-6-(5-methoxy-[2,4'-bipyridin]-6-yl)pyrimidin-2-amine title compound","46,47,33,34,45,46,31,33",Pd(PPh3)4 K3PO4 tetrakis(triphenylphosphine)palladium(0) potassium phosphate,"41,42,21,22",water dioxane,"6,7,12,14",4-(6-Bromo-3-methoxypyridin-2-yl)-6-chloropyrimidin-2-amine pyridin-4-ylboronic acid,,,"54,55,19,20,85,86,29,30,38,39,68,69,79,80",refluxed dissolved give added dissolved diluted washed,"58,60",24 hrs,"89,91",7.6 mg,"91,93",29 %
"Example 70: Synthesis of compound 11332, N-(4-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-2-fluorobenzyl)-N-(3-fluorophenyl)-1-isobutyrylazetidine-3-carboxamide N-(4-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-2-fluorobenzyl)-N-(3-fluorophenyl)azetidine-3-carboxamide hydrochloride (0.050 g, 0.109 mmol), synthesized in step 5 of Example 63, and N,N-diisopropylethylamine (0.038 mL, 0.219 mmol) were dissolved in dichloromethane (10 mL) at room temperature, and isobutyryl chloride (0.013 mL, 0.120 mmol) was added to the solution. The mixture was stirred at the same temperature for 18 hours. Water was added to the reaction mixture, followed by extraction with dichloromethane. The organic layer was washed with saturated aqueous sodium chloride solution, dried with magnesium sulfate anhydrous, filtered, and then concentrated under reduced pressure. The concentrate was purified by column chromatography (SiO2, 4 g cartridge; ethyl acetate/hexane = from 0% to 90%) and concentrated to give the title compound (0.021 g, 39.1%) as colorless oil.","1,2",70,"77,78,78,80,69,70,100,101,104,106,83,85,58,59",aqueous sodium chloride hexane dichloromethane SiO2 ethyl acetate magnesium sulfate Water,"6,7,116,118,5,6","N-(4-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-2-fluorobenzyl)-N-(3-fluorophenyl)-1-isobutyrylazetidine-3-carboxamide title compound 11332","21,22","N,N-diisopropylethylamine","29,30",dichloromethane,"7,9,36,38","N-(4-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-2-fluorobenzyl)-N-(3-fluorophenyl)azetidine-3-carboxamide hydrochloride isobutyryl chloride","33,35",room temperature,"50,51,43,44,27,28,114,115,60,61,96,97,74,75,67,68,81,82",stirred added dissolved give added purified washed extraction dried,"56,58",18 hours,"118,120",0.021 g,"120,121",39.1%
"Example 49 Preparation of (E)-3-chloro-5-(4-methoxystyryl) benzaldehyde (C68) To a stirred solution of 3-bromo-5-chlorobenzaldehyde (20.0 g, 91.32 mmol) in dimethylacetamide, 1-methoxy-4-vinylbenzene (18.3 g, 136.9 mmol) and triethylamine (50 mL, 273.96 mmol) were added, and the reaction mixture was degassed with argon for 5 minutes. Palladium(II) acetate (410 mg, 1.83 mmol) and tri-o-tolylphosphine (1.11 g, 3.65 mmol) were added, and the resulting reaction mixture was heated to 100° C. for 16 hours. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layer was dried over sodium sulfate and concentrated under reduced pressure. The resulting crude material was purified by flash column chromatography using 5-10% ethyl acetate in petroleum ether as the eluent to afford the title compound as a yellow solid (13.5 g, 54%);","1,2",49,"108,110,89,91,80,82,76,77,111,113,39,40",ethyl acetate sodium sulfate ethyl acetate water petroleum ether argon,"6,7,4,6,119,121",C68 (E)-3-chloro-5-(4-methoxystyryl) benzaldehyde title compound,"43,45,50,51,25,26",Palladium(II) acetate tri-o-tolylphosphine triethylamine,"18,19",dimethylacetamide,"19,20,12,13",1-methoxy-4-vinylbenzene 3-bromo-5-chlorobenzaldehyde,"65,67",100° C,"63,64,31,32,117,118,56,57,37,38,87,88,101,102,74,75,78,79",heated added afford added degassed dried purified poured extracted,"68,70,41,43",16 hours 5 minutes,"125,127",13.5 g,"127,128",54%
"EXAMPLE 4 Synthesis of [4-Iso-Pentoxycarbonyl-9-Fluorenylidene]Malononitrile (VIII) A mixture of 9-fluorenone-4-carboxylic acid (1.0 g, 4.46 mmol), isopentyl alcohol (7.863 g, 89.2 mmol), conc. sulfuric acid (0.05 mL) and toluene (20 mL) in a 100-mL round-bottomed flask fitted with a Dean-stark apparatus and a water condenser was magnetically stirred and refluxed for 24 h before cooling to room temperature. After the reaction, the reaction mixture was evaporated under reduced pressure in the presence of NaHCO3 (0.1 g). Subsequently, methylene chloride (100 mL) was added and the resulting solution was washed with dilute aq. NaHCO3 solution (2 times) and with water (2 times), and dried with anhydrous MgSO4. This was followed by filtration and evaporation under reduced pressure to give the crude product which was purified by flash chromatography on silica gel with hexane/ethyl acetate (volume ratio 15/1) as the eluent to afford iso-pentyl 9-fluorenone-4-carboxylate as a yellow oil (1.27 g, 97%).","1,2",4,"90,91,130,131,72,73,91,92,104,105,76,78,5,6,97,98,127,129,4,5",aq hexane NaHCO3 NaHCO3 MgSO4 ethyl acetate methylene chloride VIII water silica gel [4-Iso-Pentoxycarbonyl-9-Fluorenylidene]Malononitrile,"140,142",iso-pentyl 9-fluorenone-4-carboxylate,"22,24",sulfuric acid,"27,28",toluene,"15,17,9,11",isopentyl alcohol 9-fluorenone-4-carboxylic acid,"55,57",room temperature,"46,47,48,49,139,140,87,88,53,54,81,82,122,123,64,65,101,102",stirred refluxed afford washed cooling added purified evaporated dried,"50,52",24 h,"146,148",1.27 g,"148,149",97%
"Fourth Step: Synthesis of Intermediate 6 15.0 g (26.62 mmol) of Intermediate 4, 7.43 g (31.94 mmol) of Intermediate 5, 9.20 g (66.55 mmol) of potassium carbonate, and 0.92 g (0.8 mmol) of tetrakis(triphenylphosphine) palladium (0) were mixed with 80 mL of 1,4-dioxane and 40 mL of water in a 250 ml flask, and the mixture was heated at 100° C. under a nitrogen flow for 24 hours. An organic layer was separated therefrom and volatilized and then, added to 400 ml of methanol, and a solid crystallized therein was filtered, dissolved in monochlorobenzene, filtered with silica gel/Celite, and after removing an appropriate amount of an organic solvent, recrystallized with monochlorobenzene to obtain 11.9 g of Intermediate 6 (a yield of 67%).","0,1",Fourth,"110,111,63,64,96,98,83,84,93,94",monochlorobenzene nitrogen silica gel Celite methanol monochlorobenzene,"5,6,117,118",6 6,"33,36,25,27",tetrakis(triphenylphosphine) palladium (0) potassium carbonate,"47,48,42,43","water 1,4-dioxane","19,20,12,13",5 4,"59,61",100° C,"37,38,112,113,57,58,91,92,78,79,94,95,108,109",mixed obtain heated dissolved added filtered recrystallized,"66,68",24 hours,"113,115",11.9 g,"121,122",67%
"Synthesis Example 9: Synthesis of Compound 34 Compound 34 (6.7 g, a yield of 84%) was obtained according to the same method as Synthesis Example 1 except for using 3-(4-bromophenyl)dibenzothiophene instead of the bromometabiphenyl in Step 2 of Synthesis Example 1. calcd. C54H32N2S: C, 87.54; H, 4.35; N, 3.78; S, 4.33; found: C, 87.54; H, 4.35; N, 3.78; S, 4.33.","2,3",9,"33,34",bromometabiphenyl,"6,7,8,9",34 34,,,,,"29,30",3-(4-bromophenyl)dibenzothiophene,,,"16,17,28,29",obtained using,,,"9,11",6.7 g,"14,15",84%
"l. PREPARATION OF (S)-N-((2R,6S,8AS,14AS,20S,23AS)-2,6-DIMETHYL-5,8,14,19,23-PENTAOXOOCTADECADYDRO-1H,5H,14H,19H-PYRIDO[2,1-I]DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-20-YL)-2-(3-(1-METHYL-1H-INDOL-6-YL)UREIDO)-3-PHENYLPROPANAMIDE (COMPOUND 12). Compound 12 was synthesized from compound C (80 mg, 0.128 mmol), 6-isocyanato-1-methyl-1H-indole (26.5 mg, 0.154 mmol) and triethylamine (84 μL, 0.615 mmol) following the general synthesis method as described herein above. Compound 12 was provided as a white solid (45 mg, 44.1%);","0,1",l,,,"7,8,3,4,38,39,5,6","12 (S)-N-((2R,6S,8AS,14AS,20S,23AS)-2,6-DIMETHYL-5,8,14,19,23-PENTAOXOOCTADECADYDRO-1H,5H,14H,19H-PYRIDO[2,1-I]DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-20-YL)-2-(3-(1-METHYL-1H-INDOL-6-YL)UREIDO)-3-PHENYLPROPANAMIDE 12 12","23,24",triethylamine,,,"17,18,12,13",6-isocyanato-1-methyl-1H-indole C,,,"40,41,9,10",provided synthesized,,,"45,47",45 mg,"47,48",44.1%
"[Reaction Scheme 1-2] Synthesis of [Intermediate 1-b] In a 1-L reactor, tetrahydrofuran (500 mL) and 1,3-dibromobenzene (50 g, 212 mmol) were placed and cooled to −78° C. under a nitrogen atmosphere. Drops of 1.5M LDA (170 mL, 254 mmol) were slowly added and then stirred for 30 min. At the same temperature, DMF (18.5 g, 254 mmol) was slowly added in a dropwise manner, followed by stirring for 30 min. The reaction was terminated with an aqueous sulfuric acid solution. The organic layer was extracted and concentrated at a reduced pressure. Purification by column chromatography afforded Intermediate 1-b (49 g): yield 88%","2,3",1-2,"77,79,29,30,76,77",sulfuric acid nitrogen aqueous,"5,7,96,98",Intermediate 1-b Intermediate 1-b,"34,35",LDA,"11,12",tetrahydrofuran,"15,16,52,53","1,3-dibromobenzene DMF","25,27",−78° C,"66,67,44,45,41,42,95,96,23,24,21,22,59,60,73,74",stirring stirred added afforded cooled placed added terminated,"68,70,46,48",30 min 30 min,"98,100",49 g,"101,102",88%
"Example 30 3,7-Dimethyl-1,2-(2-methylthiazol-4-yl)ethyl)-1H-purine-2,6(3H,7H)-dione Step 1 Methyl 2-(2-methylthiazol-4-yl)acetate 2-(2-Methylthiazol-4-yl)acetic acid (50.0 mg, 0.270 mmol) was dissolved in methanol (2 mL), thionyl chloride (0.1 mL) was slowly added at 0°C. The reaction solution was slowly allowed to warm to room temperature and stirred for 2.5 hours. The reaction was quenched by addition of water (10mL) and extracted with ethyl acetate (10 mL x 3). The organic phase was dried over anhydrous sodium sulfate, filtered and the filtrate was concentrated under reduced pressure. The resulting product was purified by high performance preparative TLC plate (1:3 petroleum ether / ethyl acetate, Rf = 0.4) to give methyl 2-(2-methylthiazol-4-yl)acetate (40.0 mg, as a yellow oil) with a yield of 87%.","1,2,4,5",30 1,"51,52,95,97,92,94,2,3,69,71,56,58","water ethyl acetate petroleum ether 3,7-Dimethyl-1,2-(2-methylthiazol-4-yl)ethyl)-1H-purine-2,6(3H,7H)-dione sodium sulfate ethyl acetate","5,7,102,104",Methyl 2-(2-methylthiazol-4-yl)acetate methyl 2-(2-methylthiazol-4-yl)acetate,"19,21",thionyl chloride,,,"7,9,16,17",2-(2-Methylthiazol-4-yl)acetic acid methanol,"37,39,27,28",room temperature 0°C,"35,36,25,26,40,41,14,15,101,102,66,67,54,55,84,85,47,48",warm added stirred dissolved give dried extracted purified quenched,"42,44",2.5 hours,"104,106",40.0 mg,"114,115",87%
"Example 5 (E)-3-(3,5-difluoro-4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,2,3,4-tetr ahydrobenzo[4,5]thieno[2,3-c]pyridin-1-yl)phenyl)acrylic acid Step 1 N-(1-(benzo[b]thiophen-3-yl)propan-2-yl)-2-fluoro-2-methylpropan-1-amine 1-(benzo[b]thiophen-3-yl)propan-2-amine 5a (100 mg, 0.523 mmol, prepared by a well-known method disclosed in ""Bioorganic & Medicinal Chemistry, 2005, 13(14), 4450-4457""), 2-fluoro-2-methylpropyl trifluoromethanesulfonate 1b (152 mg, 0.680 mmol) and N,N-diisopropylethylamine (135 mg, 1.046 mmol) were dissolved in 4 mL of 1,4-dioxane. After stirring for 3 hours at 90°C, the reaction was stopped. The reaction solution was concentrated under reduced pressure. The resulting residue was purified by thin-layer chromatography with elution system A to obtain the title compound N-(1-(benzo[b]thiophen-3-yl)propan-2-yl)-2-fluoro-2-methylpropan-1-amine 5b (100 mg, yield 72%) as a yellow oil.","1,2,6,7",5 1,"2,5","(E)-3-(3,5-difluoro-4-((1R,3R/1S,3S)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,2,3,4-tetr ahydrobenzo[4,5]thieno[2,3-c]pyridin-1-yl)phenyl)acrylic acid","7,8,85,86,82,84,84,85",N-(1-(benzo[b]thiophen-3-yl)propan-2-yl)-2-fluoro-2-methylpropan-1-amine 5b title compound N-(1-(benzo[b]thiophen-3-yl)propan-2-yl)-2-fluoro-2-methylpropan-1-amine,"36,37","N,N-diisopropylethylamine","47,48","1,4-dioxane","28,30,9,10,30,31,8,9",2-fluoro-2-methylpropyl trifluoromethanesulfonate 5a 1b 1-(benzo[b]thiophen-3-yl)propan-2-amine,"54,55",90°C,"42,43,49,50,80,81",dissolved stirring obtain,"51,53",3 hours,"86,88",100 mg,"89,90",72%
"Step 1. (5-Bromo-6-methoxypyridin-2-yl)methanol To a suspension of methyl 5-bromo-6-methoxypicolinate (20 mg, 0.079 mmol) (Ark Pharm, AK100459) in ethanol (0.25 mL) was added sodium borohydride (9.6 mg, 0.25 mmol). The reaction mixture was then heated at 50° C. for 2.5 h. An additional portion of sodium borohydride (10 mg, 0.27 mmol) was added, and the reaction mixture was heated at 50° C. for an additional 2 h. The reaction was quenched with water, and the reaction mixture was partitioned between sat. NaHCO3 and EtOAc. The organic layer was removed, and the aqueous mixture was extracted with EtOAc (2×). The combined organic layers were washed with brine, dried over Na2SO4, filtered, and concentrated. Purification via silica gel chromatography (15-55% EtOAc/hexanes) afforded the desired product as a white solid (11 mg, 64%). LCMS for C7H9BrNO2 (M+H)+: calculated m/z=218.0, 220.0; found 217.9, 220.1.","1,2",1,"71,72,104,105,113,115,107,108,95,96,117,118,82,83,80,81",water brine hexanes silica gel Na2SO4 EtOAc EtOAc EtOAc NaHCO3,"120,122,2,3",desired product (5-Bromo-6-methoxypyridin-2-yl)methanol,"22,24,17,18,44,46",sodium borohydride ethanol sodium borohydride,,,"7,9,15,16",methyl 5-bromo-6-methoxypicolinate AK100459,"35,37,59,61",50° C 50° C,"51,52,118,119,57,58,21,22,33,34,102,103,105,106,111,112,69,70,77,78,93,94",added afforded heated added heated washed dried Purification quenched partitioned extracted,"38,40,64,66",2.5 h 2 h,"126,128",11 mg,"128,129",64%
"Core 3 rac-(2R,3S,4R,5R)-ethyl 3-(tert-butyl)-5-(2-methoxyphenyl)-4-nitropyrrolidine-2-carboxylate Core 3A (E)-ethyl 2-((2-methoxybenzylidene)amino)acetate To a mixture of ethyl 2-aminoacetate hydrochloride (10.76 g, 77.12 mmol) and magnesium sulfate (10.61 g, 88.2 mmol) in dichloromethane (100 mL) was added triethylamine (11.2 mL, 80.8 mmol). The mixture was stirred at room temperature for 20 minutes and 2-methoxybenzaldehyde (10.0 g, 73.45 mmol) was added dropwise. The resulting mixture was stirred at room temperature overnight. The solid was filtered off and washed with dichloromethane (300 mL). The combined filtrate was washed with water (150 mL) and brine (150 mL), dried over magnesium sulfate, filtered and concentrated to provide the title compound (E)-ethyl 2-((2-methoxybenzylidene)amino)acetate (16 g, 50.60 mmol, 68.9% yield).","1,2",3,"82,83,5,6,91,93,73,74,2,4,86,87","water 3A magnesium sulfate dichloromethane rac-(2R,3S,4R,5R)-ethyl 3-(tert-butyl)-5-(2-methoxyphenyl)-4-nitropyrrolidine-2-carboxylate brine","6,8,101,103,99,101",(E)-ethyl 2-((2-methoxybenzylidene)amino)acetate (E)-ethyl 2-((2-methoxybenzylidene)amino)acetate title compound,"32,33,20,22",triethylamine magnesium sulfate,"27,28",dichloromethane,"48,49,12,15",2-methoxybenzaldehyde ethyl 2-aminoacetate hydrochloride,"42,44,62,64",room temperature room temperature,"97,98,31,32,40,41,60,61,54,55,89,90,80,81,71,72",provide added stirred stirred added dried washed washed,"45,47",20 minutes,"103,105,105,107",16 g 50.60 mmol,"107,108",68.9%
"Step-2: Synthesis of 2-chloro-4-nitrobenzoyl chloride To a two neck RBF (1 liter) placed in ice bath, 2-chloro-4-nitrobenzoic acid (50 g, 0.248 mol, 1 eq.) was charged. Thionyl chloride (110 mL, 1.51 mol, 6.1 eq.) was added dropwise at 0° C. The reaction mixture was allowed to come to RT and then heated to reflux. The reflux was continued overnight. Thionyl chloride was evaporated and ice (approx. 150 g) was added into the reaction mixture. The aqueous reaction mass was extracted with DCM (2×200 mL). The DCM extracts were combined dried over anhydrous sodium sulfate and concentrated under vacuum to get 50 g (91.7%) of 2-chloro-4-nitrobenzoyl chloride as a light yellow liquid.",,2,"92,94,85,86,75,76,81,82,59,61",sodium sulfate DCM aqueous DCM Thionyl chloride,"104,106,3,5",2-chloro-4-nitrobenzoyl chloride 2-chloro-4-nitrobenzoyl chloride,"26,28",Thionyl chloride,,,"16,18",2-chloro-4-nitrobenzoic acid,"53,54,48,49,38,40",reflux RT 0° C,"25,26,35,36,51,52,99,100,79,80,89,90,62,63",charged added heated get extracted dried evaporated,,,"100,102",50 g,"102,103",91.7%
"Synthesis Example 13: Synthesis of Compound 359 Compound 359 was synthesized in the same manner as in Synthesis Example 9, except that 5,9-dibromo-dibenzo[c,g]fluoren-7-one was used instead of 5,9-dibromo-benzo[c]fluoren-7-one in Synthesis of Intermediate Compound (iii), and tert-butyl magnesium bromide was used instead of methylmagnesium bromide in Synthesis of Intermediate Compound (iv). Yield: 0.58 g (0.44 mmol, 63%). HR-EIMS (m/z) [M+] calcd for C98H78N4 1310.6226; found, 1310.6233.","2,3",13,"27,28,33,34,49,50,42,44","5,9-dibromo-benzo[c]fluoren-7-one iii iv methylmagnesium bromide","8,9,6,7",359 359,,,,,"22,23,35,38","5,9-dibromo-dibenzo[c,g]fluoren-7-one tert-butyl magnesium bromide",,,"39,40,10,11,24,25",used synthesized used,,,"51,53,53,55",0.58 g 0.44 mmol,"55,56",63%
"Intermediate 68: 5-Chloro-2-(difluoromethyl)-8-methyl-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridine Step A: 2-(Difluoromethyl)-6-iodo-8-methyl-[1,2,4]triazolo[1,5-a]pyridine. To a suspension of 1,2-diamino-5-iodo-3-methylpyridin-1-ium 2,4,6-trimethylbenzenesulfonate (Intermediate 12) (500 mg, 1.11 mmol) in MeOH (5.7 mL) at 0° C. was added Et3N (0.46 mL, 3.34 mmol), followed by methyl difluoroacetate (0.15 mL, 1.7 mmol) dropwise via syringe. The reaction was maintained at 45° C. and stirred for 16 h. The reaction mixture was concentrated in vacuo. Purification (FCC, SiO2, 0-50% EtOAc/hexanes) afforded the title compound (304 mg, 88%).","1,2,4,5",68 A,"2,3,64,65,66,67","5-Chloro-2-(difluoromethyl)-8-methyl-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridine SiO2 EtOAc hexanes","69,71,5,6","title compound 2-(Difluoromethyl)-6-iodo-8-methyl-[1,2,4]triazolo[1,5-a]pyridine","27,28",Et3N,"19,20",MeOH,"10,12,12,14,34,36","1,2-diamino-5-iodo-3-methylpyridin-1-ium 2,4,6-trimethylbenzenesulfonate Intermediate 12 methyl difluoroacetate","23,25,48,50",0° C 45° C,"67,68,26,27,51,52,46,47,32,33,62,63",afforded added stirred maintained followed Purification,"53,55",16 h,"71,73",304 mg,"73,74",88%
"Step 4: 8-Chloro-1-(2,6-dichlorophenyl)-2-(difluoromethyl)-5-(2,3-dihydroxypropoxy)-1,6-naphthyridin-4(1H)-one To a solution of 8-chloro-1-(2,6-dichlorophenyl)-2-(difluoromethyl)-5-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-1,6-naphthyridin-4(1H)-one (0.025 g, 0.049 mmol) in 0.5 ml of DCM was added 0.5 ml of TFA. The reaction mixture was stirred 1.5 hours. Then it was concentrated. The residue was diluted with ACN and filtered through LP-HCO3 resin to neutralize the TFA salt. The filtrate was concentrated to provide the title compound (0.020 g, 78% yield).","1,2",4,"43,45,48,50,39,40",LP-HCO3 resin TFA salt ACN,"57,59,2,3","title compound 8-Chloro-1-(2,6-dichlorophenyl)-2-(difluoromethyl)-5-(2,3-dihydroxypropoxy)-1,6-naphthyridin-4(1H)-one","22,23",TFA,"16,17",DCM,"7,8","8-chloro-1-(2,6-dichlorophenyl)-2-(difluoromethyl)-5-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-1,6-naphthyridin-4(1H)-one",,,"27,28,55,56,18,19,46,47,41,42,37,38",stirred provide added neutralize filtered diluted,"28,30",1.5 hours,"59,61",0.020 g,"61,62",78%
"The following compounds were prepared in like manner to the procedure outlined in Example 37: trans-2,2-Dichloro-N-(4-chloro-3-(2-methylhydrazine-1-carbonyl)phenyl)-3-(3,5-dichlorophenyl)cyclopropane-1-carboxamide hydrochloride (F2521) Isolated as a white solid (2.6 g, 78%).","14,15",37,,,"17,18,15,17,22,23","F2521 trans-2,2-Dichloro-N-(4-chloro-3-(2-methylhydrazine-1-carbonyl)phenyl)-3-(3,5-dichlorophenyl)cyclopropane-1-carboxamide hydrochloride solid",,,,,,,,,"18,19",Isolated,,,"23,25",2.6 g,"25,26",78%
"(9) Preparation of tert-butyl 3-((2S,5R)-6-hydroxyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-8-azabicyclo[3.2. 1]octane-8-carboxylate Tert-butyl 3-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-8-azabicyclo[ 3.2.1]octane-8-carboxylate (0.4 g, 0.82 mmol) was dissolved in methanol (10 mL), and Pd/C (50 mg) was added. The reaction solution was stirred and reacted under compressed hydrogen gas at 25 °C for 6 h, filtrated, and the filtrate was concentrated in vacuum to obtain the title compound (0.3 g, yield 93.8 %).","0,1",9,,,"53,55,3,6","title compound tert-butyl 3-((2S,5R)-6-hydroxyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-8-azabicyclo[3.2. 1]octane-8-carboxylate","34,35,20,21",hydrogen Pd/C,"16,17",methanol,"6,9","Tert-butyl 3-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-8-azabicyclo[ 3.2.1]octane-8-carboxylate","37,39",25 °C,"24,25,31,32,51,52,14,15",added reacted obtain dissolved,"40,42",6 h,"55,57",0.3 g,"58,60",93.8 %
"Example 2 5-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)-N,N-dimethylpentanamide 5-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)-N-methylpentanamide 5-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)pentanenitrile (200 mg, 0.717 mmol) was dissolved in N,N-dimethylformamide (5 mL), sodium hydride (86.0 mg, 2.15 mmol) were added at 0°C, and the reaction was stirred at 0°C for 0.5 hours. Methyl iodide (305 mg, 2.15 mmol) was added and the reaction was stirred at 25°C for 12 hours. The reaction was quenched by addition of water (30 mL), and extracted with ethyl acetate (30 mL x 3). The organic phase was dried over anhydrous sodium sulfate and filtered, and the filtrate was concentrated under reduced pressure. 5-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)-N,N-dimethylpentanamide (product 1) (50.0 mg) was obtained after purification by preparative HPLC with a yield of 23%.","1,2",2,"79,81,60,61,66,68",sodium sulfate water ethyl acetate,"93,94,3,4,2,3,91,92","1 5-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)-N-methylpentanamide 5-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)-N,N-dimethylpentanamide 5-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)-N,N-dimethylpentanamide","15,17",sodium hydride,"12,13","N,N-dimethylformamide","4,5,35,37","5-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)pentanenitrile Methyl iodide","24,25,31,32,49,50",0°C 0°C 25°C,"47,48,97,98,22,23,42,43,10,11,29,30,56,57,76,77,64,65",stirred obtained added added dissolved stirred quenched dried extracted,"51,53,33,35",12 hours 0.5 hours,"94,96",50.0 mg,"107,108",23%
"Example 35: 2-Pyridylmethylamine Formylation Reaction Catalyzed by Using One of Ten Thousand of Molar Equivalent of Ruthenium Complex 1a Steps similar to those in example 24 were employed, ruthenium complex 1a (1.2 mg, 0.002 mmol) was used as catalyst, and a reaction among 2-pyridylmethylamine (2.440 g, 20 mmol) and CO2 and H2 (each at a pressure of 35 atm) was performed in a Parr autoclave at 120° C. in an oil bath for 16 hours. N-(2-pyridyl)methylformamide was separated and obtained as a yellow liquid (2.959 g) in 96% yield.","1,2",35,,,"75,76",N-(2-pyridyl)methylformamide,"51,52,30,31,18,19,16,18,28,30",H2 1a 1a Ruthenium Complex ruthenium complex,,,"49,50,2,3,43,44",CO2 2-Pyridylmethylamine 2-pyridylmethylamine,"66,68",120° C,"36,37,60,61,79,80",used performed obtained,"73,75",16 hours,"84,86",2.959 g,"87,88",96%
"Example 25 4-(6-Fluoro-1H-indol-3-yl)-N-(1-methyl-3-piperidyl)benzamide This compound was prepared from Intermediate 3 and 3-amino-1-methylpiperidine dihydrochloride according to the procedure described in Example 1. Purification was performed using preparative HPLC to afford the title compound (14 mg, 36%). Data: LCMS (B) Rt : 6.933 min; m/z 352.2 (M+H)+.","1,2",25,,,"2,3,30,32",4-(6-Fluoro-1H-indol-3-yl)-N-(1-methyl-3-piperidyl)benzamide title compound,,,,,"8,10,11,13",Intermediate 3 3-amino-1-methylpiperidine dihydrochloride,,,"28,29,6,7",afford prepared,,,"32,34",14 mg,"34,35",36%
"Preparation Example 38 Preparation of Compound 38 After completely dissolving Compound A (10.0 g, 17.92 mmol) and 7H-benzo[c]carbazole (5.61 g, 20.61 mmol) in 320 ml of xylene in a 500 ml round bottom flask under nitrogen atmosphere, sodium tert-butoxide (2.24 g, 23.29 mol) and then bis(tri-tert-butylphosphine) palladium(0) (0.09 g, 0.19 mmol) were added thereto, and the result was heated and stirred for 3 hours. After lowering the temperature to room temperature, the result was filtered to remove the base, the xylene was vacuum concentrated, and the result was columned using tetrahydrofuran:hexane=1:18 to prepare Compound 38 (8.65 g, yield: 69%). MS[M+H]+=696","2,3",38,"80,81,90,91,35,36",hexane xylene tetrahydrofuran nitrogen,"6,7,94,95",38 38,"45,47,37,39",bis(tri-tert-butylphosphine) palladium(0) sodium tert-butoxide,"26,27",xylene,"17,18,11,12",7H-benzo[c]carbazole A,"69,71",room temperature,"92,93,9,10,52,53,58,59,60,61,65,66,83,84,88,89",prepare dissolving added heated stirred lowering concentrated columned,"62,64",3 hours,"95,97",8.65 g,"98,99",69%
"Preparation of compound 39-e. Compound 39-f (2.0 g, 4.68 mmol) was dissolved in anhydrous tetrahydrofuran (50 mL) and the reaction solution was cooled to -78°C. Then n-butyllithium (2.8 mL, 7 mmol, 2.5 M solution in n-hexane), was added dropwise to the above solution, and the stirring was continued for 1 hour after the addition. A solution of formylpiperidine (795 mg, 7.03 mmol) in tetrahydrofuran (1 mL) was added dropwise to the above solution and stirring was continued for 1 hour. The reaction mixture was allowed to warm to room temperature and quenched with saturated aqueous ammonium chloride solution (50 mL), the mixed solution was extracted with ethyl acetate (50 mL × 3). The combined organic phases were washed successively with water (50 mL) and brine (50 mL), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 2: 1) to delivera pale yellow solid 39-e (680 mg, yield: 39%).",,,"130,132,146,148,106,108,95,97,150,152,94,95,152,154,120,121,124,125",sodium sulfate silica gel ethyl acetate ammonium chloride petroleum ether aqueous ethyl acetate water brine,"3,4,162,163",39-e 39-e,"26,27",n-butyllithium,"63,64,14,15,35,36",tetrahydrofuran tetrahydrofuran n-hexane,"5,6,57,58",39-f formylpiperidine,"24,25,88,90",-78°C room temperature,"11,12,74,75,37,38,67,68,45,46,158,159,22,23,144,145,104,105,91,92,117,118,127,128,86,87",dissolved stirring added added stirring deliver cooled purified extracted quenched washed dried warm,"78,80,49,51",1 hour 1 hour,"163,165",680 mg,"166,167",39%
"Step 2. Preparation of 4-Amino-5-cyano-6-(((8-fluoro-4-oxo-2-phenyl-1,4-dihydroquinolin-3-yl)methyl) amino)pyrimidine 3-Aminomethyl-8-fluoro-2-phenylquinolin-4(1H)-one (1.34g, 0.005mol) and 50ml of isopropanol were added to a 100ml three-necked flask and stirred to be dissolved. 4-Amino-5-cyano-6-chloropyrimidine (0.93g, 0.006mol) and potassium carbonate (2.1g, 0.015mol) were then added; the temperature was raised to 80°C and reaction was carried out under reflux for 5h with stirring. TLC tracking was performed until the completion of the reaction. The reaction was stopped and suction filtration was performed. The filter cake was washed with a large amount of ethyl acetate; solvent was removed under reduced pressure; and methanol and silica gel were added to the residue for preparing a mixture for chromatography. After column chromatography separation, 1.23g of a white solid was obtained with a yield of 63.8%.","1,2",2,"82,84,91,92,93,95",ethyl acetate methanol silica gel,"114,115,4,6","solid 4-Amino-5-cyano-6-(((8-fluoro-4-oxo-2-phenyl-1,4-dihydroquinolin-3-yl)methyl) amino)pyrimidine","29,31",potassium carbonate,"12,13",isopropanol,"25,26,6,7",4-Amino-5-cyano-6-chloropyrimidine 3-Aminomethyl-8-fluoro-2-phenylquinolin-4(1H)-one,"48,49,41,42",reflux 80°C,"14,15,116,117,39,40,52,53,35,36,76,77,96,97",added obtained raised stirring added washed added,"50,51",5h,"110,111",1.23g,"121,122",63.8%
"190.7: 5-(2,3-difluorophenyl)-3-methyl-2-oxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid 100 mg (0.3 mmol) of [5-(2,3-difluorophenyl)-3-methyl-2-oxo-3,4-dihydro-2H-pyrimidin-1-yl]-methyl acetate is dissolved in 5 mL of tetrahydrofuran and 0.5 mL of water and then 0.5 mL of a 1M aqueous solution of lithium hydroxide monohydrate is added. The reaction mixture is stirred at room temperature for 1.5 h, hydrolysed and then diluted with ethyl acetate. This first ethyl acetate phase is discarded. The aqueous phase is acidified to pH=5-6 with an aqueous solution of acetic acid of concentration C=1M. The product is extracted with ethyl acetate. The organic phases are combined, washed once with water and once with a saturated aqueous solution of sodium chloride, then dried over magnesium sulphate, filtered and concentrated under vacuum. 80 mg (84%) of [5-(2,3-difluorophenyl)-3-methyl-2-oxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid is obtained in the form of a white solid.","0,1",190.7,"108,110,94,95,103,105,57,59,53,55,74,76,100,101,71,72,84,86",magnesium sulphate water sodium chloride ethyl acetate ethyl acetate acetic acid aqueous aqueous ethyl acetate,"119,121,1,3","[5-(2,3-difluorophenyl)-3-methyl-2-oxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid 5-(2,3-difluorophenyl)-3-methyl-2-oxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid","32,35,21,22",lithium hydroxide monohydrate water,"16,17,29,30",tetrahydrofuran aqueous,"8,10","[5-(2,3-difluorophenyl)-3-methyl-2-oxo-3,4-dihydro-2H-pyrimidin-1-yl]-methyl acetate","43,45",room temperature,"36,37,41,42,11,12,122,123,82,83,51,52,91,92,66,67,61,62,106,107",added stirred dissolved obtained extracted diluted washed acidified discarded dried,"46,48",1.5 h,"115,117",80 mg,"117,118",84%
"Synthesis of Compound B-30 A solution of N-(4-(9H-carbazol-9-yl)phenyl)-[1,1'-biphenyl]-2-amine (2.97 g, 7.24 mmol) in 1,2-dichlorobenzene (18 mL) was bubbled with nitrogen gas for 30 mins, and then boron tribromide (1M in dichloromethane, 12.5 mL, 12.5 mmol) was added and the reaction mixture was heated to 180° C. for 2 hours. After cooling the reaction mixture to room temperature, diphenylzinc (3.74 g, 17.0 mmol) was added to the reaction mixture inside the glovebox. The reaction mixture was heated to 120° C. for 6 hours. The reaction mixture was then cooled to room temperature (22° C.), water was added, and the reaction mixture was extracted with diethyl ether (×3). The combined organic layer was washed with water and brine solution sequentially, dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column chromatography with 10-20% dichloromethane in hexane to give Compound B-30 (3.03 g, 84% yield) as a white solid.",,,"93,94,103,105,115,116,113,114,19,20,120,121,137,138,135,136",water diethyl ether brine water nitrogen MgSO4 hexane dichloromethane,"3,4,141,142",B-30 B-30,,,"13,14,30,31","1,2-dichlorobenzene dichloromethane","57,58,7,8,26,28","diphenylzinc N-(4-(9H-carbazol-9-yl)phenyl)-[1,1'-biphenyl]-2-amine boron tribromide","44,46,91,93,55,57,89,91,77,79",180° C 22° C room temperature room temperature 120° C,"17,18,63,64,139,140,75,76,36,37,42,43,50,51,95,96,87,88,118,119,111,112,128,129,101,102",bubbled added give heated added heated cooling added cooled dried washed purified extracted,"80,82,47,49,22,24",6 hours 2 hours 30 mins,"142,144",3.03 g,"144,145",84%
"Example 76 Preparation of 2-chloro-N,N'-dimethyl-5-nitro-N'-phenylbenzohydrazide (C218) To a solution of 2-chloro-N'-methyl-5-nitro-N'-phenylbenzohydrazide (C219) (0.273 g, 0.893 mmol) in N,N-dimethylformamide (8.5 mL) cooled to 0° C. was added sodium hydride (60% oil immersion, 0.045 g, 1.116 mmol). The reaction mixture was allowed to stir at 0° C. for 15 minutes and then methyl iodide (0.070 mL, 1.116 mmol) was added. The reaction mixture was allowed to warm to room temperature and was stirred for 3 hours. The reaction was quenched with water (10 mL) and extracted with ethyl acetate (25 mL). The organic layer was washed with water (3×15 mL) and brine (15 mL) and then concentrated under reduced pressure to afford the title compound as a yellow solid (0.283 g, 98%):","1,2",76,"95,96,79,80,85,87,99,100",water water ethyl acetate brine,"5,6,111,113,4,5","C218 title compound 2-chloro-N,N'-dimethyl-5-nitro-N'-phenylbenzohydrazide","26,28",sodium hydride,"17,18","N,N-dimethylformamide","11,12,10,11,50,52",C219 2-chloro-N'-methyl-5-nitro-N'-phenylbenzohydrazide methyl iodide,"43,45,66,68,22,24",0° C room temperature 0° C,"20,21,41,42,64,65,109,110,25,26,57,58,70,71,93,94,77,78,83,84",cooled stir warm afford added added stirred washed quenched extracted,"46,48,72,74",15 minutes 3 hours,"117,119",0.283 g,"119,120",98%
"Preparation of (6S,8R)-6-(5-bromopyridin-2-yl)-7-(2,2-difluoro-3-methoxypropyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline Sodium nitrite (133 mg, 1.93 mmol) was added in water (0.5 mL) to a cooled solution of (1S,3R)-1-(5-bromopyridin-2-yl)-2-(2,2-difluoro-3-methoxypropyl)-3, 5-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-amine (771 mg, 1.75 mmol) in propionic acid (5833 μL)/water (1167 μL) at −15° C. The reaction was stirred for 30 minutes, then EtOAc (50 mL), which had been cooled in dry-ice was added. The reaction was quenched by addition of 2N Na2CO3 until bubbling ceased, then the layers were separated. The aqueous was extracted with EtOAc, then the organic was dried and evaporated. The crude product was purified by flash silica chromatography, elution gradient 0 to 50% EtOAc in heptane. Pure fractions were evaporated to dryness to afford (6S,8R)-6-(5-bromopyridin-2-yl)-7-(2,2-difluoro-3-methoxypropyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline (460 mg, 58%) as a pale yellow solid.",,,"44,45,63,64,92,93,52,53,99,100,77,78,101,102",EtOAc Na2CO3 silica dry-ice EtOAc EtOAc heptane,"2,3,110,111","(6S,8R)-6-(5-bromopyridin-2-yl)-7-(2,2-difluoro-3-methoxypropyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline (6S,8R)-6-(5-bromopyridin-2-yl)-7-(2,2-difluoro-3-methoxypropyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline","27,29,3,5",propionic acid Sodium nitrite,"12,13",water water,"20,22","(1S,3R)-1-(5-bromopyridin-2-yl)-2-(2,2-difluoro-3-methoxypropyl)-3, 5-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-amine","34,36",−15° C,"10,11,109,110,39,40,89,90,54,55,60,61,58,59,75,76,50,51",added afford stirred purified added addition quenched extracted cooled,"41,43",30 minutes,"111,113",460 mg,"113,114",58%
"Reference Example 4 Synthesis of 1-isopropyl-1H-imidazole-2-carbaldehyde Potassium carbonate (0.863 g, 6.24 mmol) and 2-iodopropane (0.614 mL, 6.24 mmol) were added to a solution of 1H-imidazole-2-carbaldehyde (0.500 g, 5.20 mmol) in N,N-dimethyl formamide (5.2 mL) at room temperature. The reaction liquid was stirred at 60° C. for 4 hours. The reaction liquid was cooled to room temperature. Ethyl acetate and distilled water were added to the reaction liquid and the reaction liquid was extracted with ethyl acetate. The organic layer was washed with a 10% aqueous solution of sodium chloride, dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, n-hexane/ethyl acetate) to obtain 1-isopropyl-1H-imidazole-2-carbaldehyde (0.355 g, 2.57 mmol, 49%) as a colorless oil.","2,3",4,"87,89,84,85,112,113,56,58,74,76,92,94,110,112,60,61",sodium chloride aqueous ethyl acetate n-hexane Ethyl acetate ethyl acetate sodium sulfate silica gel water,"116,117,5,6",1-isopropyl-1H-imidazole-2-carbaldehyde 1-isopropyl-1H-imidazole-2-carbaldehyde,"6,8",Potassium carbonate,"30,32","N,N-dimethyl formamide","24,25,13,14",1H-imidazole-2-carbaldehyde 2-iodopropane,"35,37,54,56,43,45",room temperature room temperature 60° C,"41,42,19,20,115,116,106,107,52,53,80,81,72,73,89,90,62,63",stirred added obtain purified cooled washed extracted dried added,"46,48",4 hours,"117,119,119,121",0.355 g 2.57 mmol,"121,122",49%
"Step 2: preparation of intermediate tert-butyl 2-amino-7-oxo-6.7-dihydro-4H-thiazolo[4,5-c]pyridine-5-carboxylate (3b) To a solution of tert-butyl 4-bromo-3,5-dioxo-piperidine-1-carboxylate (3a) (0.500 g, 1.71 mmol) in anhydrous MeOH (8 mL) under inert atmosphere was added thiourea (0.226 g, 3.42 mmol). After stirring 30 min at rt, TEA (0.477 mL, 3.42 mmol) was added and the mixture was refluxed 5 h. MeOH was evaporated and the residue was solubilized with EtOAc. The solution was washed with water, 10% of Na2CO3 aqueous solution and brine solution. The organic layer was dried over Na2SO4, filtered and evaporated. The solid was triturated with cyclohexane and filtered to give tert-butyl 2-amino-7-oxo-6,7-dihydro-4H-thiazolo[4,5-c]pyridine-5-carboxylate (3b) (0.350 g, 1.30 mmol, 76%) as an off white solid. MS m/z ([M+H]+) 270.","1,2",2,"76,77,63,64,84,85,69,70,54,55,72,73,93,94,73,74",brine EtOAc Na2SO4 water MeOH Na2CO3 cyclohexane aqueous,"100,101,7,8,5,7,98,100","3b 3b tert-butyl 2-amino-7-oxo-6.7-dihydro-4H-thiazolo[4,5-c]pyridine-5-carboxylate tert-butyl 2-amino-7-oxo-6,7-dihydro-4H-thiazolo[4,5-c]pyridine-5-carboxylate","40,41",TEA,"21,22",MeOH,"14,15,12,14,29,30","3a tert-butyl 4-bromo-3,5-dioxo-piperidine-1-carboxylate thiourea","51,52,39,40",refluxed rt,"35,36,46,47,97,98,28,29,67,68,91,92,82,83,61,62,56,57",stirring added give added washed triturated dried solubilized evaporated,"52,54,36,38",5 h 30 min,"101,103,103,105",0.350 g 1.30 mmol,"105,106",76%
"Step 7: Preparation of 2-(3-(4-(2-aminobenzo[d]oxazole-7-yl)-1H-pyrazole-1-yl)-1-(methylsulfonyl)azetidin-3-yl)acetonitrile To 2-(3-(4-(3-amino-2-hydroxypheyl)-1H-pyrazole-1-yl)-1- (methylsulfonyl)azetidin-3-yl)acetonitrile (300 mg, 863.58 umol) in ethyl acetate (10 mL) solution was added cyanogen bromide(100 mg, 944.1 umol) under the protection of nitrogen. The mixture was stirred at 50°C for reacting for 12 hours. LC-MS and TLC(DCM:MeOH=10:1) detected and showed that the reaction was completed. After the reaction mixture was directly spun dry, dissolved in DCM:MeOH=10:1(3 mL), separated and purified through preparative TLC(DCM:MeOH=10:1) to give 2-(3-(4-(2-aminobenzo[d] oxazole-7-yl)-1H-pyrazole-1-yl)-1- (methylsulfonyl)azetidin-3-yl)acetonitrile (200 mg, 56.0% yield) as a yellow solid.","1,2",7,"29,30,62,63",DCM MeOH MeOH nitrogen MeOH DCM DCM,"72,75,4,5",2-(3-(4-(2-aminobenzo[d] oxazole-7-yl)-1H-pyrazole-1-yl)-1- (methylsulfonyl)azetidin-3-yl)acetonitrile 2-(3-(4-(2-aminobenzo[d]oxazole-7-yl)-1H-pyrazole-1-yl)-1-(methylsulfonyl)azetidin-3-yl)acetonitrile,,,"13,15",ethyl acetate,"20,22,6,8",cyanogen bromide 2-(3-(4-(3-amino-2-hydroxypheyl)-1H-pyrazole-1-yl)-1- (methylsulfonyl)azetidin-3-yl)acetonitrile,"35,36",50°C,"33,34,71,72,19,20,43,44,66,67,60,61",stirred give added TLC purified dissolved,"39,41",12 hours,"75,77",200 mg,"77,78",56.0%
"Step 3: Preparation of N-(7-(1-(3-(cyanomethyl)-1-(methylsulfonyl)azetidin-3-yl) -1H-pyrazole-4-yl)benzo[d]thiazole-2-yl)cyclopropanecarboxamide To a solution of N-(7-(1-(3-(cyanomethyl)azetidin-3-yl)-1H-pyrazole-4-yl) benzo[d] thiazole-2-yl) cyclopropanecarboxamide(60 mg, 158.54 umol) and triethylamine(50 mg, 494.6 umol) in dichloromethane(5 mL) was added dropwise methylsulfonyl chloride(50 mg, 436.5 umol). The mixture was stirred at 0°C for 0.5 hour and stirred continuously at 25°C for 1 hour. Both LC-MS and TLC detected and showed that the reaction was completed. The reaction mixture was quenched with water(50 mL) and extracted with ethyl acetate(15 mL×3). The organic phase was combined, washed with saturated salt water(5 mL), dried with anhydrous sodium sulfate, and filtered and spun dry. The residue was separated and purified through preparative TLC(PE:EA=1:1) to give N-(7-(1-(3-(cyanomethyl)-1-(methylsulfonyl)azetidin-3-yl) -1H-pyrazole-4-yl)benzo[d]thiazole-2-yl) cyclopropanecarboxamide(45 mg, 62% yield) as a white solid.","1,2",3,"90,92,84,86,68,69,73,75",sodium sulfate salt water water PE EA ethyl acetate,"108,111,4,6",N-(7-(1-(3-(cyanomethyl)-1-(methylsulfonyl)azetidin-3-yl) -1H-pyrazole-4-yl)benzo[d]thiazole-2-yl) cyclopropanecarboxamide N-(7-(1-(3-(cyanomethyl)-1-(methylsulfonyl)azetidin-3-yl) -1H-pyrazole-4-yl)benzo[d]thiazole-2-yl)cyclopropanecarboxamide,"18,19",triethylamine,"23,24",dichloromethane,"10,14,28,30",N-(7-(1-(3-(cyanomethyl)azetidin-3-yl)-1H-pyrazole-4-yl) benzo[d] thiazole-2-yl) cyclopropanecarboxamide methylsulfonyl chloride,"46,47,38,39",25°C 0°C,"26,27,43,44,36,37,107,108,66,67,71,72,102,103,87,88,81,82",added stirred stirred give quenched extracted purified dried washed,"48,50,40,42",1 hour 0.5 hour,,45 mg,"112,113",62%
"Step 1. 4-((3-Bromo-4-methylphenyl)sulfonyl)-2-methylbutan-2-ol Methylmagnesium bromide (40 μL, 0.1 mmol, 3 M in Et2O) was added dropwise to a solution of 4-((3-bromo-4-methylphenyl)sulfonyl)butan-2-one (12 mg, 0.039 mmol) in THF (1.0 mL) at −78° C. The reaction mixture was stirred overnight during which it came to rt. The reaction mixture was cooled to 0° C., and the reaction was quenched with NH4Cl and water. The mixture was extracted with EtOAc (3×). The organic layers were filtered through a plug of Na2SO4, combined, and concentrated to afford the title compound (8.2 mg, 65%).","1,2",1,"77,78,66,67,60,61,58,59",Na2SO4 EtOAc water NH4Cl,"2,3,84,86",4-((3-Bromo-4-methylphenyl)sulfonyl)-2-methylbutan-2-ol title compound,,,"12,13,26,27",Et2O THF,"20,21,3,5",4-((3-bromo-4-methylphenyl)sulfonyl)butan-2-one Methylmagnesium bromide,"50,52,30,32,43,44",0° C −78° C rt,"14,15,82,83,36,37,48,49,72,73,56,57,64,65",added afford stirred cooled filtered quenched extracted,,,"86,88",8.2 mg,"88,89",65%
"To a mixed solution of Compound 54 (103mg, 0.154mmol) in methanol (1mL) -THF (1mL) was added 2mol / L aqueous sodium hydroxide solution (0.500mL, 1.00mmol) under ice-cooling, and the mixture was stirred at room temperature for 1 hour. The reaction mixture was extracted with ethyl acetate after addition of an aqueous hydrochloric acid solution. The organic layer was washed with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (hexane-ethyl acetate) to yield Compound 55 (78.4mg, yield 90%).",,,"80,82,67,69,44,46,50,51,83,84,63,64,51,53,60,61",silica gel sodium sulfate ethyl acetate ethyl acetate aqueous hexane brine hydrochloric acid water,"88,89",55,"20,22",sodium hydroxide,"12,13,10,11,19,20",THF methanol aqueous,"6,7",54,"33,35",room temperature,"31,32,15,16,86,87,58,59,64,65,42,43,47,48,78,79",stirred added yield washed dried extracted addition purified,"36,38",1 hour,"89,90",78.4mg,"91,92",90%
"Core 41D (E)-1-(2-nitrovinyl)-1-(trifluoromethyl)cyclopropane To a solution of 2-nitro-1-(1-(trifluoromethyl)cyclopropyl)ethanol (21.0 g, 106.4 mmol)) in dichloromethane (200 mL) at −10° C. under an inert atmosphere was added trifluoroacetic anhydride (16.52 mL, 117.2 mmol). The mixture was stirred at −15° C. for 5 minutes and then triethylamine (32.61 mL, 234.08 mmol) was added while keeping the bath temperature at −15° C. during the addition. The stirring was continued at −10° C. for 45 minutes. The reaction was monitored by TLC (stained with iodine and UV) and quenched with saturated aqueous ammonium chloride solution (150 mL). The mixture was diluted with dichloromethane (150 mL) and stirred for 5 minutes. The aqueous layer was extracted with dichloromethane (100 mL×2). The combined organic layers were dried over magnesium sulfate, filtered and concentrated. The residue was purified by silica gel column chromatography (eluted with 1/300 ethyl acetate/petroleum ether) to give the title compound (E)-1-(2-nitrovinyl)-1-(trifluoromethyl)cyclopropane (11.2 g, 61.88 mmol, 58.1% yield).","1,2",41D,"97,98,138,140,111,112,121,123,79,80,86,87,21,22,131,133,87,89",dichloromethane ethyl acetate dichloromethane magnesium sulfate iodine aqueous inert silica gel petroleum ether ammonium chloride,"146,147,2,3,144,146",(E)-1-(2-nitrovinyl)-1-(trifluoromethyl)cyclopropane (E)-1-(2-nitrovinyl)-1-(trifluoromethyl)cyclopropane title compound,"43,44,25,27",triethylamine trifluoroacetic anhydride,"13,14",dichloromethane,"7,8",2-nitro-1-(1-(trifluoromethyl)cyclopropyl)ethanol,"66,68,36,38,56,58,17,19",−10° C −15° C −15° C −10° C,"142,143,49,50,24,25,62,63,34,35,119,120,83,84,109,110,129,130,101,102,95,96",give added added stirring stirred dried quenched extracted purified stirred diluted,"103,105,39,41,69,71",5 minutes 5 minutes 45 minutes,"149,151,147,149",61.88 mmol 11.2 g,"151,152",58.1%
"Step 3: Preparation of 5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole In a 250 mL round bottom flask, 4-(benzyloxy)aniline (8.8 g, 44.34 mmol, 3.00 equiv) was added to a solution of 1-[4-(benzyloxy)phenyl]propan-1-one (4.3 g, 17.89 mmol, 1.00 equiv) in DMF/TEA (40/4.3 mL). The resulting solution was stirred for 6 hours at 125° C. The reaction was then quenched by the addition of water. The resulting mixture was extracted with ethyl acetate (20 mL×3) and the organic layers were combined, washed with brine and dried over anhydrous sodium sulfate. The organic solvent was removed under reduced pressure and the residue was applied onto a silica gel column eluting with ethyl acetate/petroleum ether (1:5). This resulted in 1.7 g (23%) of 5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole as a light brown solid.","1,2",3,"80,82,102,104,75,76,63,65,97,99,56,57",sodium sulfate ethyl acetate brine petroleum ether ethyl acetate silica gel water,"4,5,113,114",5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole 5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole,,TEA,"33,34",DMF,"12,13,25,26",4-(benzyloxy)aniline 1-[4-(benzyloxy)phenyl]propan-1-one,"45,47",125° C,"40,41,20,21,107,108,61,62,94,95,73,74,77,78,51,52",stirred added resulted extracted applied washed dried quenched,"42,44",6 hours,"109,111",1.7 g,"111,112",23%
"Intermediate 47: 5,8-Dichloro-2-ethyl-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridine To a solution of 1,2-diamino-3,6-dichloro-5-(trifluoromethyl)pyridin-1-ium 2,4,6-trimethylbenzenesulfonate (Intermediate 13, 397 mg, 0.89 mmol) in AcOH (7 mL) and MeOH (3.5 mL) was added Cu(OAc)2 (80.8 mg, 0.45 mmol) and propionaldehyde (0.19 mL, 2.67 mmol). The mixture was heated to 70° C. for 6 h. Additional Cu(OAc)2 (162 mg, 0.89 mmol) was added, and the mixture heated to 80° C. for 6 h. After cooling to rt, the solvent was removed in vacuo, and the residue suspended in EtOAc. The suspension was washed with saturated aq. NH4Cl, and the aqueous layer extracted with EtOAc (×2). The combined organics were washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated in vacuo. Purification (FCC, SiO2; 0-50% EtOAc/hexanes) afforded the title compound as a white solid (90 mg, 36%).","1,2",47,"87,88,116,117,105,106,79,80,102,103,94,95,86,87,118,119",NH4Cl hexanes SiO2 Na2SO4 EtOAc brine EtOAc aq EtOAc,"121,123,2,3","title compound 5,8-Dichloro-2-ethyl-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridine","16,17,25,26,47,48",AcOH Cu(OAc)2 Cu(OAc)2,"20,21",MeOH,"9,11,31,32,7,9","Intermediate 13 propionaldehyde 1,2-diamino-3,6-dichloro-5-(trifluoromethyl)pyridin-1-ium 2,4,6-trimethylbenzenesulfonate","67,68,41,43,59,61",rt 70° C 80° C,"119,120,57,58,24,25,39,40,53,54,114,115,103,104,65,66,83,84,92,93,77,78,100,101",afforded heated added heated added Purification dried cooling washed extracted suspended washed,"44,46,62,64",6 h 6 h,"127,129",90 mg,"129,130",36%
"Preparation of compound 1-d. Compound 1-e (5.0 g, 20.08 mmol) was dissolved in acetone (100 mL), anhydrous potassium carbonate (4.2 g, 30.12 mmol) was added, methyl iodide (4.3 g, 30.12 mmol) was slowly added and the mixture was stirred at room temperature for 16 hours. The reaction mixture was filtered and the filter cake was washed with acetone (100 mL) and the combined filtrates were concentrated under reduced pressure. The residue was dissolved in ethyl acetate (150 mL) and diluted with water (100 mL). The separated organic phase was dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure to deliver a pale yellow solid 1-d (3.1 g, yield: 59%), this product was used without further purification.",,,"74,76,81,82,92,94,57,58",ethyl acetate water sodium sulfate acetone,"3,4,109,110",1-d 1-d,"17,19",potassium carbonate,"13,14",acetone,"25,27,5,6",methyl iodide 1-e,"40,42",room temperature,"104,105,11,12,38,39,33,34,24,25,55,56,79,80,72,73,89,90",deliver dissolved stirred added added washed diluted dissolved dried,"43,45",16 hours,"110,112",3.1 g,"113,114",59%
"Example 13 Synthesis of 3-((1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-hydroxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indole-3-carbonyl)pyridin-4(1H)-one In the same manner as that of Example 1, (1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indol-10-ol (32 mg, 90 µmol), 4-oxo-1,4-dihydropyridine-3-carboxylic acid (28 mg, 0.20 mmol), triethylamine (70 µL, 0.50 mmol), and HATU (114 mg, 0.30 mmol) were reacted. To the reaction solution, a 2 N solution of ammonia in methanol was added to terminate the reaction, then the reaction solution was suspended in saturated aqueous sodium hydrogen carbonate, and the suspension was extracted three times with ethyl acetate. The combined organic layer was dried over anhydrous sodium sulfate, the insoluble substance was separated by filtration, and then the filtrate was concentrated under reduced pressure. The obtained residue was subjected to preparative TLC using methanol containing 10% concentrated aqueous ammonia and chloroform (concentration, 15%) as the developing solvent to obtain the title compound (19 mg, 44%) as white solid.","1,2",13,"65,68,113,114,118,119,120,121,76,78,49,50,117,118,64,65,47,48,86,88",sodium hydrogen carbonate methanol ammonia chloroform ethyl acetate methanol aqueous aqueous ammonia sodium sulfate,"4,5,130,132","3-((1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-hydroxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indole-3-carbonyl)pyridin-4(1H)-one title compound","25,26,31,32",triethylamine HATU,,,"19,21,14,15","4-oxo-1,4-dihydropyridine-3-carboxylic acid (1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indol-10-ol",,,"37,38,128,129,108,109,72,73,83,84,61,62,51,52",reacted obtain subjected extracted dried suspended added,,,"132,134",19 mg,"134,135",44%
"Preparation of compound 39-d. Compound 39-e (350 mg, 0.93 mmol), dimethylsulfoxide (88 mg, 1.12 mmol) and concentrated sulfuric acid (51 mg, 0.51 mmol) were dissolved in acetonitrile (3 mL) and water (1 mL). The reaction mixture was cooled to 0°C and a solution of sodium chlorite (116 mg, 1.39 mmol) in water (2 mL) was added dropwise. The reaction mixture was stirred at this temperature for 30 minutes and then allowed to warm to room temperature. The reaction mixture was concentrated under reduced pressure and the residue was diluted with water (50 mL) and extracted with ethyl acetate (50 mL × 3). The combined organic phases were dried over anhydrous sodium sulfate, filtered and the filtrate was concentrated under reduced pressure to deliver a pale yellow solid 39-d (170 mg, yield: 47%). This product was used without further purification.",,,"110,112,96,98,90,91",sodium sulfate ethyl acetate water,"3,4,127,128",39-d 39-d,"44,46,10,11,17,19",sodium chlorite dimethylsulfoxide sulfuric acid,"30,31,26,27,51,52",water acetonitrile water,"5,6",39-e,"39,40,74,76",0°C room temperature,"24,25,61,62,37,38,122,123,55,56,107,108,72,73,88,89,94,95",dissolved stirred cooled deliver added dried warm diluted extracted,"66,68",30 minutes,"128,130",170 mg,"131,132",47%
"Example 73A Methyl 4-{[(3-chloro-6-iodo-2-phenylquinolin-4-yl)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylate At RT, 376 mg (0.99 mmol) of HATU and 256 mg (1.98 mmol) of DIPEA were added to a solution of 500 mg (0.66 mmol, purity 54%) of the compound from Example 39A in 4 ml of DMF, and the mixture was stirred at RT for 30 min. Subsequently, 145 mg (0.66 mmol) of methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride, dissolved in 1 ml of DMF, were added and the mixture was stirred at 60° C. overnight. After cooling to RT, the mixture was purified twice by preparative HPLC (Method 4). This gave 74 mg (19% of theory, purity 98%) of the title compound","1,2",73A,,,"103,105,2,4",title compound Methyl 4-{[(3-chloro-6-iodo-2-phenylquinolin-4-yl)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylate,"11,12,18,19",HATU DIPEA,"66,67,41,42",DMF DMF,"58,61,33,37",methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride compound from Example 39A,"75,77,5,6,48,49,81,82",60° C RT RT RT,"93,94,73,74,68,69,20,21,46,47,61,62,79,80",gave stirred added added stirred dissolved cooling,"50,52",30 min,"94,96",74 mg,"96,97",19%
"Example 24 4-({[6-Bromo-3-methyl-2-(2-methylphenyl)quinolin-4-yl]carbonyl}amino)bicyclo[2.2.2]octane-1-carboxylic acid 140 mg (0.268 mmol) of the compound from Example 65A were dissolved in 5 ml of a THF/methanol mixture (5:1), 1.34 ml (1.34 mmol) of a 1 M lithium hydroxide solution were added and the mixture was stirred at 50° C. for 2 h. After cooling to RT, the mixture was adjusted to pH 1-2 by addition of 4 M hydrochloric acid and purified by preparative HPLC (Method 2). This gave 118 mg (83% of theory, purity 95%) of the title compound","1,2",24,"64,66",hydrochloric acid,"2,4,84,86",4-({[6-Bromo-3-methyl-2-(2-methylphenyl)quinolin-4-yl]carbonyl}amino)bicyclo[2.2.2]octane-1-carboxylic acid title compound,"32,34",lithium hydroxide,"21,22",THF methanol,"10,14",compound from Example 65A,"43,45,51,52",50° C RT,"41,42,36,37,74,75,15,16,49,50,60,61",stirred added gave dissolved cooling addition,"46,48",2 h,"75,77",118 mg,"77,78",83%
"Synthesis of compound 9-c Compound 9-d (200mg, 0.89mmol) and N-iodosuccinimide (300mg, 1.33mmol) were dissolved in acetic acid (10mL) and trifluoroacetic acid (2mL), the mixture was reacted for 6hrs at 80 °C. The mixture was cooled to room temperature, concentrated under reduced pressure to remove the solvent. The residue was purified by silica column chromatography (PE:EA = 8:1) to give compound 9-c (200mg, yield 64%).",,,"51,52,54,55",silica PE EA,"3,4,60,61",9-c 9-c,"19,21,15,17,9,10",trifluoroacetic acid acetic acid N-iodosuccinimide,,,"5,6",9-d,"36,38,29,31",room temperature 80 °C,"25,26,13,14,58,59,34,35,49,50",reacted dissolved give cooled purified,"27,28",6hrs,"61,62",200mg,"63,64",64%
"Intermediate 24 2-methoxy-3,3-dimethyl-butyric acid Intermediate 24A 2-hydroxy-3,3-dimethyl-butyric acid benzyl ester Benzyl bromide (CAS#100-39-0, 0.65 mL, 5.5 mmol, 1.5 eq) was added to a solution of 2-hydroxy-3,3-dimethylbutyric acid (472 mg, 3.6 mmol, 1.0 eq) and triethylamine (0.76 mL, 5.5 mmol, 1.5 eq) in N,N-dimethylformamide (5 mL). The reaction mixture was stirred at room temperature overnight then partitioned between water and ethyl acetate. The organic layer was washed with brine, dried on Na2SO4, filtered and concentrated in vacuo. The residue was purified by flash chromatography on silica gel (heptane/dichloromethane 100/0 to 0/100) to provide the title compound (595 mg, 75%).","5,6,1,2",24A 24,"86,87,70,71,84,86,67,68,2,4,57,58,59,61","heptane Na2SO4 silica gel brine 2-methoxy-3,3-dimethyl-butyric acid water ethyl acetate dichloromethane","93,95,6,10","title compound 2-hydroxy-3,3-dimethyl-butyric acid benzyl ester","34,35",triethylamine,"42,43","N,N-dimethylformamide","10,12,25,27,12,13","Benzyl bromide 2-hydroxy-3,3-dimethylbutyric acid CAS#100-39-0","51,53",room temperature,"91,92,20,21,49,50,55,56,68,69,79,80,65,66",provide added stirred partitioned dried purified washed,,,"95,97",595 mg,"97,98",75%
"Manganese dioxide (33.4 g, 384 mmol) was added to a suspension of (±)-(1R*,2R*)-2-{[5-(hydroxymethyl)-2-(methylsulfanyl)pyrimidin-4-yl]amino}-1-methylcyclo-pentanol (1c, 6.9 g, 25.6 mmol) in EtOAc (384 mL), and the mixture stirred in a 50° C. oil bath for 7 h, and then at room temperature overnight. Solids were removed by filtration. The flask and filter cake were washed with EtOAc (˜300 mL). The combined filtrates were filtered again to remove a small amount of residual black solid, then concentrated to give (±)-4-{[(1R*,2R*)-2-hydroxy-2-methylcyclopentyl]amino}-2-(methylsulfanyl)-pyrimidine-5-carbaldehyde (Intermediate 1, 5.84 g, 85%) as an off-white solid.",,,"54,55",EtOAc,"78,79,76,77","1 (±)-4-{[(1R*,2R*)-2-hydroxy-2-methylcyclopentyl]amino}-2-(methylsulfanyl)-pyrimidine-5-carbaldehyde","0,2",Manganese dioxide,"19,20",EtOAc,"13,14,12,13","1c (±)-(1R*,2R*)-2-{[5-(hydroxymethyl)-2-(methylsulfanyl)pyrimidin-4-yl]amino}-1-methylcyclo-pentanol","28,30,38,40",50° C room temperature,"75,76,7,8,25,26,52,53",give added stirred washed,"33,35",7 h,"79,81",5.84 g,"81,82",85%
"Synthesis Example 16 [3-(2-Fluoroethoxy)phenyl]-(4-methoxycarbonylphenyl)methyl-diphenylphosphonium bromide (TAP-020) A reaction vessel was charged with [3-(2-fluoroethoxy)phenyl]-diphenylphosphine (63.8 mg, 0.197 mmol), 4-(bromomethyl)benzoic acid methyl ester (54.8 mg, 0.239 mmol), and acetonitrile (2 mL). The reaction vessel was heated to 90° C., and the contents were refluxed under heating for 4 hours. After the reaction, the reaction solution was introduced into an open silica gel column chromatography system to elute an unreacted compound with ethyl acetate. Then, with the developing solvent being replaced by methanol:CH2Cl2=20:80, separation was done to yield a product (102 mg (0.184 mmol), 93% yield, white solid). LRMS (FAB) calculated for C29H27FO3P+ ([M-Br]): 473.2, found: 473.2 ([M-Br]).","2,3",16,"69,71,58,60,79,80",ethyl acetate silica gel methanol CH2Cl2,"3,5,86,87,5,6",[3-(2-Fluoroethoxy)phenyl]-(4-methoxycarbonylphenyl)methyl-diphenylphosphonium bromide product TAP-020,,,"26,27",acetonitrile,"17,21,12,13",4-(bromomethyl)benzoic acid methyl ester [3-(2-fluoroethoxy)phenyl]-diphenylphosphine,"35,37,41,42",90° C refluxed,"43,44,33,34,10,11,84,85,64,65,54,55,77,78",heating heated charged yield elute introduced replaced,"45,47",4 hours,"89,91,87,89",0.184 mmol 102 mg,"91,92",93%
"A mixture of Intermediate 4-hydroxy-3-(4-phenylnaphthalen-1-yl)pent-3-en-2-one, 0.65 g (3.54 mmol) of zinc(II) acetate, and 1.02 g (10.62 mmol) of sodium tert-butoxide was dissolved in 20 mL of tetrahydrofuran, and then, the reaction mixture was refluxed and stirred for 8 hours. The reaction mixture was then cooled to room temperature. Then, an extraction process was performed thereon three times by using dichloromethane and water. An organic layer obtained therefrom was dried by using magnesium sulfate and filtered by using celite. Then, column chromatography was performed thereon to obtain 1.77 g (2.66 mmol, yield=75%) of Compound 19.",,,"59,60,71,73,61,62,77,78",dichloromethane magnesium sulfate water celite,"93,94",19,"18,20",sodium tert-butoxide,"26,27",tetrahydrofuran,"10,12,4,5",zinc(II) acetate 4-hydroxy-3-(4-phenylnaphthalen-1-yl)pent-3-en-2-one,"46,48,33,34",room temperature refluxed,"21,22,85,86,35,36,68,69,74,75,44,45,50,51",dissolved obtain stirred dried filtered cooled extraction,"37,39",8 hours,"86,88,88,90",1.77 g 2.66 mmol,,75%
"(Reference Example 15) Synthesis of (R)-1-(3-(dimethylamino)pyrrolidin-1-yl)-3-(1-methyl-1H-imidazol-2-yl)propan-1,3-dione: (R)-3-dimethylaminopyrrolidine (0.106 g, 0.927 mmol) was added to ethyl 3-(1-methyl-1H-imidazol-2-yl)-3-oxopropanoate (0.200 g, 1.02 mmol) at room temperature. The reaction liquid was stirred at 110°C for 6 hours and concentrated under reduced pressure. The residue was purified by flash column chromatography (NH silica gel, chloroform/methanol) to obtain (R)-1-(3-(dimethylamino)pyrrolidin-1-yl)-3-(1-methyl-1H-imidazol-2-yl)propan-1,3-dione (0.220 g, 0.832 mmol, 90%) as a colorless oil.","2,3",15,"49,50,47,49",chloroform methanol silica gel,"5,6,52,53","(R)-1-(3-(dimethylamino)pyrrolidin-1-yl)-3-(1-methyl-1H-imidazol-2-yl)propan-1,3-dione (R)-1-(3-(dimethylamino)pyrrolidin-1-yl)-3-(1-methyl-1H-imidazol-2-yl)propan-1,3-dione",,,,,"6,7,14,16",(R)-3-dimethylaminopyrrolidine ethyl 3-(1-methyl-1H-imidazol-2-yl)-3-oxopropanoate,"21,23,29,30",room temperature 110°C,"12,13,51,52,27,28,41,42",added obtain stirred purified,"31,33",6 hours,"53,55,55,57",0.220 g 0.832 mmol,"57,58",90%
"Example 60 6-[6-(3,5-Dimethyl-isoxazol-4-yl)-pyridin-2-ylmethyl]-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-7-ylamine Obtained by starting from 6-(6-Chloro-pyridin-2-ylmethyl)-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-7-ylamine (example 3) and 3,5-Dimethyl-4-isoxazolboronic acid. The mixture filtered over silica gel and purified by RP-HPLC (modifier: trifluoroacetic acid). Yield: 28 mg (47% of theory)","1,2",60,"24,26,17,19",trifluoroacetic acid silica gel,"2,3","6-[6-(3,5-Dimethyl-isoxazol-4-yl)-pyridin-2-ylmethyl]-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-7-ylamine",,,,,"7,8,11,13","6-(6-Chloro-pyridin-2-ylmethyl)-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-7-ylamine 3,5-Dimethyl-4-isoxazolboronic acid",,,"3,4,20,21,15,16",Obtained purified filtered,,,"27,29",28 mg,"29,30",47%
"Step 2: Preparation of (4-(3-hydroxyprop-1-ynyl)phenyl)(piperidin-1-yl)methanone (4-(3-hydroxyprop-1-ynyl)phenyl)(piperidin-1-yl)methanone was obtained (374 mg, yield 90%) by the same method as described in Step 3 of Example 1 using the (4-bromophenyl)(piperidine-1-yl)methanone (458.2 mg, 1.71 mmol) obtained in Step 1 and propargyl alcohol (0.199 ml, 3.42 mmol).","1,2",2,,,"5,6,4,5",(4-(3-hydroxyprop-1-ynyl)phenyl)(piperidin-1-yl)methanone (4-(3-hydroxyprop-1-ynyl)phenyl)(piperidin-1-yl)methanone,,,,,"26,27,36,38",(4-bromophenyl)(piperidine-1-yl)methanone propargyl alcohol,,,"7,8",obtained,,,"8,10",374 mg,"11,12",90%
"Step 3: Preparation of (S)-7-amino-5-(2-(5-chloro-4-oxo-3-(m-tolyl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one 31 mg of (S)-7-amino-5-(2-(5-chloro-4-oxo-3-(m-tolyl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one was prepared as a white solid according to the same manner as described in step 8 of Example 1 except that (S)-7-amino-5-(2-(5-chloro-4-oxo-3-(m-tolyl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)-1-(4-methoxybenzyl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one was used (0.06 mmol, yield: 67%).","1,2",3,,,"8,9,4,5","(S)-7-amino-5-(2-(5-chloro-4-oxo-3-(m-tolyl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one (S)-7-amino-5-(2-(5-chloro-4-oxo-3-(m-tolyl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one",,,,,"30,31","(S)-7-amino-5-(2-(5-chloro-4-oxo-3-(m-tolyl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-yl)-1-(4-methoxybenzyl)-3-methyl-2,3-dihydropyrimido[4,5-d]pyrimidine-4(1H)-one",,,"10,11",prepared,,,"33,35,5,7",0.06 mmol 31 mg,"36,37",67%
"Example 76: Synthesis of compound 11356, N-(4-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-2-fluorobenzyl)-N-(3-fluorophenyl)propionamide [Sep 1] Synthesis of methyl 3-fluoro-4-((N-(3-fluorophenyl)propionamido)methyl)benzoate Methyl 3-fluoro-4-(((3-fluorophenyl)amino)methyl)benzoate (0.100 g, 0.361 mmol), synthesized in step 2 of Example 73, and N,N-diisopropylethylamine (0.126 mL, 0.721 mmol) were dissolved in dichloromethane (10 mL) at room temperature, and propionyl chloride (0.041 mL, 0.469 mmol) was added to the solution. The mixture was stirred at the same temperature for 18 hours. Water was added to the reaction mixture, followed by extraction with ethyl acetate. The organic layer was washed with saturated aqueous sodium chloride solution, dried with magnesium sulfate anhydrous, filtered, and then concentrated under reduced pressure. The concentrate was purified by column chromatography (SiO2, 4 g cartridge; ethyl acetate/hexane = from 0% to 50%) and concentrated to give the title compound (0.100 g, 83.2%) as colorless oil.","1,2,8,9",76 1,"84,85,85,87,6,7,64,65,107,108,5,6,75,77,111,113,90,92","aqueous sodium chloride N-(4-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-2-fluorobenzyl)-N-(3-fluorophenyl)propionamide hexane Water SiO2 11356 ethyl acetate ethyl acetate magnesium sulfate","11,13,123,125",methyl 3-fluoro-4-((N-(3-fluorophenyl)propionamido)methyl)benzoate title compound,"27,28","N,N-diisopropylethylamine","35,36",dichloromethane,"13,15,42,44",Methyl 3-fluoro-4-(((3-fluorophenyl)amino)methyl)benzoate propionyl chloride,"39,41",room temperature,"33,34,121,122,56,57,49,50,73,74,103,104,81,82,66,67,88,89",dissolved give stirred added extraction purified washed added dried,"62,64",18 hours,"125,127",0.100 g,"127,128",83.2%
"Step 5. tert-Butyl 5-(4-amino-2-(difluoromethoxy)-6-fluorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine-1-carboxylate tert-Butyl 5-chloro-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine-1-carboxylate (330 mg, 0.989 mmol, Intermediate 1), 3-(difluoromethoxy)-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (360 mg, 1.186 mmol), chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (Pd XPhos G2) (75 mg, 0.096 mmol) and potassium phosphate (406 mg, 1.91 mmol) were placed in a flask and the flask was evacuated and backfilled with nitrogen three times. Then dioxane (20 mL) and degassed water (2 mL) were added, and the reaction mixture was stirred at 90° C. for 2 h. After cooling to r.t., the reaction mixture was diluted with ethyl acetate, and the resulting mixture was washed with brine. The separated organic phase was dried over sodium sulfate. The solvents were evaporated in vacuo and the obtained crude product was purified by Biotage Isolera™ (291 mg, 62%).","1,2",5,"98,100,45,46,90,91,81,83",sodium sulfate nitrogen brine ethyl acetate,"2,4,110,111","tert-Butyl 5-(4-amino-2-(difluoromethoxy)-6-fluorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine-1-carboxylate product","17,18,26,28,18,21","chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) potassium phosphate Pd XPhos G2","54,55,49,50",water dioxane,"4,6,12,13,10,12","tert-Butyl 5-chloro-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine-1-carboxylate 3-(difluoromethoxy)-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline Intermediate 1","74,75,66,68",r.t. 90° C,"64,65,108,109,58,59,112,113,43,44,33,34,72,73,88,89,79,80,96,97",stirred obtained added purified backfilled placed cooling washed diluted dried,"69,71",2 h,"116,118",291 mg,"118,119",62%
"Preparation of (6S,8R)-6-(4-bromo-2,6-difluorophenyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline 3,4-Dihydro-2H-pyran (0.103 mL, 1.13 mmol) and p-toluenesulfonic acid monohydrate (2 mg, 0.01 mmol) were added to a stirred solution of (6S,8R)-6-(4-bromo-2,6-difluorophenyl)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline (104 mg, 0.23 mmol) in DCM (1.5 mL). The reaction was maintained under reflux conditions for 1 hour. After cooling, the reaction was diluted with DCM, washed with saturated aqueous NaHCO3, dried over MgSO4, filtered, and concentrated under reduced pressure. The resulting residue was purified by flash silica chromatography, elution gradient 0 to 30% EtOAc in hexanes. Product fractions were concentrated to dryness to afford (6S,8R)-6-(4-bromo-2,6-difluorophenyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline (117 mg, 95%) as pale yellow solid. m/z: ES+ [M+H]+ 544.",,,"80,81,49,50,78,79,53,54,57,58,54,55,71,72",hexanes DCM EtOAc aqueous MgSO4 NaHCO3 silica,"2,3,89,90","(6S,8R)-6-(4-bromo-2,6-difluorophenyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline (6S,8R)-6-(4-bromo-2,6-difluorophenyl)-8-methyl-3-(tetrahydro-2H-pyran-2-yl)-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline","9,12",p-toluenesulfonic acid monohydrate,"29,30",DCM,"3,4,23,24","3,4-Dihydro-2H-pyran (6S,8R)-6-(4-bromo-2,6-difluorophenyl)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline","37,38",reflux,"17,18,35,36,88,89,55,56,68,69,47,48,50,51",added maintained afford dried purified diluted washed,"40,42",1 hour,"90,92",117 mg,"92,93",95%
"Preparation of (R)-N-(1-(3-amino-2-methylphenyl)propan-2-yl)-1-fluorocyclopropane-1-carboxamide (R)-3-(2-aminopropyl)-2-methylaniline (1.70 g, 10.4 mmol) was dissolved in DMF (29.9 mL) and treated with 1-fluorocyclopropane-1-carboxylic acid (1.00 g, 9.61 mmol), HATU (4.02 g, 10.6 mmol), and TEA (2.68 mL, 19.22 mmol). The reaction was stirred at room temperature for 3 hours and then quenched with water and extracted with EtOAc. The organic layer was washed with saturated aqueous sodium chloride, dried over sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was dried under vacuum overnight to remove residual DMF. The residue was then adsorbed onto silica and purified by flash column silica chromatography, elution gradient 0 to 80% ethyl acetate in hexanes to afford (R)-N-(1-(3-amino-2-methylphenyl)propan-2-yl)-1-fluorocyclopropane-1-carboxamide (1.47 g, 61.1%) as a light yellow solid.",,,"52,53,95,96,60,61,65,67,48,49,61,63,108,110,88,89,111,112,101,102",EtOAc silica aqueous sodium sulfate water sodium chloride ethyl acetate DMF hexanes silica,"114,115,2,3",(R)-N-(1-(3-amino-2-methylphenyl)propan-2-yl)-1-fluorocyclopropane-1-carboxamide (R)-N-(1-(3-amino-2-methylphenyl)propan-2-yl)-1-fluorocyclopropane-1-carboxamide,"23,24,29,30",HATU TEA,"11,12",DMF,"17,19,3,4",1-fluorocyclopropane-1-carboxylic acid (R)-3-(2-aminopropyl)-2-methylaniline,"39,41",room temperature,"15,16,37,38,113,114,9,10,86,87,50,51,93,94,46,47,63,64,97,98,57,58",treated stirred afford dissolved remove extracted adsorbed quenched dried purified washed,"42,44",3 hours,"115,117",1.47 g,"117,118",61.1%
"Example 86 (2S,3S,4S,5S)-3-tert-butyl-4-{[(5-tert-butyl-2-methoxyphenyl)methyl]amino}-5-(3-chlorophenyl)-1-{[(propan-2-yl)oxy]carbonyl}pyrrolidine-2-carboxylic acid Example 86A (2S,3R,4S,5S)-2-ethyl 1-isopropyl 3-(tert-butyl)-5-(3-chlorophenyl)-4-nitropyrrolidine-1,2-dicarboxylate (2S,3R,4S,5S)-Ethyl 3-(tert-butyl)-5-(3-chlorophenyl)-4-nitropyrrolidine-2-carboxylate (Core 29, 2.003 g, 5.64 mmol) was dissolved in toluene (6.64 mL) and triethylamine (1.967 mL, 14.11 mmol) was added, followed by slow addition of isopropyl carbonochloridate (3.39 mL, 6.77 mmol) solution after cooling in an ice-water bath to ˜10° C. The addition was at such a rate that the temperature was maintained at or below ambient temperature during the addition (2-3 minutes). After the addition was complete, the reaction was removed from the water bath and stirred at ambient temperature for 1 hour. Isopropyl chloroformate (0.4 mL) was added, and the reaction was stirred at ambient temperature for 30 more minutes. The mixture was diluted with diethyl ether and stirred with saturated aqueous sodium bicarbonate for 20 minutes before separating the layers, washing the organic layer twice with 1 M aqueous HCl and brine then drying over sodium sulfate, filtering, and concentrating to give a crude residue, which was loaded onto a 40 g silica gel cartridge eluting with a gradient of 5-100% ethyl acetate/heptanes over a period of 40 minutes to provide impure product. The product was precipitated from hexanes to give (2S,3R,4S,5S)-2-ethyl 1-isopropyl 3-(tert-butyl)-5-(3-chlorophenyl)-4-nitropyrrolidine-1,2-dicarboxylate (2.086 g, 4.73 mmol, 84% yield).","1,2,5,6",86 86A,"142,143,124,125,125,127,149,151,2,4,192,193,143,144,145,146,175,177,166,168,118,120","aqueous aqueous sodium bicarbonate sodium sulfate water (2S,3S,4S,5S)-3-tert-butyl-4-{[(5-tert-butyl-2-methoxyphenyl)methyl]amino}-5-(3-chlorophenyl)-1-{[(propan-2-yl)oxy]carbonyl}pyrrolidine-2-carboxylic acid hexanes HCl brine ethyl acetate silica gel heptanes diethyl ether","186,187,158,159,195,198,6,9","product residue (2S,3R,4S,5S)-2-ethyl 1-isopropyl 3-(tert-butyl)-5-(3-chlorophenyl)-4-nitropyrrolidine-1,2-dicarboxylate (2S,3R,4S,5S)-2-ethyl 1-isopropyl 3-(tert-butyl)-5-(3-chlorophenyl)-4-nitropyrrolidine-1,2-dicarboxylate","24,25",triethylamine,"20,21",toluene,"95,97,36,38,9,11,12,13","Isopropyl chloroformate isopropyl carbonochloridate (2S,3R,4S,5S)-Ethyl 3-(tert-butyl)-5-(3-chlorophenyl)-4-nitropyrrolidine-2-carboxylate 29","90,92,50,52,107,109",ambient temperature ˜10° C ambient temperature,"105,106,194,195,184,185,100,101,30,31,88,89,18,19,44,45,34,35,116,117,155,156,121,122,134,135,147,148,169,170,161,162,190,191",stirred give provide added added stirred dissolved cooling addition diluted give stirred washing drying eluting loaded precipitated,"181,183,93,95,128,130,110,113",40 minutes 1 hour 20 minutes 30 more minutes,"198,200,200,202",2.086 g 4.73 mmol,"202,203",84%
"(10) Preparation of (2R,5R)-2-((2-azaspiro[3.3]heptan-6-yl)carbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate At 0°C, tetra(n-butyl)ammonium (2R,5R)-2-((2-(tert-butoxylcarbonyl)-2-azaspiro[3.3]heptan-6-yl)carbamoyl)-7-oxo-1,6-diazabicycl o[3.2.1]octan-6-yl sulfate (0.17 g, 0.24 mmol) was dissolved in DCM (2 mL), then trifluoroacetic acid (1 mL) was added.. After reaction for 0.5 h, the reaction solution was poured into acetonitrile (10 mL), solid was precipitated, then isopropanol (5 mL) was added, filtrated, the filter cake was washed with acetonitrile (10 mL), and dried to obtain the product (50 mg, yield was 57.8 %),","0,1",10,"40,41,59,60,47,48",acetonitrile acetonitrile isopropanol,"67,68,3,6","product (2R,5R)-2-((2-azaspiro[3.3]heptan-6-yl)carbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate","23,25",trifluoroacetic acid,"19,20",DCM,"8,12","tetra(n-butyl)ammonium (2R,5R)-2-((2-(tert-butoxylcarbonyl)-2-azaspiro[3.3]heptan-6-yl)carbamoyl)-7-oxo-1,6-diazabicycl o[3.2.1]octan-6-yl sulfate","7,8",0°C,"65,66,28,29,30,31,17,18,57,58,51,52,38,39",obtain added reaction dissolved washed added poured,"32,34",0.5 h,"68,70",50 mg,"72,74",57.8 %
"Example Synthesis and Spectral Data. Step 1 A solution of 1,2,4,5-benzenetetraamine tetrahydrobromide (2.3 g, 5 mmol) in 50 mL of 48% HBr was placed in a 500 mL round bottomed flask, and it was stirred and cooled in an ice-water bath (approx. 0-5° C.). A solution of NaNO2 (5.25 g in 100 mL of water) was added dropwise over a period of 2 h. After the addition, the reaction mixture was kept at 0° C. for an additional 1 h and then removed from the cooling bath and heated at 90-100° C. for 3 h. The mixture was set aside overnight for slow crystallization. The grayish-brown solid was separated, washed with water and dried to give Compound a, 4,8-dibromo-1,6-dihydrobenzo[1,2-d:4,5-d']bis([1,2,3]triazole), (139 g, 86% yield).","6,7",1,"111,112",water water,"118,119,117,118","4,8-dibromo-1,6-dihydrobenzo[1,2-d:4,5-d']bis([1,2,3]triazole) a","21,22,47,48",HBr NaNO2,"54,55",water,"10,12","1,2,4,5-benzenetetraamine tetrahydrobromide","42,44,73,75,90,92",0-5° C 0° C 90-100° C,"56,57,71,72,115,116,88,89,23,24,36,37,109,110",added kept give heated placed cooled washed,"62,64,78,80,93,95",2 h 1 h 3 h,"119,121",139 g,"121,122",86%
"Example 14 4-(6-fluoro-1H-indol-3-yl)-N-[(1R)-2-hydroxy-1-methyl-ethyl]benzamide This compound was prepared from Intermediate 3-a and (2R)-2-aminopropan-1-ol according to the procedure described in Example 3. Purification was performed using preparative HPLC to afford the title compound (7 mg, 25%). Data: LCMS (B) Rt : 9.262 min; m/z 313.1 (M+H)+.","1,2",14,,,"4,5,2,3,29,31",compound 4-(6-fluoro-1H-indol-3-yl)-N-[(1R)-2-hydroxy-1-methyl-ethyl]benzamide title compound,,,,,"11,12,9,10",(2R)-2-aminopropan-1-ol 3-a,,,"6,7,27,28",prepared afford,,,"31,33",7 mg,"33,34",25%
"Synthesis of compound 29-b Ethyl mercaptoacetate (2.4g, 20mmol) and potassium carbonate (3.0g, 24mmol) were added to a solution of compound 29-c (4.4g, 20mmol) in DMF (40mL). The mixture was heated to 45°C and stirred for 12hrs, cooled to room temperature, followed by adding ice water (200mL), solid was precipitated and filtered out. The solid was washed with water (100mL×3) and dried under vacuum to give white solid 29-b (5.1g, yield 89.5%). The product was used directly for the next step without further purification.",,,"44,45,57,58",water water,"3,4,67,68",29-b 29-b,"9,11",potassium carbonate,"24,25",DMF,"4,6,20,21",Ethyl mercaptoacetate 29-c,"31,32,38,40",45°C room temperature,"64,65,33,34,14,15,29,30,36,37,55,56,42,43",give stirred added heated cooled washed adding,"35,36",12hrs,"68,69",5.1g,"70,71",89.5%
"Intermediate 17B 1-(3-formyl-4-methoxy-phenyl)-cyclobutanecarbonitrile 1-(3-[1,3]Dioxolan-2-yl-4-methoxy-phenyl)-cyclobutanecarbonitrile (134 mg, 0.52 mmol, 1.0 eq) was dissolved in acetone (15 mL). A spatula of p-toluenesulfonic acid (PTSA) (CAS#104-15-4) was added and the reaction mixture was stirred at room temperature for 72 hours. The mixture was concentrated in vacuo and the residue was purified by flash chromatography on silica gel (heptane/dichloromethane 50/50 to 0/100) to give the title compound (51 mg, 46%). LC/MS (ESI+) m/z 216.2 (M+H)+.","1,2",17B,"54,55,52,54",heptane dichloromethane silica gel,"61,63,2,3",title compound 1-(3-formyl-4-methoxy-phenyl)-cyclobutanecarbonitrile,"22,23,21,22,19,21",CAS#104-15-4 PTSA p-toluenesulfonic acid,"13,14",acetone,"3,4","1-(3-[1,3]Dioxolan-2-yl-4-methoxy-phenyl)-cyclobutanecarbonitrile","32,34",room temperature,"59,60,11,12,30,31,24,25,47,48",give dissolved stirred added purified,"35,37",72 hours,"63,65",51 mg,"65,66",46%
"Step 1. 6-Chloroimidazo[1,2-a]pyridin-8-amine To a solution of 5-chloro-2,3-diaminopyridine (1 g, 7 mmol) in ethanol (50 mL) was slowly added chloroacetaldehyde (3.5 mL, 27 mmol, 50% in H2O). The reaction mixture was refluxed for 6 h. Heating was discontinued, and the reaction mixture was stirred overnight. The reaction mixture was concentrated. Et2O was added to the resulting residue, and the solvent was removed in vacuo. The resulting oil was dissolved in water, and the aqueous layer was basified by addition of 1 M NaOH (aq). The aqueous layer was then extracted with DCM (3×). The combined organic layers were dried over MgSO4, filtered, and concentrated. Purification via silica gel chromatography (1-10% MeOH in DCM) afforded the title compound as a light brown solid (0.9 g, 80%).","1,2",1,"110,111,100,101,70,71,82,83,112,113,50,51,91,92,83,84,106,108",MeOH MgSO4 water NaOH DCM Et2O DCM aq silica gel,"115,117,2,3","title compound 6-Chloroimidazo[1,2-a]pyridin-8-amine",,,"26,27,13,14",H2O ethanol,"7,8,19,20","5-chloro-2,3-diaminopyridine chloroacetaldehyde","31,32",refluxed,"113,114,18,19,89,90,52,53,104,105,98,99,68,69,78,79",afforded added extracted added Purification dried dissolved addition,"33,35",6 h,"122,124",0.9 g,"124,125",80%
"Example 11 Synthesis of 4-((1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-hydroxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indole-3-carbonyl)pyridin-2(1H)-one In the same manner as that of Example 1, (1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indol-10-ol (54 mg, 0.15 mmol), 2-methoxyisonicotinic acid (54 mg, 0.35 mmol), triethylamine (140 µL, 1.00 mmol), and HATU (195 mg, 0.51 mmol) were reacted. To the reaction solution, a 2 N solution of ammonia in methanol was added to terminate the reaction, and then the reaction solution was concentrated under reduced pressure. The residue was suspended in chloroform, and then the suspension was washed with 6% aqueous ammonia. The aqueous layer was extracted with chloroform, the combined organic layers were dried over anhydrous magnesium sulfate, then the insoluble substance was separated by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was subjected to column chromatography (aminosilica gel, 16 g) using methanol containing 10% concentrated aqueous ammonia and chloroform as the elution solvent to obtain ((1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-hydroxy-1,2,3a,4,5,6,7,11c-octahydro-3H-6, 11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indol-3-yl)(2-methoxypyridin-4-yl)methanone (61 mg, 82%) as white solid.","1,2",11,"132,133,123,125,49,50,81,82,97,99,71,72,47,48,133,134,4,5,88,89,80,81,128,129,135,136","aqueous aminosilica gel methanol ammonia magnesium sulfate chloroform ammonia ammonia 4-((1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-hydroxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indole-3-carbonyl)pyridin-2(1H)-one chloroform aqueous methanol chloroform","142,144","((1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-hydroxy-1,2,3a,4,5,6,7,11c-octahydro-3H-6, 11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indol-3-yl)(2-methoxypyridin-4-yl)methanone","31,32,25,26",HATU triethylamine,,,"14,15,19,21","(1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(epiminoethano)-1,5a-methanonaphth[1,2-e]indol-10-ol 2-methoxyisonicotinic acid",,,"141,142,37,38,86,87,77,78,94,95,119,120,69,70,51,52",obtain reacted extracted washed dried subjected suspended added,,,"144,146",61 mg,"146,147",82%
"Example 13 1,1-Dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)-α-[N-(2-sulphoethyl)carbamoyl] benzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine ammonium salt 1,1-Dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-[N-((R)-α-carboxybenzyl) carbamoylmethoxy]-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine (Example 25; 50mg, 0.078mmol) was dissolved in 3ml DCM. Tetrabutylammonium taurine (88mg, 0.236mmol) was added and the mixture was stirred for 30 min. TBTU (30mg, 0.093mmol) was added and the mixture was stirred overnight. The solution was concentrated and purified by preparative HPLC using a C8 column (50x250mm). A gradient (20/80 to 60/40) of MeCN/0.1M ammonium acetate buffer was used as eluent. Lyophilization yielded 43mg of a product mixture, which was further purified by flash chromatography (5g) using a gradient of 3-20% MeOH in DCM as eluent. The fractions containing the title compound were collected and concentrated. MeOH and water were added and lyophilization yielded 17mg (29% yield). NMR (400MHz) 0.8 (t, 6H), 1.0-1.2 (m, 6H), 1.25-1.4 (m, 2H), 1.4-1.5 (m, 2H), 1.55-1.7 (m, 2H), 2.1 (s, 3H), 2.85-3.0 (m, 2H), 3.5-3.7 (m, 2H), 3:95 (brs, 2H), 4.6 (ABq, 2H), 5.45 (s, 1H), 6.6 (s, 1H), 7.05 (t, 1H) 7.15-7.45 (m, 10H); m/z: 747.","1,2",13,"75,77,105,106,92,93,107,108,90,91",product mixture MeOH DCM water MeOH,"99,101,2,6","title compound 1,1-Dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)-α-[N-(2-sulphoethyl)carbamoyl] benzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine ammonium salt","63,65,31,32",ammonium acetate TBTU,"16,17,62,63",DCM MeCN,"17,19,6,8","Tetrabutylammonium taurine 1,1-Dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-[N-((R)-α-carboxybenzyl) carbamoylmethoxy]-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine",,,"27,28,13,14,35,36,112,113,22,23,71,72,67,68,109,110,102,103,80,81",stirred dissolved added yielded added yielded used added collected purified,"29,31",30 min,"113,114",17mg,"114,115",29%
"46.3: (5-benzyl-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-acetic acid 75.6 mg (0.6 mmol) of potassium carbonate and 27 μl (0.4 mmol) of iodomethane are added to a solution of (5-benzyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-methyl acetate in 5 ml of dimethylformamide. The reaction mixture is heated at 50° C. for 1.5 h. 0.6 ml (0.6 mmol) of a 1M aqueous solution of lithium hydroxide is added with 1 ml of water and 2.5 ml of tetrahydrofuran. After stirring for 20 hours at room temperature, the mixture is hydrolysed with 1N aqueous solution of hydrochloric acid and then diluted with ethyl acetate. The product is extracted with ethyl acetate. The organic phases are combined, washed twice with water and once with a saturated aqueous solution of sodium chloride, then dried over magnesium sulphate, filtered and concentrated under vacuum. 100 mg (100%) of (5-benzyl-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-acetic acid is obtained in the form of a colourless oil.","0,1",46.3,"95,97,82,84,79,80,119,121,111,112,105,106,114,116,88,90",ethyl acetate hydrochloric acid aqueous magnesium sulphate aqueous water sodium chloride ethyl acetate,"130,132,1,3","(5-benzyl-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-acetic acid (5-benzyl-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-acetic acid","51,53,48,49,59,60,8,10",lithium hydroxide aqueous water potassium carbonate,"29,30,64,65",dimethylformamide tetrahydrofuran,"16,17,23,25","iodomethane (5-benzyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-methyl acetate","36,38,71,73",50° C room temperature,"54,55,66,67,18,19,34,35,133,134,76,77,86,87,117,118,93,94,102,103",added stirring added heated obtained hydrolysed diluted dried extracted washed,"68,70,39,41",20 hours 1.5 h,"126,128",100 mg,"128,129",100%
"Example 2. Preparation of SM-2: 1,1-Difluoro-2-oxo-2-(1-adamntylamino) ethanesulfonyl fluoride A 100 mL flask was charged with CH2Cl2 (20 mL) under nitrogen stream at 0° C. and then 2-(fluorosulfonyl)difluoroacetyl fluoride (8.49 g, 47.1 mmol, 1.2 eq.) was added and the mixture was stirred for 10 minutes at 0° C. A CH2Cl2 (20 mL) solution of 1-adamantylamine (5.94 g, 39.3 mmol, 1.0 eq.) and Pyridine (3.10 g, 39.3 mmol, 1.0 eq.) was added drop wise to the mixture over 15 minutes and subsequently the mixture was stirred for 4 hours at 0° C. to room temperature. CH2Cl2 (40 mL) and 1N HCl (40 mL) were added to the final reaction mixture and then the lower layer was separated and washed with 1N HCl (40 mL) and brine (40 mL). The solution was dried over anhydrous MgSO4 and filtrated and then CH2Cl2 was removed in an evaporator. The target compound as yellow solid (11.77 g) in 96.2% yield was obtained.","1,2",2,"119,120,93,94,123,124,19,20,98,99,132,133,137,138",HCl CH2Cl2 brine nitrogen HCl MgSO4 CH2Cl2,"5,8,4,5,144,146","1,1-Difluoro-2-oxo-2-(1-adamntylamino) ethanesulfonyl fluoride SM-2 target compound","61,62",Pyridine,"48,49,15,16",CH2Cl2 CH2Cl2,"53,54,26,28",1-adamantylamine 2-(fluorosulfonyl)difluoroacetyl fluoride,"22,24,88,90,91,93,45,47",0° C 0° C room temperature 0° C,"35,36,69,70,155,156,13,14,40,41,83,84,129,130,116,117,139,140,102,103",added added obtained charged stirred stirred dried washed removed added,"85,87,76,78,42,44",4 hours 15 minutes 10 minutes,"149,151",11.77 g,"152,153",96.2%
"Step 2: Preparation of (S)-5-chloro-3-(pyridine-3-yl)-2-(pyrrolidine-2-yl)quinazoline-4(3H)-one 2.6 g of (S)-5-chloro-3-(pyridine-3-yl)-2-(pyrrolidine-2-yl)quinazoline-4(3H)-one was prepared as a white solid by using 3.83 g (8.97 mmol) of tert-butyl (S)-2-(5-chloro-4-oxo-3-(pyridine-3-yl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-carboxylate prepared in step 1 according to the same manner as described in step 3 of Preparative Example 1 (7.80 mmol, yield: 87%).","1,2",2,,,"8,9,4,5",(S)-5-chloro-3-(pyridine-3-yl)-2-(pyrrolidine-2-yl)quinazoline-4(3H)-one (S)-5-chloro-3-(pyridine-3-yl)-2-(pyrrolidine-2-yl)quinazoline-4(3H)-one,,,,,"22,24","tert-butyl (S)-2-(5-chloro-4-oxo-3-(pyridine-3-yl)-3,4-dihydroquinazoline-2-yl)pyrrolidine-1-carboxylate",,,"10,11",prepared,,,"5,7,42,44",2.6 g 7.80 mmol,"45,46",87%
"Step 4: N-(5-(1,4-homopiperazin-1-yl)pyridin-2-yl)-5-fluoro-4-(6,7-dihydro-3-isopropyl-2-methyl-2H-pyrazolo[4,3-c]pyridin-5(4H)-yl)pyrimidine-2-amine In a nitrogen atmosphere, to a solution of tert-butyl 4-(6-(5-fluoro-4-(6,7-dihydro-3-isopropyl-2-methyl-2H-pyrazolo[4,3-c]pyridin-5(4H)-yl)pyrimidin-2-yl-amino)pyridin-3-yl)-1, 4-homopiperazine-1-carboxylate (250.00 mg, 441.95 µmol, 1.00 equivalent) in dichloromethane (5.00 mL) was added trifluoroacetic acid (3 mL) at 25°C. The reaction mixture was stirred at 25°C for half an hour. LC/MS showed completion of the reaction and detected the desired product. The reaction solution was concentrated to give a crude product. The crude product was purified by preparative HPLC (hydrochloric acid) to give the title compound (127.94 mg, 274.80 µmol, 62.18% yield).","1,2",4,"5,6,72,74",nitrogen hydrochloric acid,"2,3,77,79,63,64","N-(5-(1,4-homopiperazin-1-yl)pyridin-2-yl)-5-fluoro-4-(6,7-dihydro-3-isopropyl-2-methyl-2H-pyrazolo[4,3-c]pyridin-5(4H)-yl)pyrimidine-2-amine title compound product","26,28",trifluoroacetic acid,"21,22",dichloromethane,"11,14","tert-butyl 4-(6-(5-fluoro-4-(6,7-dihydro-3-isopropyl-2-methyl-2H-pyrazolo[4,3-c]pyridin-5(4H)-yl)pyrimidin-2-yl-amino)pyridin-3-yl)-1, 4-homopiperazine-1-carboxylate","31,32,38,39",25°C 25°C,"25,26,75,76,36,37,58,59,68,69",added give stirred concentrated purified,"40,43",half an hour,"81,83,79,81",274.80 µmol 127.94 mg,"83,84",62.18%
"Synthesis Example 12: Synthesis of Compound 43 Compound 43 (5.62 g, a yield of 79%) was obtained according to the same method as Synthesis Example 1 except for using 4-(biphenyl-3-yl)-2-bromoquinazoline instead of the bromometabiphenyl in Step 2 of Synthesis Example 1. calcd. C56H34N4: C, 88.16; H, 4.49; N, 7.34; found: C, 88.16; H, 4.49; N, 7.34.","2,3",12,"33,34",bromometabiphenyl,"8,9,6,7",43 43,,,,,"29,30",4-(biphenyl-3-yl)-2-bromoquinazoline,,,"16,17",obtained,,,"9,11",5.62 g,"14,15",79%
"Step 3 Synthesis of compound 61e The compound 61e (276 mg, 37%) was obtained by the similar synthesis of the step 6 of Example 1 using the compound 61d (725 mg, 1.00 mmol).","1,2",3,,,"8,9,5,6",61e 61e,,,,,"28,29",61d,,,"25,26,13,14",using obtained,,,"9,11",276 mg,"11,12",37%
"Intermediate 20: 2-Isopropylpyrazolo[4,3-b]pyridine To a suspension of 3-nitropyridine-2-carbaldehyde (200 mg, 1.3 mmol) in 1,4-dioxane (8.0 mL) were added isopropylamine (140 μL, 1.6 mmol) and 4 Å molecular sieves (400 mg). The reaction mixture was stirred at rt for 2 h. The reaction mixture was cooled to 10° C. and sodium cyanoborohydride (110 mg, 1.8 mmol) and acetic acid (120 μL, 2.1 mmol) were added. The reaction mixture was stirred at 10° C. for 30 min and then at rt for 20 h, followed by heating at 100° C. for 24 h. The reaction mixture was cooled to room temperature, filtered through a pad of Celite and evaporated. The residue was purified by FCC (SiO2; 50% EtOAc/hexanes) to afford the title compound as a dark yellow oil (46 mg, 22% yield).","1,2",20,"115,116,104,105,113,114",EtOAc Celite SiO2 hexanes,"2,3,119,121","2-Isopropylpyrazolo[4,3-b]pyridine title compound","49,51,56,58",sodium cyanoborohydride acetic acid,"13,14","1,4-dioxane","18,19,7,8",isopropylamine 3-nitropyridine-2-carbaldehyde,"97,99,86,88,70,72,46,48,78,79,36,37",room temperature 100° C 10° C 10° C rt rt,"17,18,63,64,117,118,68,69,44,45,84,85,34,35,99,100,110,111,95,96",added added afford stirred cooled heating stirred filtered purified cooled,"80,82,89,91,73,75,38,40",20 h 24 h 30 min 2 h,"126,128",46 mg,"128,129",22%
"Synthesis of 1-(5-chloropyridin-2-yl)-4-{3-[4-(difluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}pyrrolidin-2-one (Compound 62) (62-1) Synthesis of 1-[(4-methoxyphenyl)methyl]-5-oxopyrrolidine-3-carboxylic acid (Compound 62-1) A mixed solution of itaconic acid (2.6 g, 20 mmol) and (4-methoxyphenyl)methanamine (2.7 g, 20 mmol) in DMF (3 mL) was stirred at 100 °C for 22 hours. After cooling to room temperature, the solvent was evaporated off under reduced pressure, water (30 mL) was added to the obtained residue, and the mixture was stirred for 20 minutes to crystallize. The insolubles were collected by filtration followed by washing with water to obtain 4.5 g (yield 89 %) of the title compound","5,6",62-1,"2,3,53,54,82,83,4,5","1-(5-chloropyridin-2-yl)-4-{3-[4-(difluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}pyrrolidin-2-one water water 62","92,94,8,10,11,12",title compound 1-[(4-methoxyphenyl)methyl]-5-oxopyrrolidine-3-carboxylic acid 62-1,,,"29,30",DMF,"23,24,16,18",(4-methoxyphenyl)methanamine itaconic acid,"43,45,35,37",room temperature 100 °C,"84,85,33,34,57,58,41,42,80,81,66,67",obtain stirred added cooling washing stirred,"68,70,38,40",20 minutes 22 hours,"85,87",4.5 g,"88,90",89 %
"Example 10 To a suspension of 6-(2-aminothiazol-4-yl)-3,4-dihydroquinolin-2(1H)-one (0.100 g, 0.408 mmol) and 2-phenylthiazole-5-carboxylic acid (0.092 g, 0.448 mmol), and pyridine (0.15 mL, 1.832 mmol) in acetonitrile (4 mL) in a sealed tube was added propylphosphonic anhydride solution (50 wt % in ethyl acetate, 0.85 mL, 1.432 mmol). The sealed tube was heated to 48.5° C. for 4 days and the precipitation formed. After cooling, the precipitated solid was collected by filtration and washed with cold dichloromethane to give N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)-2-phenylthiazole-5-carboxamide (0.156 g, 88%) as a beige solid.","1,2",10,"75,76",dichloromethane,"78,79","N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)-2-phenylthiazole-5-carboxamide","34,36,19,20",propylphosphonic anhydride pyridine,"41,43,25,26",ethyl acetate acetonitrile,"6,7,12,14","6-(2-aminothiazol-4-yl)-3,4-dihydroquinolin-2(1H)-one 2-phenylthiazole-5-carboxylic acid","53,55",48.5° C,"51,52,33,34,77,78,72,73",heated added give washed,"56,58",4 days,"79,81",0.156 g,"81,82",88%
"Example 40 4-(5-Fluoro-1H-indol-3-yl)-N-[(1S)-2-hydroxy-1-methyl-ethyl]benzamide This compound was prepared from Intermediate 4 and (2S)-2-aminopropan-1-ol according to the procedure described in Example 1. Purification was performed using preparative HPLC to afford the title compound (9.5 mg, 30%). Data: LCMS (B) Rt : 9.308 min; m/z 313.1 (M+H)+.","1,2",40,,,"2,3,29,31",4-(5-Fluoro-1H-indol-3-yl)-N-[(1S)-2-hydroxy-1-methyl-ethyl]benzamide title compound,,,,,"11,12,8,10",(2S)-2-aminopropan-1-ol Intermediate 4,,,"6,7,27,28",prepared afford,,,"31,33",9.5 mg,"33,34",30%
"Step 4. 7-Bromo-2-(trifluoromethyl)imidazo[1,2-f][1,2,4]triazin-4-ol A solution of 2-(trifluoromethyl)imidazo[2,1-f][1,2,4]triazin-4-ol (1.46 g, 7.19 mmol) in DMF (25 mL) was treated with NBS (1.41 g, 7.91 mmol) for 1 h. The reaction mixture was diluted with water (100 mL), acidified to pH 2 using 1 N HCl, and was extracted with EtOAc twice. The combined organic extracts were washed with water (3×100 mL) and brine (100 mL), dried over Na2SO4, filtered and concentrated to afford a white solid (1.92 g, 95%). LCMS for C6H3BrF3N4O (M+H)+: calculated m/z=282.9, 284.9; found 283.0, 285.0.","1,2",4,"60,61,42,43,47,48,65,66,32,33,56,57",brine HCl EtOAc Na2SO4 water water,"73,74,2,3","solid 7-Bromo-2-(trifluoromethyl)imidazo[1,2-f][1,2,4]triazin-4-ol","18,19",NBS,"12,13",DMF,"6,7","2-(trifluoromethyl)imidazo[2,1-f][1,2,4]triazin-4-ol",,,"16,17,70,71,35,36,45,46,54,55,63,64,30,31",treated afford acidified extracted washed dried diluted,"24,26",1 h,"74,76",1.92 g,"76,77",95%
"Preparation of (R)-2-methyl-3-(2-((2,2,2-trifluoroethyl)amino)propyl)aniline 2,2,2-Trifluoroethyl trifluoromethanesulfonate (1.3 g, 2.8 mmol) was added to a stirred to solution of (R)-3-(2-aminopropyl)-2-methylaniline (0.460 g, 2.80 mmol; prepared according to Example 3) and diisopropylethylamine (0.636 mL, 3.64 mmol) in 1,4-dioxane (10 mL). The reaction was heated at 65° C. for 15 hours and then cooled and concentrated under reduced pressure. The resulting residue was dissolved in EtOAc (50 mL) and washed with a mixture of saturated aqueous NaHCO3 and saturated aqueous sodium chloride. The aqueous layer was extracted with EtOAc (20 mL), and the combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. The resulting residue was dissolved in MeOH, adsorbed onto diatomaceous earth under reduced pressure, and purified by flash silica chromatography, elution gradient 1 to 6% MeOH in DCM. Product fractions were concentrated to dryness to afford (R)-2-methyl-3-(2-((2,2,2-trifluoroethyl)amino)propyl)aniline (0.30 g, 44%) as a pale orange gum.",,,"111,113,72,73,129,130,120,121,84,85,76,78,95,96,71,72,127,128,108,109,75,76,61,62",diatomaceous earth NaHCO3 DCM silica EtOAc sodium chloride MgSO4 aqueous MeOH MeOH aqueous EtOAc,"2,3,138,139","(R)-2-methyl-3-(2-((2,2,2-trifluoroethyl)amino)propyl)aniline (R)-2-methyl-3-(2-((2,2,2-trifluoroethyl)amino)propyl)aniline","28,29",diisopropylethylamine,"34,35","1,4-dioxane","17,18,3,5","(R)-3-(2-aminopropyl)-2-methylaniline 2,2,2-Trifluoroethyl trifluoromethanesulfonate","42,44",65° C,"10,11,137,138,40,41,65,66,109,110,82,83,117,118,106,107,59,60,93,94",added afford heated washed adsorbed extracted purified dissolved dissolved dried,"45,47",15 hours,"139,141",0.30 g,"141,142",44%
"Example 34. (R)-3-((3-(ethyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)pyrrolidine-1-yl)sulfonyl)benzonitrile 67.0 mg of (R)-N-ethyl-N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine was added to a 5-mL round-bottomed flask and then dissolved with 1.45 mL of dichloromethane (CH2Cl2). After 60.5 mg of 3-cyanobenzenesulfonyl chloride was added to the solution, the reaction mixture was treated with 0.0500 mL of N,N-diisopropylethylamine and then stirred at room temperature for about 1 hour. The reaction mixture was concentrated under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=0:100→1:80→1:50). The resulting fraction was concentrated under reduced pressure and then further under vacuum. As a result, 84.3 mg of (R)-3-((3-(ethyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)pyrrolidine-1-yl)sulfonyl)benzonitrile was obtained with a yield of about 73.3%.","1,2",34,"73,74",CH2Cl2 MeOH,"93,94,2,3","(R)-3-((3-(ethyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)pyrrolidine-1-yl)sulfonyl)benzonitrile (R)-3-((3-(ethyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)pyrrolidine-1-yl)sulfonyl)benzonitrile","43,44","N,N-diisopropylethylamine","22,23,21,22",CH2Cl2 dichloromethane,"6,7,27,29","(R)-N-ethyl-N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine 3-cyanobenzenesulfonyl chloride","48,50",room temperature,"30,31,8,9,95,96,38,39,46,47,16,17,68,69",added added obtained treated stirred dissolved purified,"52,54",1 hour,"90,92",84.3 mg,"101,102",73.3%
"2-[4-hexyl-5-(trifluoromethyl-2-thienyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane A solution of 13.8 g (58.4 mmol, 1.00 eq) 3-hexyl-2-(trifluoromethyl)thiophene was cooled down to −78° C. and 25.7 ml (64.3 mmol, 1.10 eg, 2.50 mol/l) n-BuLi was added dropwise. After 30 min, 13.1 g (70.1 mmol, 1.20 eq) 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was added and stirring continued for 30 min. The cooling bath was removed and the reaction mixture stirred over night at room temperature. It was quenched with water and extracted three times with EtOAc. The combined organic layers were dried over Na2SO4 and evaporated. The crude product was purified by column chromatography (dichloromethane/n-hexane 1:4). A pale yellow oil was obtained (11.6 g, 55%). MS=362.3-hexyl-5-(3-hexyl-2-thienyl)-2-(trifluoromethyl)thiophene.",,,"67,68,73,74,92,93,81,82",3-hexyl-5-(3-hexyl-2-thienyl)-2-(trifluoromethyl)thiophene water n-hexane EtOAc dichloromethane Na2SO4,"97,98,0,1","oil 2-[4-hexyl-5-(trifluoromethyl-2-thienyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane","26,27",n-BuLi,,,"39,40,10,11","2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 3-hexyl-2-(trifluoromethyl)thiophene","61,63,15,17",room temperature −78° C,"57,58,99,100,12,13,28,29,43,44,41,42,69,70,88,89,79,80,65,66",stirred obtained cooled added stirring added extracted purified dried quenched,"46,48,31,33",30 min 30 min,"100,102",11.6 g,"102,103",55%
"Intermediate 8B (2-methoxy-5-(trifluoromethyl)pyridin-3-yl)methanol Ethyl 2-methoxy-5-(trifluoromethyl)nicotinate (59.54 g, 253 mmol) was dissolved in tetrahydrofuran (506 mL). After cooling to 5° C., a solution of lithium aluminum hydride (177 mL, 177 mmol) in tetrahydrofuran was added over 40 minutes, maintaining an internal temperature 10° C. After 1 hour, the reaction was quenched by the addition of 50 mL of acetone, diluted with methyl tert-butyl ether (300 mL) and stirred with 300 mL of saturated aqueous potassium sodium tartrate (Rochelle's salt) until two clear layers were present. The reaction mixture was extracted with ethyl acetate and the combined extracts were washed with brine, dried over sodium sulfate, filtered, and concentrated to provide a residue, which was purified by flash chromatography (0 to 30% ethyl acetate in heptane) to provide (2-methoxy-5-(trifluoromethyl)pyridin-3-yl)methanol (40.28 g, 194 mmol, 77% yield).","1,2",8B,"102,104,99,100,123,124,57,58,60,63,120,122,76,78,73,76,90,92,72,73",sodium sulfate brine heptane acetone methyl tert-butyl ether ethyl acetate Rochelle's salt potassium sodium tartrate ethyl acetate aqueous,"2,3,126,127",(2-methoxy-5-(trifluoromethyl)pyridin-3-yl)methanol (2-methoxy-5-(trifluoromethyl)pyridin-3-yl)methanol,"23,26",lithium aluminum hydride,"31,32,12,13",tetrahydrofuran tetrahydrofuran,"3,5",Ethyl 2-methoxy-5-(trifluoromethyl)nicotinate,"41,43,18,20",10° C 5° C,"16,17,33,34,37,38,10,11,125,126,66,67,58,59,113,114,100,101,88,89,52,53,97,98",cooling added maintaining dissolved provide stirred diluted purified dried extracted addition washed,"35,37,44,46",40 minutes 1 hour,"127,129,129,131",40.28 g 194 mmol,"131,132",77%
"Step 2: preparation of intermediate tert butyl N-[(1R)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-[methoxy(methyl)amino]-2-oxo-ethyl]carbamate (5b) To a solution of tert-butyl N-[(1R)-1-(hydroxymethyl)-2-[methoxy(methyl)amino]-2-oxoethyl]carbamate (5a) (5.42 g, 21.8 mmol), imidazole (4.46 g, 65.5 mmol) and DMAP (133 mg, 1.1 mmol) in anhydrous DMF (17 mL) at rt was portionwise added tert-butyldimethylsilyl chloride (3.95 g, 26.2 mmol). The mixture was stirred for 2 h then poured in H2O (50 mL). The aqueous layer was extracted with EtOAc (2 x 40 mL). The organic layer was washed with 1 M HCl (50 mL), brine (40 mL), dried over Na2SO4 and concentrated in vacuo. The residue was purified by flash chromatography on silica gel (cyclohexane/EtOAc 100/0 to 50/50) to provide tert-butyl N-[(1R)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-[methoxy(methyl)amino]-2-oxo-ethyl]carbamate (5b) (7.09 g, 19.5 mmol, 89%) as a colorless oil.","1,2",2,"100,102,87,88,79,80,102,103,66,67,82,83,57,58",EtOAc silica gel Na2SO4 HCl cyclohexane EtOAc brine H2O,"108,110,8,9,110,111,5,8",tert-butyl N-[(1R)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-[methoxy(methyl)amino]-2-oxo-ethyl]carbamate 5b 5b tert butyl N-[(1R)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-[methoxy(methyl)amino]-2-oxo-ethyl]carbamate,"26,27,20,21",DMAP imidazole,"33,34",DMF,"13,15,15,16,41,43",tert-butyl N-[(1R)-1-(hydroxymethyl)-2-[methoxy(methyl)amino]-2-oxoethyl]carbamate 5a tert-butyldimethylsilyl chloride,"37,38",rt,"50,51,40,41,107,108,75,76,55,56,95,96,85,86,64,65",stirred added provide washed poured purified dried extracted,"52,54",2 h,"111,113,113,115",7.09 g 19.5 mmol,"115,116",89%
"Example 9 Synthesis of (2S, 3R)-tert-butyl-3-methyl-2((R)-(4-methylphenyl)sulfonylthiazine-3-amin oformyl)valerate (Compound 9) The product (1.53 g, yield: 65%) as a white solid was prepared in accordance with the steps in Example 5, by using 1.31 g (7 mmol) L-isoleucine tert-butyl ester as Raw material 2. m.p. 80-82°C. 1H-NMR (400 MHz, CDCl3) δ: 7.76 (2H, d, J=8.41Hz), 7.37 (2H, d, J=8.40Hz), 7.01 (1H, d, J=8.67Hz), 4.78 (1H, t, J=3.40Hz), 4.47 (1H, m), 4.25 (1H, t, J=5.20Hz), 3.44 (1H, t, J=12.43Hz), 3.13 (1H, d, J=13.72Hz), 2.60-0.93 (24H, m). MS-EI (m/z): 471.1982[M+H]+.","1,2",9,"47,48",CDCl3,"8,9,4,7,10,11","9 (2S, 3R)-tert-butyl-3-methyl-2((R)-(4-methylphenyl)sulfonylthiazine-3-amin oformyl)valerate product",,,,,"35,38",L-isoleucine tert-butyl ester,,,"20,21,30,31",prepared using,,,"11,13",1.53 g,"14,15",65%
"(Comparative) Example 4: Synthesis of PQS (Compound 4) Synthesis of 1-chloro-2-nonanone (4a) 0.134 g Magnesium (5.54 mmol) and THF (5.5 ml) were stirred under an argon atmosphere.0.87 ml 1-Bromoheptane (4.85 mmol) was added and the reaction vessel was flushed with argon. The reaction was stirred for 1 h at room temperature and afterwards added to a solution of N-methoxy-N-methylchloroacetamide (0.500 g, 3.69 mmol) in toluene (5 ml) and THF (10 ml) at 0°C. The mixture was stirred at room temperature for 1.5 h. To this solution was added cold 2M HCl (5 ml) and the layers were separated. The aqueous phase was extracted with n-hexane (3x50ml). The combined organic layers were washed with Brine solution (3x50ml), dried over anhydrous MgSO4 and filtered. The solvent was evaporated and the product was purified by column chromatography on silica gel using hexane/ethyl acetate (9:1). The product was obtained as a yellow oil (m = 0.480 g, 74 %). Rf = 0.65 (hexane/ethyl acetate 9:1).","2,3",4,"7,8,40,41,119,120,113,114,90,91,25,26,135,137,5,6,104,105,138,139,158,159",ethyl acetate 4 argon MgSO4 Brine HCl ethyl acetate argon silica gel PQS n-hexane hexane hexane,"10,11,142,143,11,12",1-chloro-2-nonanone product 4a,"14,15",Magnesium,"68,69,64,65,18,19",THF toluene THF,"28,29,58,59",1-Bromoheptane N-methoxy-N-methylchloroacetamide,"78,80,49,51,72,73",room temperature room temperature 0°C,"22,23,38,39,53,54,32,33,76,77,44,45,144,145,130,131,87,88,116,117,111,112,102,103",stirred flushed added added stirred stirred obtained purified added dried washed extracted,"81,83,46,48",1.5 h 1 h,"151,153",0.480 g,"153,155",74 %
"(4) Preparation of tert-butyl 8-((2S,5R)-6-hydroxyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-3-azabicyclo[3.2. 1]octane-3-carboxylate Tert-butyl 8-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-3-azabicyclo[ 3.2.1]octane-3-carboxylate (0.5 g, 1.03 mmol) was dissolved in methanol (10 mL), and Pd/C (50 mg) was added. The reaction system was stirred and reacted at 25 °C under compressed hydrogen gas for 16 h, filtrated, and the filtrate was concentrated in vacuum to obtain the title compound in colorless form (0.37 g, yield 90.2 %).","0,1",4,,,"53,55,3,6","title compound tert-butyl 8-((2S,5R)-6-hydroxyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-3-azabicyclo[3.2. 1]octane-3-carboxylate","20,21,37,38",Pd/C hydrogen,"16,17",methanol,"6,9","Tert-butyl 8-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)-3-azabicyclo[ 3.2.1]octane-3-carboxylate","33,35",25 °C,"51,52,24,25,31,32,14,15",obtain added reacted dissolved,"40,42",16 h,"58,60",0.37 g,"61,63",90.2 %
"Step 4: Preparation of 5-formyl-2- trifluoromethylbenzonitrile Analogous to the process for preparing Compound g' in Step 4 in Example 14, Compound I' was reduced to produce Compound m': 5-formyl-2-trifluoromethylbenzonitrile (1.3 g, yield 96%). MS(ESI)m/z:200[M+1]+.","1,2",4,"13,14",g',"27,28,4,6,28,29",m' 5-formyl-2- trifluoromethylbenzonitrile 5-formyl-2-trifluoromethylbenzonitrile,,,,,"21,22",I',,,"23,24,25,26",reduced produce,,,"29,31",1.3 g,"32,33",96%
"Example 31 1-(2-(2,4-Dimethylthiazol-5-yl)ethyl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione Step 1 Methyl 2-(2,4-dimethylthiazol-5-yl) acetate 2-(2,4-Dimethylthiazol-5-yl)acetic acid (50.0 mg, 0.250 mmol) was dissolved in methanol (2 mL) and thionyl chloride (0.1 mL) was slowly added at 0°C. The reaction solution was slowly allowed to warm to room temperature and stirred for 2.5 hours. The reaction was quenched by addition of water (20 mL) and the reaction solution was extracted with ethyl acetate (20 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated under reduced pressure, and purified by high performance preparation plate (1:3 petroleum ether / ethyl acetate, Rf = 0.3) to give the product methyl 2-(2,4-dimethylthiazol-5-yl) acetate (32.0 mg, as a yellow liquid) with a yield of 70%.","4,5,1,2",1 31,"63,65,2,3,77,79,53,54,98,100,95,97","ethyl acetate 1-(2-(2,4-Dimethylthiazol-5-yl)ethyl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione sodium sulfate water ethyl acetate petroleum ether","5,8,107,110","Methyl 2-(2,4-dimethylthiazol-5-yl) acetate methyl 2-(2,4-dimethylthiazol-5-yl) acetate","21,23",thionyl chloride,,,"17,18,8,10","methanol 2-(2,4-Dimethylthiazol-5-yl)acetic acid","39,41,29,30",room temperature 0°C,"37,38,27,28,104,105,42,43,15,16,88,89,74,75,49,50,61,62",warm added give stirred dissolved purified dried quenched extracted,"44,46",2.5 hours,"110,112",32.0 mg,"120,121",70%
"Step 2. 4-Bromo-3-fluoro-5-methylaniline N-Bromosuccinimide (15.8 g, 89 mmol) was added to a solution of 3-fluoro-5-methylaniline (Combi-Blocks, 11 g, 88 mmol) in DMF (80 mL) cooled to 0° C. in an ice bath. The reaction mixture was stirred at 0° C. for 30 minutes. After warming to r.t., the reaction was stirred for an additional 1 hour. Water and EtOAc were then added, and the organic phase was washed with saturated aqueous NaHCO3 and brine. The organic phase was then dried over magnesium sulfate and the solvents were evaporated under reduced pressure. The crude product was purified by Biotage Isolera™ (17.2 g, 96%).","1,2",2,"81,83,70,71,56,57,58,59,71,72,73,74",magnesium sulfate aqueous Water EtOAc NaHCO3 brine,"2,3,93,94",4-Bromo-3-fluoro-5-methylaniline product,"3,4",N-Bromosuccinimide,"21,22",DMF,"14,15",3-fluoro-5-methylaniline,"38,40,26,28,46,47",0° C 0° C r.t.,"36,37,95,96,9,10,24,25,50,51,44,45,79,80,67,68,61,62",stirred purified added cooled stirred warming dried washed added,"41,43,54,56",30 minutes 1 hour,"99,101",17.2 g,"101,102",96%
"Intermediate 11 2-(tert-butyl)-5-methoxyisonicotinaldehyde Intermediate 11A 2-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)-5-methoxypyridine (2-Bromo-5-methoxypyridin-4-yl)methanol (Anichem; 0.500 g, 2.293 mmol), tert-butyldimethylsilyl chloride (TBDMS-Cl, 0.415 g, 2.75 mmol), and imidazole (0.234 g, 3.44 mmol) were stirred in CH2Cl2 (10 mL) for 3 days at room temperature. After this time, the mixture was diluted with CH2Cl2 and washed with water and brine. The organic layer was dried over Na2SO4, filtered, and concentrated in vacuo to provide the title compound 2-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)-5-methoxypyridine (0.660 g, 87% yield).","4,5,1,2",11A 11,"58,59,51,52,2,3,45,46,49,50",Na2SO4 brine 2-(tert-butyl)-5-methoxyisonicotinaldehyde CH2Cl2 water,"69,70,5,6,67,69",2-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)-5-methoxypyridine 2-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)-5-methoxypyridine title compound,"20,21",imidazole,"28,29",CH2Cl2,"6,7,14,15,12,14",(2-Bromo-5-methoxypyridin-4-yl)methanol TBDMS-Cl tert-butyldimethylsilyl chloride,"35,37",room temperature,"65,66,26,27,43,44,47,48,56,57",provide stirred diluted washed dried,"32,34",3 days,"70,72",0.660 g,"72,73",87%
